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Abstract
Numerous mutations in histone H3 lysine 4 (H3K4) and H3 lysine 36 (H3K36) mod-
ifying enzymes have been reported in human disease, yet the role of the H3K4 and
H3K36 residues in mammals remain unclear due to the clustered arrays of many his-
tone genes. Replication-dependent canonical H3 (H3.1/H3.2) exists as multiple gene
copies and supplies nucleosomes for packaging of newly synthesized DNA during
replication. The histone variant H3.3 differs from canonical H3 by only 4 to 5 amino
acids, which allow nucleosome assembly independent of DNA replication throughout
the cell cycle and in post-mitotic cells. In this study, I set out to investigate the role of
the K4 and K36 residues in the histone H3.3 variant, which is enriched at active regions
of the mammalian genome and encoded by two isolated genes; therefore amenable to
functional analysis. Using CRISPR-Cas9, I mutated the K4 or K36 residue of endoge-
nous H3.3 to unmodifable alanine (A) in mouse embryonic stem cells (ESCs) and
revealed that the K4A mutation, but not K36A, resulted in widespread gene expres-
sion changes and impairment of neuronal differentiation into glutamatergic neurons.
Furthermore, K4A resulted in significant H3.3 protein depletion at transcription start
sites and active enhancers of ESCs - without effects at other sites. Genomic regions de-
pleted of H3.3K4A showed concerted alterations of histone modifications (decreased
K27 acetylation and increased K4 methylation) regardless of gene expression changes.
In differentiated neurons, the K4A mutation impacted protein stability and resulted
in widespread proteasomal degradation of the mutant histone. Thus, H3.3K4 is re-
quired for site-specific nucleosome maintenance at regulatory regions, histone stability
and cellular differentiation of ESCs. H3.3K36 is not required for H3.3 deposition and
turnover inside coding regions, and the K36A mutation affected gene expression at
later stages of neurodevelopment. Furthermore, the K36A mutation globally depleted
H3K36 di-metylation levels in ESCs, which resulted in a spread of the repressive mark
H3K27me3, suggesting that H3K36 di-methylation is required to restrict the activity
of PRC2. This study demonstrates a direct link between a specific histone residue
(H3K4) and histone maintenance at promoters and enhancers, and that H3.3 provides
a platform for analyzing the role of histone residues in mammals.

Zusammenfassung
Zahlreiche Mutationen in Histon-Methyltransferasen, die H3 Lysin 4 (H3K4) und H3
Lysin 36 (H3K36) modifizieren können, liegen menschlichen Krankheiten zugrunde.
Trotzdem bleibt es unklar, welche Relevanz die Lysinreste H3K4 und H3K36 in Säugetieren
haben, weil die Histongene in zahlreichen Kopien innerhalb von sich wiederholen-
den Genclustern vorliegen. Die Replikations-abhängigen H3 Proteine (H3.1/H3.2)
werden von mehreren Genen kodiert, die während der Replikation die notwendi-
gen Nukleosomen bereitstellen um die neu synthetisierte DNA im Zellkern zu ver-
packen. Die Histonvariante H3.3 unterscheidet sich vom kanonischen H3 in nur 4
bis 5 Aminosäuren, welches es ermöglichen, dass Nukleosomen unabhängig von der
DNA Replikation während des gesamten Zellzyklus und auch in post-mitotischen
Zellen zusammengesetzt werden. In dieser Studie habe ich die Funktion von Lysin
4 und 36 in der Histonvariante H3.3 untersucht, welche vor allem in aktiven Regio-
nen des menschlichen Genoms angereichert ist und von nur zwei unabhängigen Gene
kodiert wird, was H3.3 zu einem passenden Kandidaten für eine funktionelle Anal-
yse macht. Mit Hilfe von CRISPR-Cas9 habe ich Lysin 4 oder Lysin 36 im endogenen
H3.3 von murinen embryonischen Stammzellen in einen unmodifizierbaren Alaninrest
(K4A/K36A) umgewandelt. So konnte ich zeigen, dass die K4A, aber nicht die K36A,
Mutation die Genexpression in Stammzellen umfassend beeinflusst und die neuronale
Differenzierung verhindert. Desweiteren hat die K4A Mutation eine signifikante Re-
duktion des H3.3 Proteins an Transkriptionsstartstellen und aktiven Enhancern zur
Folge, ohne dass es sein Vorkommen an anderen Stellen beeinflusste. Die Regionen des
Genoms, die von der Reduktion betroffen waren, zeigten abgestimmte Änderungen an
Histonmodifikationen (verminderte K27 Acetylierung und erhöhte K4 Methylierung),
die unabhängig von den Genexpressionsänderungen waren. In differenzierten Neuro-
nen hingegen beeinflusste die H3.3K4A Mutation die Histonstabilität und resultierte
in umfangreichen Abbau des mutierten Histons durch das Proteasomensystem. Da-
raus lässt sich schließen, dass H3.3K4 für die Erhaltung von Nukleosomen an regu-
latorischen Elementen, Histonstabilität und zelluläre Differenzierung von embryonis-
chen Stammzellen notwendig ist. H3.3K36 hingegen war nicht notwendig fuer die De-
position und den Austausch von H3.3 in Genen und die K36A Mutation beeinflusste
die Genexpression erst während der neuronalen Entwicklung. Desweiteren führte die
H3.3K36A Mutation zu einer umfassenden Verminderung der H3K36 Dimethylierung
und gleichzeitigen Ausbreitung von repressiver H3K27 Trimethylierung. Dies deutet
darauf hin, dass H3K36 Dimethylierung die Funktion hat die Aktivität von PRC2
einzuschränken. Diese Arbeit zeigt eine direkte Verbindung zwischen einem spezifis-
chen Histon Lysinrest (H3K4) und der Erhaltung von Histonen an Promotoren und
Enhancern auf. Mutationen in H3.3 bieten somit eine geeignete Plattform um die
Funktion von Histonresten in Säugetieren zu testen.

Acknowledgement
I would like to express my genuine appreciation for the guidance and support of my
supervisor, Kyung-Min Noh. I truly appreciate your constant encouragement and
dedication to this project. I have spent four memorable years at EMBL Heidelberg,
which have been full of opportunities and joy. I would also like to extend my gratitude
to the members of my TAC and PhD defense committees, Eileen Furlong, Frank Lyko,
Oliver Stegle, Judith Zaugg, Ingrid Lohmann, and Sandra Hake. Special thanks to
the members of the outstanding core facilities at EMBL Heidelberg (Gene Core, FACS,
Proteomics), especially to Malte Paulsen, Diana Ordonez and Vladmir Benes for their
time and expertise. Special thanks to Nichole Diaz for all her help and guidance in the
cell culture, and for being her amazing self. Also, I would like to thank Daria Bunina,
Simone Sidoli and Marlena Lübke for their efforts and contributions to this project.
And to the current and past members of the Noh group and the Genome Biology Unit
for helpful discussions and for providing such a great working environment.
I would also like to thank all my friends who supported and encouraged me and
made my time as a PhD student all the more enjoyable. There are so many precious
memories I share with you that I will not forget for the rest of my life. I want to thank
all my flatmates and friends back home who are simply the best thing to come home
to. Also, I want to thank Matthias who has always given me a reason to wake up in
the morning. Many thanks to my beloved sisters and grandma.
I dedicate this thesis to my parents who have always been there for me and helped me
in my education, I love you.

Contents Page
List of Figures
List of Tables
1 Introduction 1
1.1 Histones & Chromatin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Histone modifications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2.1 Histone Acetylation . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.2 Histone methylation . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.3 Properties of histone modifications . . . . . . . . . . . . . . . . . 4
1.3 Histone variants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.3.1 Histone H3 variants . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3.2 H3 in proliferating and quiescent cells . . . . . . . . . . . . . . . 9
1.3.3 Contributions of H3.3 to development and viability of multicel-
lular organisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.4 Chromatin assembly and remodeling . . . . . . . . . . . . . . . . . . . . 12
1.4.1 Chromatin assembly by histone chaperones . . . . . . . . . . . . 12
1.4.2 Chromatin remodeling . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.4.3 Histone turnover . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.5 Systems to probe the contribution of histone residues to nucleosome
function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
1.6 Aims & Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2 CRISPR-mediated gene editing of mammalian histone H3.3 23
2.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2.1 Delivery of Cas9 and guide into mouse embryonic stem cells . . 26
2.2.2 Optimization of CRISPR-Cas9 mediated gene editing in ESCs . . 26
2.2.3 High-throughput screening for CRISPR editing . . . . . . . . . . 28
2.2.4 Knockout of H3.3A . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.2.5 CRISPR off-target analysis for large chromosomal deletions . . . 33
2.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.4 Materials & Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3 Functional characterization of histone H3.3 mutants 46
3.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.2.1 Characterization of H3.3K4A and H3.3K36A mutant ESCs and
their developmental potential . . . . . . . . . . . . . . . . . . . . . 50
3.2.2 Impact of H3.3K4A and H3.3K36A mutations on gene expression
in ESCs and neurons . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.2.3 The epigenetic landscape of H3.3K4A and H3.3K36A mutants . 66
3.3 Discussion & Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.4 Materials & Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4 Supplementary Material 88
Bibliography 93
List of Figures
1.1 Structure of the nucleosome core particle . . . . . . . . . . . . . . . . . . 1
1.2 Post-translational modifications of the N-terminal histone tails . . . . . 3
1.3 Schematic genomic region depicting the distribution of histone modifi-
cations at promoters, enhancers, gene bodies and boundary elements. . 7
1.4 Post-translational modifications of the N-terminal histone tails . . . . . 8
1.5 Assembly pathways of histone H3 variants throughout the cell cycle. . . 13
1.6 Schematic representation of histone exchange at regulatory elements
and inside coding regions. . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.1 CRISPR-Cas9 mediated genome engineering. . . . . . . . . . . . . . . . . 24
2.2 Transduction efficiency in ESCs with a plasmid-based CRISPR system
using nucleofection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.3 Comparison of single-stranded and double-stranded DNA repair tem-
plates for CRISPR editing in untreated and Scr7-treated ESCs. . . . . . . 28
2.4 Mismatch qPCR screen detects CRISPR-mediated point-mutations in
H3.3B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.5 Sanger sequencing confirming the successful integration of nucleotide
changes into H3.3B at lysine 4 and 36. . . . . . . . . . . . . . . . . . . . . 31
2.6 Successful knock-out of H3f3a in CRISPR clones. . . . . . . . . . . . . . . 33
2.7 Prediction of chromosomal rearrangements from RNA-Sequencing data. 36
2.8 Comparison between RNA-Seq and DNA-Seq data in predicting chro-
mosomal rearrangements . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.9 Overview of CRISPR-editing workflow in mouse ESCs. . . . . . . . . . . 38
3.1 Experimental design to study the role of histone H3.3K4 and H3.3K36
residues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.2 Morphology of control and K4A/K36A mutant ESCs. . . . . . . . . . . . 51
3.3 Self-renewal of K4A/K36A mutant ESCs is maintained but K4A results
in slower cell growth during neuro-differentiation. . . . . . . . . . . . . 51
3.4 Cell cycle analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.5 H3.3K4A, but not K36A, results in erratic morphology during neuro-
differentiation from ESCs. . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.6 H3.3K4A and K36A induce distinct changes in transcription in ESCs and
neurons. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.7 Gene expression analysis of H3.3K4/K36A mutant ESCs. . . . . . . . . . 55
3.8 Gene expression analysis of H3.3K4/K36A mutant neurons. . . . . . . . 56
3.9 H3.3K4A affects the activation of developmental genes and repression
of pluripotency genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.10 H3.3K4A, but not K36A, is depleted at TSS and enhancers in ESCs. . . . 58
3.11 H3.3K4A is depleted at TSS, but not TES. . . . . . . . . . . . . . . . . . . 59
3.12 H3.3K36 and H3.3K4A are not required for histone turnover at TES. . . 60
3.13 H3.3K4A mutation does not affect deposition by chaperones. . . . . . . 61
3.14 Remodelers Chd1, Chd4, Chd8, Ep400, Smarca4 are enriched at regula-
tory regions and Chd1 displays a similar enrichment profile to H3.3 at
promoters in ESCs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.15 Lysine 4 residue is required for histone H3 protein stability in differen-
tiated neurons. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.16 H3.3K4A instability is noe due to lower expression of H3.3-specific chap-
erones. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.17 Lysine 4 residue is required for histone H3 protein stability in HEK293T
cells. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.18 H3.3K36A mutation reduces global levels of H3K36me2/me3 and H3K27ac,
and inversely increases H3K27me3 levels, whereas H3.3K4A mutation
reduces H3K4me3 levels. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.19 Turnover analysis of histone modifications in H3.3K36A mutants by
Mass Spectrometry. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.20 Splicing analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.21 H3.3K4A mutation induces histone modification changes at regulatory
elements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
S1 Gating strategy for Cas9-GFP-positive cells flow cytometry analysis. . . 88
S2 In vitro differentiation of ESCs into mature glutamatergic neurons. . . . 89
S3 Gating strategy for cell cycle analysis by flow cytometry. . . . . . . . . . 89
S4 Proteasomal degradation is not responsible for H3.3K4A depletion at TSS. 90
S5 Quality control of ChIP-Seq data. . . . . . . . . . . . . . . . . . . . . . . . 91
S6 Promoters and enhancers of differentially expressed and unchanged
genes are similarly affected by H3.3 depletion, but H3K27ac reduction
correlates with gene expression in H3.3K4A mutants. . . . . . . . . . . . 92
List of Tables
2.1 Summary of CRISPR editing screens to introduce point-mutations into
histone H3.3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
ATRX α-thalassemia/mental retardation X-linked
ATAC-seq Assay for Transposase-Accessible Chromatin using sequencing
bp base pair
CENP-A Centromere protein A
ChIP-Seq Chromatin immunoprecipitation coupled with DNA sequencing
ChIP Chromatin Immunoprecipitation
Ct Cycle treshold
D. Drosophila
Daxx Death-domain associated protein
DEG differentially expressed genes
DMEM Dulbecco’s modified Eagle’s medium
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic Acid
dNTP deoxynucleotidetriphosphate
EB embryoid body
E. Coli Escherichia Coli
e.g. exempli gratia
EDTA Ethylenediaminetetraacetic acid
ESC embryonic stem cell
GFP green fluorescent protein
FCS Fetal Calf Serum
FW Forward
HAT histone acetyltransferase
HDAC histone deacetylase
HDR homology-directed repair
HEK human embryonic kidney cells
HMT Histone methyltransferases
HMTase Histone methyltransferase
hrs hours
HP1 heterochromatin protein 1
i.e. id est
kbp kilo base pair
MEF mouse embryonic fibroblast
min minutes
Mll mixed-lineage leukemia
mRNA messenger-RNA
NGS next generation sequencing
NHEJ Non-homologous end-joining
NPC neural precursor cell
ORF Open Reading Frame
PCR Polymerase Chain Reaction
Pc Polycomb proteins
Pen/Strep Penicillin/Streptomycin
Pol II RNA Polymerase II
qPCR quantitative real-time PCR
RNA Ribonucleic Acid
RPKM reads per kilo base per million
RT Reverse Transcription
rt room temperature
RV Reverse
S. Saccharomyces
SAM S-adenosyl methionine
sec seconds
Seq Sequencing
SWI/SNF SWItch/Sucrose Non-Fermentable
TBE Tris-Borate-EDTA
TES transcription end sites
TSS transcription start sites
UCSC University of California Santa Cruz
UV Ultra Violet
1 | Introduction
1.1 Histones & Chromatin
In the nucleus of eukaryotic cells, histone proteins are tightly associated with DNA
molecules and the resulting DNA-protein complex is called chromatin. The fundamen-
tal repeating units of chromatin are the nucleosomes (Kornberg and Thomas, 1974). A
single nucleosome contains an octamer of the four core histone proteins - H2A, H2B,
H3, and H4 - around which a DNA segment of 146 bp is wound (Luger et al., 1997).
(Fig. 1.1). The linker histone, H1, interacts with DNA between nucleosomes.
Figure 1.1: Structure of the nucleosome core particle. DNA of 146 bp (brown and green) is wrapped
around an histone octamer consisting of H3 (blue), H4 (lightgreen), H2A (yellow), H2B (red). The un-
structured histone tails are protruding from the nucleosome core. Nucleosome particle is viewed down
the DNA superhelix axis (left) and perpendicular to it (right). Image was taken from Luger et al. (1997).
The association with histones compacts long DNA molecules to fit into the nucleus of
cells, which is only 10-20 micrometres in size. Each human cell contains roughly 2 me-
ters of linear DNA, but the packaging into nucleosomes shortens the molecule length
about sevenfold and further coiling results in an even shorter chromatin fiber with
a diameter of approximately 30 nanometers (Annunziato, 2008). Despite their signifi-
cant role in packing DNA, histones are much more than just static scaffolding proteins,
and many discoveries in recent years have shown that they act as modulators of essen-
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tially all DNA-related processes, including transcription, DNA replication and repair
(Kouzarides, 2007). Transcription and replication require that polymerases, enzymes
that read and copy DNA, can access the DNA template directly, but chromatin com-
paction and nucleosomes present barriers to these processes (Li et al., 2007). Therefore,
cells require reversible mechanisms for opening up chromatin structure, and these are
often regulated by the packaging histones themselves. Histones exhibit at least three
dynamic properties that regulate accessibility of the underlying DNA:
1. Histones can be enzymatically modified (e.g. by the addition of acetyl, methyl,
phosphate or other groups) (Kouzarides, 2007).
2. Histones are diversified by many histone variants, which can confer specific struc-
tural and functional properties to the nucleosome (Talbert and Henikoff, 2010; Henikoff
and Smith, 2015).
3. Histones can be displaced or shifted by chromatin remodeling complexes, thereby
exposing underlying DNA sequences to polymerases and other enzymes (Narlikar
et al., 2013).
These properties are dynamic and reversible because modified or variant nucleosomes
can be displaced from chromatin, and higher-order chromatin can be re-established
after transcription or replication is completed by protein complexes that facilitate com-
paction.
1.2 Histone modifications
Histone proteins are basic proteins, which allows them to tightly interact with the
negatively charged phosphate backbone of a DNA molecule. Structural analysis of
nucleosomes has revealed that the histone octamer forms a core nucleosome parti-
cle around which the DNA is wrapped (Fig. 1.1). While the histone core is folded
and difficult to access, the histone N- and C-terminal tails are unstructured and pro-
trude from the nucleosome core, making them the most accessible parts of histones
(Luger et al., 1997). The N-terminal tails contain many modifiable residues and are
the most heavily modified part of histones (Fig. 1.2), but some modifications have also
been detected within the globular core (Masumoto et al., 2005; van Leeuwen et al.,
2002; Lawrence et al., 2016). The N-terminal tail of histone H3 features the most ex-
tended tail sequence with more than 30 known modification events (Bannister and
Kouzarides, 2011; Kouzarides, 2007). Often it is the occurence of multiple modifica-
tions that define a distinct chromatin state and they have been proposed to exert their
effects via diverse mechanisms. Histone acetylation and methylation are relevant for
the content of this thesis and their biological functions are described below in more
detail, followed by a general description of the properties of histone modifications.
2
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Figure 1.2: Schematic representation of post-translational modifications of the N-terminal histone
tails. Commonly modified histone residues (K = lysine, R = arginine, S = serine, T = threonine) are
depicted and the position of the modified amino acid is shown in black. Image taken from Lawrence
et al. (2016).
1.2.1 Histone Acetylation
Acetylation of lysines is highly dynamic and regulated by the opposing action of
two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases
(HDACs) (Bannister and Kouzarides, 2011). HATs catalyse the transfer of an acetyl
group from the cofactor acetyl-CoA to the ε-amino group of lysine residues. This
neutralizes lysine’s positive charge and has the potential to reduce the electrostatic
interactions between histones and DNA. Generally, HATs are less specific and often
modify multiple residues within the histone N-terminal tails. Thanks to their ability
to destabilize nucleosomes, HATs are considered to act as transcriptional coactiva-
tors. HDAC enzymes oppose the effects of HATs and reverse lysine acetylation, an
action that restores the positive charge of the lysine. This potentially stabilizes the
nucleosome, which is consistent with HDACs being predominantly transcriptional
repressors.
1.2.2 Histone methylation
Histone methylation occurs on the side chains of lysines and arginines and it is diver-
sified by the fact that lysines may be mono-, di- or tri-methylated, whereas arginines
may be mono- and di-methylated (symmetrically or asymmetrically) (Bannister and
Kouzarides, 2011; Hyun et al., 2017). Unlike acetylation and phosphorylation, histone
3
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methylation does not alter the charge of the histone protein. Histone methyltrans-
ferases (HMTases) catalyse the transfer of a methyl group from S-adenosyl methion-
ine (SAM) to a lysine’s ε-amino group. Most HMTases methylate lysines within the N-
terminal tails and are highly specific for their substrate. Strikingly, all of the HMTases
that methylate N-terminal lysines contain a so-called SET domain that harbours the
enzymatic activity (Dillon et al., 2005) with the only exception of the Dot1 enzyme
that methylates H3K79 within the histone globular core and does not contain a SET
domain (Feng et al., 2002). Lysine demethylases, which reverse the action of HMTases,
also possess a high level of substrate specificity with respect to their target lysine.
They are also sensitive to the degree of methylation, and often only demethylate one
specific state (e.g. dimethylation), whereas other enzymes are capable of demethylat-
ing all states. Remarkably, lysine methylation is recognized by more distinct domain
types than any other modification, which could be attributed to the modification’s di-
versity and importance. Domains that promote protein binding to methylated lysines
in the tail region of histone H3 include PHD fingers or the so-called Tudor ’royal’ fam-
ily of domains (comprising Tudor, PWWP, chromodomains, and MBT domains) (Lu
and Wang, 2013; Kim et al., 2006; Champagne and Kutateladze, 2009; Maurer-Stroh
et al., 2003). Proteins associated with the remodeling and manipulation of chromatin
often contain chromodomains and famous examples include transcriptional repres-
sors HP1, recruited to heterochromatin by recognition of tri-methylated H3K9 by its
chromodomain (Lachner et al., 2001; Bannister et al., 2001). Whereas histone acetyla-
tion is mostly associated with open chromatin, histone methylation can recruit both
transcriptional activators and repressors.
1.2.3 Properties of histone modifications
Histone modifications can change the overall charge of histone proteins, thus mod-
ulating the interaction with DNA.
Acetylation and phosphorylation of residues introduce negative charges to histones,
which can disrupt electrostatic interactions between histones and DNA. This presum-
ably destabilizes histones and opens chromatin structure, thereby facilitating DNA
access to the transcriptional machinery or other chromatin binding complexes (Ban-
nister and Kouzarides, 2011).
Modification can act indirectly by regulating the recruitment of specialized effector
enzymes which change chromatin structure.
The effector proteins contain specialized domains that recognize and bind a distinct
modification state of histone N-terminal tail residues, and bring upon a certain down-
stream effect. In general, activating modifications attract chromatin remodelers and
basal transcription factors to promote transcription. For example, the recognition of
acetylated histone tails by specialized bromodomains is often the prerequisite for as-
sociation of chromatin remodeling complexes to nucleosomes, which can then open
4
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chromatin structure (Winston and Allis, 1999). This includes the SWI/SNF-remodeller
ATPases that contain a bromodomain that binds acetylated histone tails (Hassan et al.,
2002). Repressive modifications generally deter basal transcription factors and attract
proteins that promote chromatin packaging and compaction. This is the case for the
transcriptional repressor HP1, which is recruited to heterochromatin by recognition of
tri-methylated H3K9 by its chromodomain (Bannister et al., 2001; Lachner et al., 2001).
Several chromatin-associated factors interact with modified histone tails via multiple
domains, whereas others have specific domains within them that allow the simulta-
neous recognition of several modifications and other nucleosomal features (Lawrence
et al., 2016).
Histone modifications can confer epigenetic memory.
Histone modifications are stable marks that can potentially be inherited and main-
tained through mitosis (Probst et al., 2009; Almouzni and Cedar, 2016). During repli-
cation, DNA molecules are decompacted and pre-established chromatin structure is
lost. At replication forks, polymerases require direct access to the DNA template,
which requires the transient disruption of histone-DNA interaction of nearby nucle-
osomes. Parental histones can be recycled and segregated onto nascent DNA behind
the replication fork, and gaps are filled by replication-dependent de novo deposition
of new histones (Groth et al., 2007). This opens a window of opportunity during
S-phase for cells to switch to another lineage as required during differentiation or
development, or to stay commited to the same lineage as the mother cell by maintain-
ing chromatin states. For the maintenance of histone modifications, parental histones
could be used as a template that promote the modification of new histones in the
daughter cells. If parental and new histones are distributed randomly on nascent
DNA, the copying of modification from neighboring parental histones to new histones
can help in re-establishing chromatin states that maintain cell identity (Probst et al.,
2009). Conversely, unequal distribution of parental histones carrying modifications
might allow developmental decisions and lineage specifications. These mechanisms
are effective in regions where many nucleosomes carry the same histone modification,
particularly heterochromatic regions that are marked by repressive H3K9me3 that is
recognized by HP1 protein (Bannister et al., 2001; Lachner et al., 2001). However, par-
ticular marks are restricted to few nucleosomes, which is often observed for histone
marks at regulatory regions. Such modifications might be more difficult to transmit
through mitosis, or they require different mechanisms for inheritance, such as splitting
of histone tetramers between dividing cells (Xu et al., 2010).
Histone modifications define chromatin regions.
Eukaryotic genomes are roughly divided into two distinct chromatin environments:
A relatively relaxed and accessible compartment, containing most regulatory regions
and active genes, referred to as euchromatin; and a relatively compact compartment,
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containing transcriptionally repressed regions such as centromeres and telomeres, and
many of the inactive genes, referred to as heterochromatin (Jenuwein, 2001). However,
it should be noted that this view is simplified, and more genomic domains have been
defined to describe chromatin architecture in vivo (de Wit et al., 2008; Filion et al., 2010).
Nevertheless, these two main compartments are enriched with certain histone modifi-
cations, whereas they seem relatively devoid of other modifications (Fig. 1.3). Faculta-
tive or constitutive heterochromatin is marked by specific histone modifications, such
as H3K9me2, H3K9me3, and H3K27me3 (Kharchenko et al., 2011), and it can form at-
tachments between chromosomes and the nuclear envelope (Hochstrasser et al., 1986),
which is a repressive environment (Pickersgill et al., 2006). Euchromatin is associated
with other modifications than heterochromatin, and regions inside euchromatin that
regulate transcription or sites of active transcription are rich in multiple modifications.
For instance, active enhancers contain relatively high levels of H3K4me1 and the tran-
scriptional start sites (TSS) of active genes possess a high enrichment of H3K4me3
(Heintzman et al., 2007; Barski et al., 2007; Schneider et al., 2004). Similarly, histone
acetylation is associated with active regulatory regions and H3K27ac is detected at
both active enhancers and TSS (Wang et al., 2008; Rada-Iglesias et al., 2011; Bonn et al.,
2012; Creyghton et al., 2010). In addition, H3K36me3 is highly enriched throughout
the entire transcribed region (Bannister et al., 2005). On-going research is trying to
unravel how some enzymes are recruited to specific locations and how different mod-
ifications are integrated in order to regulate DNA processes such as transcription or
gene repression.
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Figure 1.3: Schematic genomic region depicting the distribution of histone modifications at promot-
ers, enhancers, gene bodies and boundary elements. Euchromatin is enriched for histone modifications
associated with active regulatory elements (promoters and enhancers) and actively transcribed regions.
Active promoters are commonly marked by H3K4 methylation (H3K4me2/me3), acetylation (ac), and
the histone variant H2A.Z. Enhancers are relatively enriched for H3K4me1, H3K4me2, H3K27ac and the
histone acetyltransferase p300. Transcribed regions are enriched for H3K36me3 and H3K79me2. CTCF
is commonly found at boundary elements that act as insulators between different functional elements.
Repressed genes inside heterochromatin are often located inside large domains marked by H3K9me2
and/or H3K9me3 or H3K27me3. Image is taken from Zhou et al. (2011).
1.3 Histone variants
Like histone modifications, the use of histone variants contributes to the regulatory
repertoire of chromatin. Differences in the amino acid sequence and most impor-
tantly different expression and deposition patterns throughout the cell cycle allow for
their specialized features. Characterization of histone variants is still ongoing, and
the functions of some specialized histone variants have been well characterized. Fa-
mous examples include CENP-A, a histone H3 variant that substitutes for histone H3
specifically in nucleosomes of centromeric chromatin and that has unique properties
essential for centromere function, kinetochore assembly and chromosome segregation
during mitosis (Dunleavy et al., 2005). Or H2A.Z, a H2A variant which is incorpo-
rated into and destabilizes nucleosomes at promoter region, thereby promoting gene
activation (Zlatanova and Thakar, 2008; Bonisch and Hake, 2012; Zhang et al., 2005; Jin
et al., 2009). In the following, I would like to focus on the histone variant H3.3 and its
canonical counterparts H3.1/H3.2, because it is relevant for the content of this thesis.
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1.3.1 Histone H3 variants
In animals, two main classes of histone H3 genes encode distinct H3 proteins: the
‘canonical’, replication-dependent histone H3 (H3.1 and H3.2) and the replication-
independent histone variant H3.3 (Elsaesser et al., 2010). These variants, expressed at
distinct times during the cell cycle, do not impart any considerable structural alter-
ation to the nucleosomes, but contribute to the chromatin assembly and the genomic
localization of nucleosomes.
Figure 1.4: Schematic overview of protein sequences and genes of histone H3 variants in animals
and yeast. (a) Alignment of the histone H3 protein sequences in mammals, Drosophila, Trichoplax and
two yeast species. The amino acids that distinguish the H3 variants are indicated, and dots indicate
additional differences in yeast. H3.3 varies from H3.1/H3.2 at serine 31 in the histone tail and in three
amino acids 87-90 in the histone core. Histone H3.1 is specific to mammals and varies from H3.2 in
one amino acid at position 96. Yeast species only have one H3 protein. (b) Phylogenetic analysis of the
H3 variants suggest that yeast H3 is an H3.3-like protein and displays a higher similarity in its coding
sequence to the H3.3 variant than to H3.1/2 in animals. (c) Overview of the genes encoding H3 proteins
in the indicated species. The number of H3 genes have expanded greatly from yeast and basal animals
(Trichoplax) to higher-order species such as Drosophila and mammals. Image and analysis was obtained
from Elsaesser et al. (2010).
Replication-dependent canonical H3
The majority of histones are synthesized during S phase for rapid deposition behind
replication forks in order to package replicating DNA. These histones are generally
referred to as canonical or replication-dependent (RD) histones. In higher eukaryotes,
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canonical histone H3 genes, together with those of H2A, H2B, and H4, occur as multi-
ple copies inside histone clusters. Increasing copy numbers of canonical histone genes
in evolution indicate that histone clusters have expanded to supply sufficient nucle-
osomes to package increasingly larger genomes. The genes of canonical histone are
short, intronless genes that lack a poly(A) tail, but instead have a conserved 3’ stem
loop (Elsaesser et al., 2010). These common features are likely to be responsible for a
regulated expression of canonical histones during S-phase in a replication-dependent
manner (Harris et al., 1991). In mammals one can distinguish between two canoni-
cal H3 variants: H3.1 and H3.2, which only differ by a single amino acid (Fig. 1.4a).
H3.2 is shared by all animals, whereas H3.1 variant additionally occurs exclusively in
mammals, thus arguing for a later evolutionary separation (Postberg et al., 2010).
Replication-independent histone variant H3.3
The third H3 protein is histone variant H3.3. Two distinct genes encode mammalian
H3.3 (H3.3A and H3.3B) that are located outside of histone cluster, contain introns,
and give rise to classical polyadenylated mRNAs. Unlike canonical H3, the expres-
sion of H3.3 genes is cell-cycle-independent and H3.3 serves as a substrate for both
replication-dependent deposition and histone replacement processes that occur out-
side of S phase (Elsaesser et al., 2010). Overall, the amino acid sequence of H3 is
mostly conserved, with only few amino acids distinguishing H3.3 from its canonical
counterparts (5 amino acid positions are different to H3.1) (Fig. 1.4a). The first dif-
ference is amino acid variation in residues 87–90 of the histone core region ("AAIG"
vs. "SAVM"), which is necessary for assembly of H3.3 into nucleosomes by histone
chaperones such as Hira (discussed in section 1.4). The second difference is a substi-
tution in the N-terminal tail at residue 31 (“A” vs “S”). This change is not required
for selective deposition, but may be an important site for mitosis-specific phosphory-
lation (Hake et al., 2005). In yeast species S. cerevisiae and S. pombe, all H3 genes,
apart from centromeric CENP-A, encode for only one H3 variant that shares higher
sequence similarity with H3.3 than with canonical H3 (Fig. 1.4b). Therefore, phy-
logenetic analysis has suggested that H3.3 and yeast H3 share a common ancestor
(Fig. 1.4b), which gave rise to all H3 variants in all opisthokonts (animals, fungi,
and eukaryotic microorganisms) (Postberg et al., 2010; Elsaesser et al., 2010). With in-
creasing genome complexity during evolution, ancestral H3 genes are thought to have
expanded and formed the canonical histone clusters to supply sufficient nucleosomes
during replication for packaging of increasingly larger genomes (Fig. 1.4c).
1.3.2 H3 in proliferating and quiescent cells
In proliferating cells, the canonical H3.1 and H3.2 represent the dominant isoforms
and H3.3 contributes approximately one fourth of the total pool of histone H3 (McKit-
trick et al., 2004; Maze et al., 2015). This amount of H3.3 would still be sufficient to
package essentially all actively transcribed genes (McKittrick et al., 2004) and based
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on the observations that specifically H3.3 contains modifications associated with tran-
scriptionally active chromatin, it has been proposed that H3.3 “barcodes” regions of
active chromatin (Hake and Allis, 2006) in proliferating cells. Chromatin immuno-
precipitation coupled with DNA sequencing (ChIP-Seq) have allowed a more detailed
map of H3.3 deposition, revealing specific H3.3 incorporation throughout the gene
body of transcribed genes as well as into promoter regions in dividing Drosophila and
mammalian cells (Wirbelauer et al., 2005; Mito et al., 2005, 2007; Goldberg et al., 2010).
H3.3 enrichment has also been observed at promoters of inactive genes, which could
indicate that these promoters are in a poised state (Mito et al., 2007; Tamura et al.,
2009). Furthermore, H3.3 enrichment also occurs at genic and intergenic regulatory
regions in animals, such as enhancers (Goldberg et al., 2010; Mito et al., 2007). There-
fore, H3.3 enriched foci occur at active chromatin regions in dividing cells.
When cells exit the cell cycle and differentiate, they no longer produce or incorpo-
rate replication-dependent histones, but require a continuous supply of histones to
compensate for nucleosome displacement during transcription and other DNA-related
processes. Especially neurons, which are formed early during embryonic development
and remain in a non-proliferating state for years, accumulate H3.3-containing nucle-
osomes (Maze et al., 2015). Indeed, H3.3 constitutes around 90% of all H3 protein
in brains of adult mice and rats (Pina and Suau, 1987). Consequently, replication-
independent H3.3 is deposited in all chromatin types and becomes the predominant
H3 variant in non-proliferating cells (quiescent, G1, and G2 cells) (Maze et al., 2015).
Even though a detailed map of H3.3 enriched loci in aged brain by ChIP-Seq is not
available yet, it may resemble the broad and even distribution of canonical H3 with no
or few enriched foci.
1.3.3 Contributions of H3.3 to development and viability of multicellular
organisms
Loss-of-function and replacement studies for genes encoding H3 variants or its chap-
erones have proven insightful to identify their contribution to animal viability and
development in Drosophila and mammals.
Drosophila melanogaster
Individual homozygous disruption of either one of the H3.3 genes in Drosophila (H3.3A
and H3.3B) has little phenotypic effect on the overall organism. In contrast, combined
disruption of both genes results sterility in both sexes and slightly reduced viability,
but with no obvious morphological defects in adult flies (Hodl and Basler, 2009; Sakai
et al., 2009). Viability, but not sterility, can be rescued by replacement of H3.3 with
canonical H3, now expressed outside of S-phase. Vice versa, replacement of canoni-
cal H3 with H3.3 does not result in any impairment. Similary, the histone chaperone
Hira, which deposits H3.3 into chromatin (discussed in more detail in section 1.4),
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is also essential for fertility. Specifically, during fertilization it helps in decondensing
paternal chromatin by assembling H3.3-containing nucleosomes in the male pronu-
cleus (Bonnefoy et al., 2007; Loppin et al., 2005). In Drosophila, both Hira and H3.3 are
required for fertility and for transcriptional regulation of specific genes, but not for
viability in development and adult animals (Bonnefoy et al., 2007; Hodl and Basler,
2009; Nakayama et al., 2007; Sakai et al., 2009). Furthermore, histone H3 variants can
replace each other in both replication-dependent and replication-independent chro-
matin assembly (Sakai et al., 2009).
Mammals
Loss-of-function studies of H3.3 have disrupted one of the two H3.3-encoding genes
(H3f3a or H3f3b) successfully in mice (Bush et al., 2013; Couldrey et al., 1999; Tang et al.,
2013; Jang et al., 2015). One study by Jang et al. (2015) found that regardless which
H3.3 gene was removed, mice were normal and fertile in both sexes, suggesting that
both H3.3 genes are not required for completion of a mouse life cycle. In other studies,
disruption of either H3f3a or H3f3b results in developmental defects, partial neonatal
lethality, and reduced fertility (Tang et al., 2013, 2015). The discrepancy between stud-
ies in regard to viability and fertility in single-gene knockouts is likely due to genetic
background differences. A mixed background (mainly C57BL/6 and 129) and result-
ing genetic heterogeneity may have contributed to the better viability and fertility of
knockouts as a result of hybrid vigor (Jang et al., 2015). In spite of this, all studies
conclude a partial redundancy of H3.3 genes and that only one gene is absolutely re-
quired for mouse development, viability and fertility. In contrast, complete removal
of both H3.3 genes results in severe developmental retardation and early embryonic
lethality (Roberts et al., 2002). Similarly, knockdown of both H3.3 genes leads to early
embryonic developmental arrest, chromosome missegregation, and chromatin conden-
sation (Lin et al., 2013). At the cellular level, H3.3 loss triggers cell cycle suppression
resulting in reduced cell proliferation and increased cell death (Jang et al., 2015). In
mouse embryonic stem cells (ESCs) H3.3 has been shown to be required for proper
establishment of repressive histone marks at the promoters of developmentally regu-
lated genes, thereby contributing to their silencing in vitro (Banaszynski et al., 2013).
However, embryonic patterning and marker gene expression patterns remain intact in
double-knockout mutant embryos (that rarely survive post-implantation), suggesting
that H3.3 is not absolutely required for transcriptional regulation of developmental
genes in vivo. In line with this, loss of Hira in mice causes defects in early embryogen-
esis (Roberts et al., 2002). Hira-deficient mouse ESCs or human cells show a dramatic
reduction in H3.3 incorporation into genes and regulatory elements, but display only
minor transcriptional defects (Goldberg et al., 2010; Ray-Gallet et al., 2002). In mam-
mals, H3.3 and its chaperone Hira are absolutely required for embryonic development
and animal’s survival. Thus, the presence of different H3 species seems more im-
portant in mammals than in Drosophila and different chromatin assembly pathways
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can only partly compensate for each other. However, more experimental evidence is
needed to confidently assess the contributions of each H3 variant.
1.4 Chromatin assembly and remodeling
The bulk of newly synthesized histones are incorporated during DNA replication, a
process that requires both the making and breaking of nucleosomes. But also outside
of S-phase nucleosomes are continuously displaced to create sites of accessible DNA
required for recruitment of transcription factors or to allow passage of transcribing
RNA polymerases (Venkatesh and Workman, 2015). In eukaryotic cells, the assem-
bly and disassembly of nucleosomes accompanying genomic processes are complex
operations involving many steps and proteins of various functions. Histone chaper-
ones play a crucial role in these processes, but their function is intimately coupled
to the making and breaking of histone-DNA interactions by chromatin remodeling
complexes. In the following, I want to give a brief summary on how nucleosome
turnover, assisted by histone modifications and histone variants, can establish or alter
the regional properties of chromatin, restructure higher-order chromatin and provide
accessible DNA templates for cellular machinery.
1.4.1 Chromatin assembly by histone chaperones
Histone chaperones are a diverse family of histone-binding proteins that prevent non-
nucleosomal interactions between histones and DNA. They are involved at multiple
steps after histone synthesis to sequester core histones from DNA until they can be
properly assembled into nucleosome, which is the energetically most favorable confor-
mation (Ransom et al., 2010). Histone chaperones must also ensure timely reassembly
of chromatin following unwinding and separation of DNA strands during replication
and transcription (Winkler and Luger, 2011; Gurard-Levin et al., 2014). Eukaryotes
have evolved specific histone chaperones for one or more histone variants and possi-
bly even specific chaperones for the recycling of old histones versus incorporation of
newly synthesized histones. Deposition of the canonical histone H3 is coupled to DNA
synthesis during replication and possibly DNA repair, whereas histone variant H3.3
serves as the replacement variant for the replication-independent deposition pathway
(Fig. 1.5). Several histone chaperone complexes involved in these distinct chromatin
assembly pathways have been characterized and they are largely conserved from yeast
to mammals. In yeast, the precise role of many chaperones is partially obscured by
the functional redundancy between them, whereas in other organisms many of the
chaperones are essential, highlighting their critical role in biology.
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Figure 1.5: Assembly pathways of histone H3 variants throughout the cell cycle. Canonical H3.1/H3.2
are mainly expressed and assembled into nucleosomes in a replication-dependent manner during S-
phase by the histone chaperone CAF-1. Variant H3.3 can additionally be deposited onto chromatin
outside of S-phase by the chaperone complexes Hira and ATRX/Daxx. Hira mediated H3.3 deposition
into genic regions, whereas ATRX/Daxx predominantely assembly H3.3 into nucleosomes at repetitive
heterochromatic sites. The replication-independent assembly of H3.3 results in accumulation of H3.3 in
nucleosomes of post-mitotic cells such as neurons compared to highly proliferative ESCs. The chaperone
FACT destabilizes and reassembles nucleosomes during transcription by Pol II.
1.4.1.1 Replication-dependent assembly of canonical H3
The bulk of newly synthesized canonical histones are incorporated during DNA repli-
cation by CAF-1 (chromatin assembly factor 1) (Smith and Stillman, 1989; Burgess
and Zhang, 2013). CAF-1 acts as a histone chaperone that facilitates the incorpora-
tion of two dimers, or one tetramer, of H3-H4 onto replicating DNA as a first step in
nucleosome assembly (Tagami et al., 2004). Histones H2A-H2B can bind to this chro-
matin precursor subsequent to DNA replication to complete the nucleosome (Krude,
1995; Gurard-Levin et al., 2014). Similarly, nucleosome disassembly, the reversal of the
assembly process, is initiated with partial DNA unwrapping and loss of H2A–H2B
dimers, followed by the loss of the H3–H4 tetramer from the DNA. In agreement with
this model, H3-H4 dimers have been shown to be much more stably associated with
DNA than H2A-H2B dimers (Kireeva et al., 2002; Kulaeva et al., 2010). But at the same
time, the exchange of any nucleosomal histone contained within the H3-H4 tetramer
for a new histone would require disassembly of the entire nucleosome.
1.4.1.2 Replication-independent assembly of H3.3
Histone variant H3.3 is expressed and can be deposited either during DNA repli-
cation or in a replication-independent (RI) manner throughout the cell cycle (Ah-
mad and Henikoff, 2002; Wu et al., 1982). The chaperone systems responsible for
replication-independent deposition of newly synthesized H3.3 are the Hira complex
and Atrx/Daxx complex. Both complexes recognize the H3.3 variant region “AAIG”
in the histone core (Ricketts et al., 2015; Ahmad and Henikoff, 2002), but mediate
deposition into different genomic regions.
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The Hira complex
The Hira complex deposits H3.3 (Tagami et al., 2004) into euchromatic regions such
as promoters, gene bodies and cis-regulatory elements (enhancers), and into transient
nucleosome free regions (Goldberg et al., 2010; Ray-Gallet et al., 2011). The loss of
Hira results in a dramatic reduction of H3.3 incorporation at promoters and gene
bodies, but not at many intergenic transcription factor binding sites (Goldberg et al.,
2010). This suggests that H3.3 can be deposited by other (unknown) chaperones or
chaperone-independent pathways specifically into nucleosomes at regulatory regions.
Hira-mediated deposition throughout the cell cycle is specific to H3.3 and cannot be
extended to canonical H3 (Ray-Gallet et al., 2011). On the other hand, in the absence
of replication-dependent H3 deposition by CAF-1, Hira can also deposit H3.3 at sites
of DNA replication in human cells (Ray-Gallet et al., 2011).
The ATRX/Daxx complex
The ATRX/Daxx complex mediates H3.3 deposition into repetitive heterochromatin,
such as retrotransposons, pericentromeric and telomeric regions (Lewis et al., 2010;
Delbarre et al., 2013; Drane et al., 2010; Goldberg et al., 2010; Iwase et al., 2011) and into
specific genes in response to neuronal signaling (Michod et al., 2012). H3.3 deposition
by the ATRX/Daxx chaperone is believed to contribute to epigenetic silencing of a few,
but not all repetitive regions, as has been shown for retrotransposons (Elsasser et al.,
2015). Loss of the ATRX protein results in aneuploidy and defects in chromosomal
segregation (Baumann et al., 2010). Additionally, both ATRX and Daxx mutations are
often found in pediatric gliomas and neuroblastomas (Schwartzentruber et al., 2012;
Cheung et al., 2012) and in other cancer types (Heaphy et al., 2011; Jiao et al., 2011),
suggesting that these mutations drive disease in a particular developmental context
(Dyer 2017). Thus, the interplay between ATRX/Daxx and H3.3 histones at telomeres
and other repetitive sequences could contribute to silencing of these elements, which
may be critical to maintain genome integrity and prevent formation of cancer.
FACT complex
FACT (facilitates chromatin transcription), is a histone chaperone that can deposit hi-
stones onto DNA (Belotserkovskaya et al., 2003) and is also involved in nucleosome
reorganization during transcription, replication and DNA repair (Winkler and Luger,
2011). During transcriptional elongation, FACT destabilizes the nucleosome by dis-
placing the H2A/H2B dimers to allow passage of the transcribing RNA polymerase
through a nucleosomal DNA template (Belotserkovskaya et al., 2003). It also facilitates
the subsequent recovery of the nucleosome after transcription by holding the H3/H4
tetramer on DNA and promoting the deposition of the H2A/H2B dimer to reform the
nucleosome (Hsieh et al., 2013; Chen et al., 2018). Therefore, FACT has a dual func-
tion in destabilizing the nucleosome to facilitate transcription and in maintaining the
original nucleosome composition. In this way, FACT could play a role in preserving
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the original histones with pre-established histone modifications during transcription
or DNA replication (Chen et al., 2018).
1.4.2 Chromatin remodeling
Chromatin remodelers are large, multiprotein complexes that can mobilize nucleo-
somes to provide regulated access to DNA sequences. They play important roles in
many chromatin functions: to space nucleosomes properly during chromatin assem-
bly, to enable the controlled access of transcription factors to specific genes, to reg-
ulate the assembly of RNA-polymerases at promoters and allow the access of DNA-
repair factors to sites of DNA lesions (Saha et al., 2006). Furthermore, remodelers
may help the replication-independent nucleosome assembly machinery to fill in gaps
where nucleosomes have been ejected (Lewis et al., 2010; Konev et al., 2007). Often,
chromatin remodelers are driven energetically by ATP hydrolysis inside their ATPase
domain and they are subgrouped into the four largest families: SWI/SNF, ISWI, CHD
(NuRD), and INO80 (Clapier and Cairns, 2009). Members of these families function
in different biological processes and prefer different nucleosomal substrates. Most re-
modelers can move nucleosomes to occupy alternative positions by sliding the histone
octamer along the DNA. This activity depends on ATP-dependent DNA translocation
by the ATPase domain (Saha et al., 2002, 2005; Zofall et al., 2006; Clapier and Cairns,
2009). The sliding activity can create an evenly spaced arrangement of nucleosomes
on DNA, or distribute nucleosomes unevenly, potentially to open up binding sites on
chromatin. In contrast to these sliders, other remodelers have evolved a mechanism
for ejection of nucleosomes or the exchange of histone dimers (Saha et al., 2006). Hi-
stone exchange mediated by chromatin remodeling complexes can contribute to the
deposition of histone variants: A member of the INO80 family deposits histone vari-
ant H2A.Z by ejecting a H2A/H2B dimer from the nucleosome and inserting a less
stable H2A.Z/H2B dimer in its place (Luk et al., 2010; Mizuguchi et al., 2004; Krogan
et al., 2003), which can promote gene activation (Bonisch and Hake, 2012; Zhang et al.,
2005; Jin et al., 2009). Furthermore, ATRX, which deposits histone variant H3.3 into
heterochromatic regions as part of the Daxx/Atrx complex, also contains an ATPase
domain and belongs to the SWI/SNF family of chromatin remodeling proteins (Lewis
et al., 2010).
1.4.2.1 Recognition of histone substrates by chromatin remodeling complexes
The binding of chromatin remodelers to histones and nucleosomal DNA can be reg-
ulated by the histone modification state. The modification state helps determine
whether the nucleosome is an appropriate substrate for a remodeler complex (Saha
et al., 2006). This recognition is often mediated by protein domains that chromatin
remodelers share with histone modifying enzymes, such as bromodomains and chro-
modomains. Bromodomains allow remodeling complexes to selectively interact with
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acetylated histone tails (Winston and Allis, 1999; Dhalluin et al., 1999; Jacobson et al.,
2000) as seen for SWI/SNF-remodeling complexes (Hassan et al., 2002; Awad and
Hassan, 2008). Some remodelers contain bromodomains that selectively binds one
particular acetylated lysine residue in the histone tail, as seen for the yeast RSC com-
plex that binds acetylated H3K14 (Kasten et al., 2004), which might help in targeting
remodelers to particular genes. A subset of chromodomains might carry out a corre-
sponding function to mediate the recognition of methylated lysine residues (Fischle
et al., 2003; Min et al., 2003). For example, the mammalian remodeler Chd1 localizes
to actively transcribed genes through recognition of H3K4 methylation by its double-
chromodomain (Flanagan et al., 2005; Sims et al., 2005), a hallmark of active chromatin
(Schneider et al., 2004). In yeast and Drosophila, the chromodomain of Chd1 does not
selectively bind H3K4-methylated histone tails and is not required for the recruitment
of Chd1 to chromatin (Morettini et al., 2011; Sims et al., 2005), but might stimulate
the remodeling activity (Morettini et al., 2011; Hauk et al., 2010; Radman-Livaja et al.,
2012). Thereby, Chd1 can accelerate the H3 exchange close to promoters, and reduce
exchange towards transcriptional end sites (Radman-Livaja et al., 2012). This example
shows that deposition of histone modifications and nucleosome exchange are tightly
connected processes.
1.4.3 Histone turnover
The process of swapping histones incorporated into chromatin for free histones is
called histone exchange and the rate at which this exchange occurs is referred to as
histone turnover (Venkatesh and Workman, 2015). Accordingly, regions with high
turnover have a constant influx of newly synthesized histones, whereas low turnover
regions contain longer lived nucleosomes, as seen inside compacted heterochromatin
(Aygun et al., 2013) or at sites where old histones are actively recycled. The availability
of histone variants outside of S-phase results in the substitution of canonical histones
in nucleosomes with variant histones during exchange processes (Wirbelauer et al.,
2005). Specifically, Hira promotes the assembly of H3.3–H4 to substitute for displaced
nucleosomes (Tagami et al., 2004; Ahmad and Henikoff, 2002; Ray-Gallet et al., 2011),
which results in the accumulation of H3.3 at sites of high histone turnover. The rate at
which nucleosomal H3.3 incorporation (or displacement) occurs, has been established
as a measure for histone turnover (Deaton et al., 2016; Kraushaar et al., 2013).
1.4.3.1 Site-specific histone turnover
Sequence-specific transcription factors have to compete with nucleosomes for binding
sites inside regulatory regions of the genome (Henikoff, 2008). Consequently, the bind-
ing of transcription factors, with assistance from co-activators like chromatin remodel-
ers, may lead to nucleosome displacement. In support of this, promoter regions often
show low nucleosome densities (Mito et al., 2005; Sekinger et al., 2005) and regula-
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tory regions are bound by multiple chromatin remodelers (de Dieuleveult et al., 2016).
Furthermore, promoter and enhancer regions are enriched with H3.3-containing nu-
cleosomes, which have been shown to undergo rapid turnover (Kraushaar et al., 2013;
Deaton et al., 2016; Huang and Zhu, 2014). Inside coding regions, histone exchange
occurs at lower turnover rates is coupled to transcription by Pol II (An overview is
depicted in Fig. 1.6b).
Promoter regions
Promoters display high turnover rates compared to other genomic regions and the
highest turnover generally occurs at highly transcribed genes (Kraushaar et al., 2013;
Dion et al., 2007; Deaton et al., 2016). This implies that transcription initiation by Pol II
could lead to substantial H3.3 turnover. However, H3.3 turnover at promoter regions
does not linearly correlate with transcriptional activity (Kraushaar et al., 2013; Huang
and Zhu, 2014). Interestingly, histone exchange also occurs at inactive promoters (Mito
et al., 2007; Kraushaar et al., 2013; Dion et al., 2007; Rufiange et al., 2007), although with
a lower turnover rate, possibly to keep promoters in a poised state and to facilitate
their activation upon induction. Thus, promoters are either active and display high
H3.3 turnover or are inactive and display low H3.3 turnover. Similar observations
have been made for replication-independent H3 turnover in S. cerevisiae (Dion et al.,
2007). Therefore, the engagement of RNA Pol II and likely the binding of sequence-
specific transcription factors, but not necessarily the transcription frequency of Pol II,
correlate with H3.3 turnover at promoters.
Enhancer regions
Enhancers also display relatively high H3.3 turnover (Kraushaar et al., 2013; Deaton
et al., 2016). Given that enhancers are enriched for sequence-specific transcription fac-
tor binding sites and that enhancers are often occupied by Pol II (Kim et al., 2010),
high H3.3 turnover at enhancers may be the result of very similar mechanisms that are
in action at promoter regions. The highest turnover rates have been observed at regu-
latory regions occupied by multiple transcription factors, suggesting that transcription
factor binding events indeed contribute to turnover rates (Deaton et al., 2016). Further-
more, cis-regulatory elements that contribute to transcriptional repression instead of
activation, such as Polycomb response elements, are enriched with H3.3 and display
high turnover in Drosophila (Mito et al., 2007). This suggests that higher accessibility
of regulatory regions does not necessarily result in gene activation, and H3.3 turnover
may have multiple functions in distinct genomic locations that are not always corre-
lated with activity of chromatin (Banaszynski et al., 2013).
Gene bodies
Given the physical disruption of nucleosomes that must accompany RNA polymerase
passage, it follows that histone exchange occurs frequently inside gene bodies of
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highly transcribed genes (Schwartz and Ahmad, 2005; Schwabish and Struhl, 2004;
Wirbelauer et al., 2005). Indeed, H3.3 is enriched in all transcribed genes (Wirbelauer
et al., 2005) and H3.3 exchange at gene bodies closely correlates with transcription
rates (Deal et al., 2010), which suggests that the passage of Pol II and its associated
factors may regulate histone turnover in gene bodies directly (Venkatesh and Work-
man, 2015). However, compared to promoter and enhancer regions, gene bodies show
relatively low levels of nucleosome turnover and H3.3 exchange rates (Dion et al., 2007;
Kraushaar et al., 2013; Rufiange et al., 2007; Deal et al., 2010). One explanation for the
observed lower turnover is that during transcription, nucleosomes are temporarily dis-
assembled ahead of, and subsequently assembled behind, the transcription machinery,
preferentially by reassembly of parental histones and, to a lesser extent, by the incorpo-
ration of newly synthesized histones (Svensson et al., 2015; Hsieh et al., 2013). Histone
recycling in gene bodies depends on the protein complex FACT (Belotserkovskaya
et al., 2003; Chen et al., 2018; Jamai et al., 2009). Alternatively, engagement and ini-
tiation of Pol II may be a more dynamic process than Pol II elongation, and possibly
the transcription initiation complex is assembled multiple times before progressing
into the gene body, which would also result in comparably higher turnover rates at
promoters.
In conclusion, the highest dynamic exchange occurs at promoter and enhancer regions,
which display continuous binding and removal, respectively, of the transcription ma-
chinery and sequence-specific transcription factors. The continuous rapid exchange of
H3.3 nucleosomes at promoters and enhancers could transiently expose transcription
factor binding sites, thus keeping these sites accessible (Henikoff, 2008). The binding
of transcription factors with chromatin in turn is also dynamic (Lickwar et al., 2012),
allowing reassembly of nucleosomes after their dissociation. Collectively, these highly
dynamic regions with fast histone turnover are most likely the result of the combined
action of chromatin remodelers, the binding and dissociation of transcription factors
and the engagement of the transcriptional machinery (Huang and Zhu, 2014). Histone
turnover at gene bodies is slower, coupled to transcription by Pol II, and appears to be
regulated by mechanisms that are distinct from the ones that function at cis-regulatory
elements.
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Figure 1.6: Schematic representation of histone exchange at regulatory elements and inside coding
regions. (a) During nucleosomal assembly, two H3–H4 heterodimers form a tetramer and are joined by
two dimers of H2A-H2B to form a full nucleosomes around which DNA is wrapped. The replacement of
H3 and H4 requires the preciding removel of the H2A-H2B dimers from the nucleosome, whereas H2A-
H2B dimers can be exchanged without disrupting the H3-H4 tetramer. (b) Histone exchange processes at
promoter and coding regions result in the replacement of canonical H3 with the H3.3 variant, resulting in
the enrichment of H3.3 at these sites. At promoters and the +1 nuclesome, canonical H2A is additionally
exchanged for the H2A.Z variant. The rates of histone exchange differ between the promoter and cod-
ing regions. Pre-transcriptional exchange at promoters occurs more rapidly, whereas co-transcriptional
exchange occurs more slowly. (c) Specific histone variants such as H2A.Z can destabilize nucleosomes.
Schematic representation depicts the loop (L1) region mediating the interaction between two H2A or
two H2A.Z proteins. H2A.Z destabilizes heterotypic nucleosomes (H2A.Z-H2A) by weakening the in-
teraction between these loop structures. (d) Factors that contribute to histone exchange over promoters
and coding regions. Proteins that regulate the exchange include histone chaperones, chromatin remod-
eling complexes and the Pol II transcriptional machinery itself. Modifications of histones and of CTD
(carboxy-terminal domain) of Pol II are also associated with histone exchange processes and these can
vary between promoters and coding regions. Image was taken from Venkatesh and Workman (2015).
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1.4.3.2 Histone modifications and turnover
Histone modifications are marking different regions of genes, and have been impli-
cated to contribute to local turnover properties. H3.3-containing nucleosomes at en-
hancers and promoters display rapid turnover and these regions are associated with
the histone modifications H3K4me1, H3K4me3, H3K9ac, H3K27ac and co-occupancy
with the histone variant H2A.Z (Kraushaar et al., 2013). Furthermore, H3.3 itself is
often marked by active histone modifications (McKittrick et al., 2004; Hake and Al-
lis, 2006). In contrast, turnover is anti-correlated with H3K27me3 (Kraushaar et al.,
2013), a repressive mark often marking poised promoters and silenced chromatin.
H3K27me3 can recruit reader proteins to promote the formation of higher order chro-
matin structure (Li and Reinberg, 2011; Margueron et al., 2008), which may reduce
histone turnover. Interestingly, in mammalian cells histone turnover is anti-correlated
with H3K36me3 (Kraushaar et al., 2013), an active modification marking transcribed
gene bodies. This negative correlation has also been observed in S. cerevisiae, where
H3K36 methylation is thought to suppress histone exchange at active genes (Smolle
et al., 2012). Gene bodies themselves have lower histone turnover than regulatory
regions, suggesting that there may indeed be a functional link with H3K36me3. Sim-
ilarly, nucleosomes inside heterochromatic regions have low turnover rates and are
marked by H3K9me3 in yeast (Aygun et al., 2013). Thus, the association of distinct
histone marks with regions of high and low turnover, respectively, suggests that there
may be a causal relationship between histone modifications and the rate of nucleo-
some exchange. However, experimental evidence is controversial and other in vitro
experiments in yeast suggest that turnover and modifications are largely independent
events (Ferrari and Strubin, 2015). Especially in mammalian cells, it remains to be
tested whether H3K36 methylation does indeed contribute to the comparably low hi-
stone turnover rates observed at gene bodies, and whether H3K4 methylation, H3K9
and H3K27 acetylation instead accelerate turnover at cis-regulatory elements.
1.5 Systems to probe the contribution of histone residues to
nucleosome function
A particularly powerful approach for studying the biological function of specific hi-
stone residues is to change the residue to a different amino acid that cannot be ap-
propriately modified or that mimics a certain modification state. In this way, one can
address the importance of the residue itself and gain information about histone modi-
fications at this site. Systematic histone H3 mutation studies in Saccharomyces cerevisiae
and Drosophila melanogaster have delivered direct clues for the functional significance
of histone residues in individual organisms (Dai et al., 2008; Hodl and Basler, 2012;
Pengelly et al., 2013). However, similar studies in mammals are challenged due to
the presence of large multi-loci gene clusters. In yeast, genome engineering based on
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homologous recombination is highly efficient and has been successfully applied to hi-
stones to generate systematic histone H3 and H4 substitutions and deletion mutants
to probe the contribution of each residue to nucleosome function (Dai et al., 2008). S.
cerevisiae carries only two gene copies for histone H3 and Boeke and colleagues have
removed the first of these gene copies and exchanged the second gene (Dai et al., 2008).
In this way, they could systematically substitute each residue of H3 with alanine, and
additionally substituted all modifiable residues with amino acids mimicking modi-
fied and unmodified states. Furthermore, they introduced deletion mutants that are
lacking parts of or the whole N-terminal tail of H3. In D. melanogaster, the replication-
dependent histone genes are found at a single locus (Lifton et al., 1978). Herzig and
colleagues successfully combined the deletion of this endogenous histone gene clus-
ter with its substitution by transgenes (Gunesdogan et al., 2010), thereby allowing the
first characterization of histone residue and histone variant function in animal devel-
opment (Pengelly et al., 2013; Hodl and Basler, 2009, 2012; McKay et al., 2015). This
system has been further developed to simplify the exchange using BACs to deliver the
transgenes (McKay 2015). These studies have revealed an increasing dependency on
histone tail residues in multicellular organisms, potentially because they are required
during animal development. Viable deletions in yeast, including deletions of the entire
N-terminal tail or mutation of individual residues Dai et al. (2008), can have dramatic
consequences for Drosophila development and are often lethal at a certain develop-
mental stage (McKay et al., 2015; Meers et al., 2017). Thus, probing the importance
of histone tail residues in higher organisms is essential to determine their function
in humans. However, implementing systematic histone exchange tools in mammals
is technically challenging because canonical histones are encoded inside gene clus-
ters located at multiple chromosomal locations (Marzluff et al., 2002), e.g. the human
genome contains more than 60 canonical histone genes that are located at three differ-
ent loci (Marzluff et al., 2002).
These complications prevented systematic testing of replication-dependent canonical
histones so far, and the complete exchange of all genes may remain impossible. The
genes of replication-independent histone variants however, such as H3.3, exist in fewer
copies outside the histone clusters (Elsaesser et al., 2010). Recent advances in genome
engineering techniques, namely the CRISPR-Cas9-System, made targeted mutations
inside these genes feasible, opening the possibility for systematic histone mutations in
the mammalian system.
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1.6 Aims & Motivation
Numerous mutations in histone H3 modifying enzymes have been reported in human
disease, yet the role of the histone residues themselves remains unclear in mammals
due to the clustered arrays of many histone genes. In this study, I aim to investi-
gate the role of histone residues (e.g. K4 and K36) in the histone H3.3 variant, which
is enriched at active genes and regulatory regions of genome. H3.3 is encoded by
two isolated genes outside of histone clusters; therefore amenable to functional anal-
ysis. I set out to mutate the H3.3 encoding genes as a platform to analyze the role
of histone residues in mammals. In this way, I want to address the long-standing
questions of the functional requirement of histone residues and their modifications
for transcription, histone turnover and the epigenetic landscape in neurodevelopment.
In the second chapter of this thesis, I describe the development of an experimental
strategy that allows the investigation of histone residues in histone variant H3.3 in
mammalian cells. Using CRISPR-Cas9, I aim to mutate specific lysine residues (e.g.
K4 and K36) of endogenous H3.3 to alanine in mouse embryonic stem cells (ESCs).
The mutation will change the property of the residue itself and prevent modifications
at this site. In Chaper 3, I describe the experimental results obtained from H3.3K4A
and H3.3K36A mutant cells. First, I assess the contributions of H3.3K4 and H3.3K36
residues to transcriptional regulation during neuronal development. Using an in vitro
differentiation system, I differentiate mutant ESCs into neural precursor cells (NPCs)
and post-mitotic glutamatergic neurons to investigate whether specific H3.3 residues
are required to give rise to specialized cell types. Gene expression profiles are ana-
lyzed by means of RNA sequencing at different developmental stages to assess if gene
regulation is perturbed. Second, I profile how lysine residues in H3.3 contribute to
H3.3 deposition into distinct chromatin types, such as active genes and regulatory re-
gions. Last, I address how the epigenetic landscape of mouse ESCs is perturbed by
H3.3 mutations using antibody-based approaches such as immunoblot and ChIP-Seq
and antibody-independent approaches such as mass spectrometry.
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of mammalian histone H3.3
2.1 Background
CRISPR-mediated genome engineering provides a powerful tool to study the role and
function of genes and proteins. In the past decades, the advances in genome and tran-
scriptome sequencing techniques have shed light on the genetic causes underlying
many human diseases, such as neurodevelopmental disabilities or cancer. Sometimes,
a single point-mutation in a protein coding gene has been identified as the primary
cause of the disease. CRISPR-Cas offers the possibility to introduce or remove such
a mutation of interest to understand disease mechanisms and even bears therapeutic
potential. Precise genome editing can also help in understanding the role of histone
residues and their post-translational modifications in mammalian gene regulation.
Generally, CRISPR-Cas is an adaptive immunity system that protects bacteria and ar-
chae against foreign DNA (Makarova et al., 2011; Jinek et al., 2012). In recent years,
components of this system have been modified and made applicable for genome en-
gineering in mammalian cells (Charpentier and Doudna, 2013; Ran et al., 2013). The
main components are the endonuclease Cas9 that can cleave double-stranded DNA
molecules, and a single-guide RNA (sgRNA). The sgRNA acts as a scaffold and di-
rects Cas9 to a genomic site of interest by a short 20 nucleotide complementary guide
sequence. The requirement for Cas9 to bind and cleave the targeted genomic sequence
is a protospacer adjacent motif (PAM) in the DNA, most commonly a „5’-NGG“ motif
where N is any nucleotide followed by two guanine nucleotides.
CRISPR-Cas mediated double-strand cleavage can be repaired in cells by two differ-
ent repair mechanisms: Non-homologous end-joining (NHEJ) and homology-directed
repair (HDR) (Fig. 2.1). Both pathways repair the double-strand break, but the result-
ing genotype is different. During NHEJ, the two DNA strands are ligated without a
homologous DNA sequence as a template for repair. This often results in deletions,
insertions or indels at the repair site, which is useful to generate a knock-out of a
particular gene. Meanwhile, HDR is a more precise repair mechanism that requires a
DNA template with homology to the repair site such as a homologous chromosome
or an exogenously supplied repair template. The HDR pathway can be exploited to
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Figure 2.1: CRISPR-Cas9 mediated genome engineering. Cas9 introduces double-strand breaks (DSB)
into the DNA, which can can be repaired by the Non-homologous end-joining (NHEJ) or the homology-
directed repair (HDR) pathway. NHEJ ligates the DNA strands in an error-prone way that results in
insertion or deletion (Indel) mutations at the repair site. Indels can cause frameshift and the formation of
premature stop codons, resulting in gene knock-out. The more precise HDR pathway repairs the DNA
according to a repair template, which can be a plasmid or single-stranded DNA with homology to the
DSB site. This pathways allows precise gene editing by introduction of nucleotide changes of interest.
Image was obtained from Ran et al. (2013).
generate small, precise modifications in the genome in the presence of an exogenously
introduced repair template that carries the desired nucleotide changes (editing) (Ran
et al., 2013). Studies showed that the frequency of CRISPR-editing via the HDR path-
way is low (Ran et al., 2013). Thus, it is required to establish a robust way for high-
throughput screening of many clonal cell lines. So far, screening for genome editing is
mostly done by restriction digest (Ran et al., 2013) or Sanger sequencing. Restriction
digest requires the introduction of nucleotide changes that give rise to a restriction
site to help identifying edited clones. However, this procedure is tedious and it is
not always feasible to change nucleotides in a way to create a restriction site, while
maintaining the amino acid sequence of the encoded protein. Alternatively, Sanger
sequencing is the most reliable technique to identify editing events in cells, but it is
expensive if applied to large numbers of clonal cell lines.
The first chapter of my thesis describes how I tested and adapted the CRISPR-Cas9
system developed by Ran et al. (2013) to be applicable for mutation of histone variant
H3.3 in ESCs, specifically to exchange lysine residues 4 and 36 (H3.3K4 and H3.3K36)
with alanine. As only one of the two H3.3-encoding genes is required for animal sur-
vival and development (Tang et al., 2013, 2015; Jang et al., 2015), I knock-out H3f3a and
introduce point-mutations in the second gene, H3f3b. Furthermore, I develop a new
screening method to reliably detect editing events in clonal cell lines as an alternative
to restriction digest or Sanger sequencing. The new strategy should 1) be more time-
effective than screening by restriction digest, 2) reduce the costs of screening many
cell lines compared to Sanger sequencing and 3) abolish the need to insert a restriction
site into the genome, which is not always possible depending on the targeted genomic
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sequence. Finally, I address the issue of large chromosomal deletions and rearrange-
ments that have been reported to occur during CRISPR editing (Lee and Kim, 2018;
Zhang et al., 2015). For this, I tested whether RNA-Sequencing data generated from
clonal cell lines can be used for a large-scale CRISPR off-target analysis.
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2.2 Results
I conducted the experiments, collected and analyzed the data in this chapter, unless indicated
otherwise. Nichole Diaz assisted me with cell culture work. Christopher Buccitelli (in the
group of Jan Korbel) analyzed DNA-Sequencing data in Fig. 2.8 and advised in the off-target
analysis from RNA-Seq data.
2.2.1 Delivery of Cas9 and guide into mouse embryonic stem cells
To target the H3.3 encoding genes H3f3a and H3f3b for gene editing, I used the
plasmid-based CRISPR system developed by Ran et al. (2013). The plasmid encodes a
fusion protein of Cas9 and green fluorescent protein (GFP), which allows cell selection
by flow cytometry, and a single-guide RNA for targeting of Cas9 to a genomic site.
The delivery of this plasmid and a repair template is crucial for successful editing, but
primary cells, including ESCs, are difficult to transfect using traditional transduction
methods such as liposomal reagents. I tested if electroporation with a nucleofector
system (nucleofection) is suitable for the delivery of the CRISPR plasmid into ESCs
and analyzed the efficiency by flow cytometry. Overall, around 5.4% of all sorted cells
were GFP-positive and therefore successfully transduced (Fig. 2.2). This proportion
is sufficiently high to obtain the required cell numbers for gene editing. Next, I con-
tinued with optimizing the conditions for gene editing of endogenous H3.3 using this
CRISPR-Cas9 system.
Figure 2.2: Transduction efficiency in ESCs with a plasmid-based CRISPR system using nucleo-
fection. Nucleofected ESCs were analyzed by flow cytometry for GFP expression, which represents
successful delivery of the Cas9-encoding plasmid. Displayed are GFP-signal (x-axis) against RFP-signal
(y-axis) and rectangles indicate areas of positive cells expressing the analyzed Cas9-GFP fusion protein.
Gating strategy for this experiment is depicted in Supplementary Fig. S1.
2.2.2 Optimization of CRISPR-Cas9 mediated gene editing in ESCs
Gene editing through the HDR pathway occurs at lower frequencies than gene knock-
out via the NHEJ pathway, but treatment with small molecules has been proposed to
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promote the frequency of HDR in cells. I tested the efficiency of two small molecules,
Scr7 and L755,507, to promote gene editing of the H3.3 genes (H3f3a or H3f3b). Scr7
has been reported to promote editing via HDR by inhibiting the activity of DNA lig-
ase IV, an important enzyme in the competing NHEJ pathway (Maruyama et al., 2015;
Chu et al., 2015). L755,507 is a β3-adrenergic receptor partial agonist reported to en-
hance gene editing, but the mode of action is unknown (Yu et al., 2015). The treatment
with individual small molecules at concentrations between 1-10 µM did not visibly
reduce cell viability. To minimize potential toxicity, I treated the cells with the small
molecules only for a short period of the culture (12 hours before and 24 hours after
delivery of the Cas9-plasmid and single-stranded repair template by nucleofection).
In untreated ESCs, I did not obtain edited cell lines carrying the mutation of interest,
neither with L755,507 treatment. Using the Scr7 inhibitor, I obtained edited cell lines
that had incorporated nucleotide changes according to a supplied repair template.
Thus, treatment with Scr7 inhibitor resulted in a higher frequency of editing events
than without treatment or by treatment with L755,507 and in this experimental set-up
proved to be essential for obtaining edited cell lines (Table 2.1). Overall, the editing
frequency of either H3f3a or H3f3b is around 0-2% of transduced cells for homozygous
editing and 1-10% for heterozygous editing.
Table 2.1: Summary of CRISPR editing screens to introduce point-mutations into histone H3.3. Non-
treated or treated ESCs were transduced with two CRISPR-Cas9 plasmids targeting both the H3f3a and
H3f3b gene. Total number of clonal cell lines that were screened and the detected edited clonal cell lines
(heterozygous or homozygous) are indicated.
Edited Edited
Gene Treatment Clones total Heterozygous Homozygous
H3f3a no drug 56 0 0
H3f3b no drug 56 0 0
H3f3a L755,507 49 0 0
H3f3b L755,507 49 0 0
H3f3a Scr7 43 2 (4.7%) 0
H3f3b Scr7 43 0 1 (2.3%)
H3f3a Scr7 57 10 15.8% 1 (1.8%)
H3f3b Scr7 57 1 (1.8%) 1 (1.8%)
To further maximize the editing frequency in ESCs, I tested the efficiency of short tem-
plates (200 bp) that are either single- or double-stranded in the presence or absence
of Scr7 inhibitor treatment. The repair templates carried a restriction site that gets
inserted at the repair site in case of successful editing and the efficiency of editing
can be estimated by restriction digest in a bulk of cells sorted by flow cytometry. The
combination of Scr7 treatment with a single-stranded repair donor (ssDNA) yielded
the highest frequency of editing (Fig. 2.3). This is in agreement with studies that have
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reported the advantages of using a short single-stranded DNA sequence (ssDNA) over
a long double-stranded plasmid DNA as the repair template (Ran et al., 2013; Chen
et al., 2011). For editing of H3.3, the combination of ssDNA with a Scr7 treatment
proved to be the most suitable conditions.
Despite the efforts to optimize the conditions for CRISPR-targeting, the observed fre-
quencies (Table 2.1) for precise genome editing were too low to mutate both H3.3
encoding genes in one round of CRISPR targeting. Thus, I decided to mutate only the
H3f3b gene (encoding H3.3B protein) and remove the H3f3a gene by CRISPR-mediated
knock-out. The editing frequencies I observed in the initial experiments for homozy-
gous editing of H3f3b were between 0-2.3% per screen and I estimated that it would
require screening of 100-200 clonal cell lines to obtain a successfully edited clone per
mutation.
ssDNA dsDNA ssDNA dsDNA
- +Restriction Digest - + - +
1 μM
repair template
HDR (%) 0.7 3.9 10.8 2.4
- + - +
none
Scr7 treatment - - 1 μM - 
Figure 2.3: Comparison of single-stranded and double-stranded DNA repair templates for CRISPR
editing in untreated and Scr7-treated ESCs. Cells were transduced with CRISPR-Cas9 plasmids target-
ing the H3f3b gene and indicated repair templates carrying a restriction site for genomic insertion. A
bulk of transduced cells expressing Cas9-GFP was selected by flow cytometry. The targeted H3f3b locus
was amplified by PCR and subjected to restriction digest. Digestion pattern was analyzed by agarose
gel electrophoresis. Successful integration of the restriction site by HDR results in cleavage of the PCR
product (blue arrowhead) and the occurrence of smaller digestion products (orange arrowheads). HDR
frequency was calculated as the ratio of band intensities.
2.2.3 High-throughput screening for CRISPR editing
The systematic exchange of multiple residues of H3.3 in mammalian cells can only
be achieved if a reliable method allows high-throughout screening of many clonal cell
lines at reduced costs. Whereas Sanger sequencing is a fast and precise method for
screening, it is expensive if applied to many cell lines. Instead, screening by restriction
digest is inexpensive, but tedious and requires the insertion of a restriction site into
the targeted genomic locus.
Studies used real-time quantitative PCR (qPCR) to measure the methylation status
of a single cytosine at a specific positions in the DNA. For this, specific primers are
designed to recognize a single nucleotide polymorphism that arises after bisulfite con-
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version of methylated DNA at the most 3’end of the primer (Dugast-Darzacq and
Grange, 2009). I tested if a similar strategy can be employed to detect CRISPR-editing
by designing mutation-specific primers that recognize the inserted nucleotide changes
of interest (Fig. 2.4a,b). I will refer to this screening method as Mismatch-qPCR. I
sorted transduced cells by single cell sorting and performed Mismatch qPCR after
CRISPR targeting. Using this method, I was able to separate edited clones from wild
type clones by shifts to lower cycle numbers (rounds of amplification) (Fig. 2.4c). In
combination with a primer that recognizes the unchanged wild type allele, it was pos-
sible to distinguish heterozygous from homozygous clones. Heterozygous clones with
one mutant and one wild type allele amplify in a qPCR reaction with both primer
sets, while homozygous clones only amplify using the mutation-specific primer. Us-
ing the already established restriction digest method, I confirmed homozygosity and
heterozygosity of the clonal lines, which can be identified by the complete or incom-
plete digestion of a PCR product (Fig. 2.4c). The results from restriction digest were
in agreement with the results from the qPCR screen.
Using the optimized conditions for CRISPR-editing in ESCs and the developed Mis-
match qPCR screen, I generated cell lines edited homozygously at either lysine 4 or
lysine K36 of H3.3B. By means of Sanger sequencing, I determined the exact genotype
of the edited clones and confirmed that the lysine to alanine mutation was introduced
in addition to the synonymous mutations inside the guide binding site in both alle-
les of H3f3b (Fig. 2.5a,b). For some other clones that were detected by screening, I
observed incomplete repair resulting in additional small deletions around the guide
binding site. These clones were discarded and only clones that have incorporated
all nucleotide changes correctly from the repair template were used for downstream
analysis. Next, I went on to remove the H3f3a gene by CRISPR-mediated knock-out.
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Figure 2.4: Mismatch qPCR screen detects CRISPR-mediated point-mutations in H3.3B. (a) Guide
sequences were designed to target Cas9 close to the mutation site of interest. The single-stranded DNA
repair template contains nucleotide changes to introduce a target mutation (lysine-to-alanine), and 3
additional synonymous mutations into the guide binding site or into the PAM to prevent re-cleavage
after repair. Optionally, synonymous mutations can give rise to a new restriction site used to validate
clones. The mutation-specific primer includes nucleotide changes that arise after CRISPR-editing at the
most 3’end. The wild-type (WT) primer recognizes the same, but unmodified genomic site. (b) Examples
of two mutation-specific primers for Mismatch qPCR that detect editing of lysine 4 to alanine in H3.3B by
recognizing either the K4A mutation or the synonymous mutations inside the guide. (c) Mismatch qPCR
screen of CRISPR cell lines using mutation-specific and wild-type primers. Successful amplification result
in an increase of the fluorescent signal (y-axis) at lower cycle numbers (x-axis). DNA of homozygously
edited clones is amplified only with mutation-specific primers, whereas heterozygous clones are also
amplified using the wild-type primer. (d) Confirmation of editing events by restriction digest using a
newly introduced restriction site after CRISPR targeting. DNA of wildtype cells (WT) and positive clones
predicted by Mismatch qPCR screening were used for PCR amplification followed by restriction digest
with BanI. Digestion pattern was analyzed by agarose gel electrophoresis. Digestion of the PCR product
(red arrowhead) of wild type DNA results in a larger product (blue arrowhead) than from edited DNA
(orange arrowheads) with an additional integrated restriction site. Restriction digestion confirms the
detected editing events by qPCR.
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Figure 2.5: Sanger sequencing confirming the successful integration of nucleotide changes into H3.3B
at lysine 4 and 36. (a) Sanger-sequencing results of the H3.3B locus for H3.3K4A and H3.3K36A mu-
tant cells. Blat tool is used to compare the results with the wildtype genome (mm10) and the search
is visualized using UCSC. Zoom into the region of the first coding exon reveals successful introduction
of lysine-to-alanine mutation at either K4 or K36, respectively, and the introduction of 3 additional syn-
onymous mutations inside guide recognition site or PAM. (b) Analysis of chromatograms from Sanger
sequencing confirms the homozygous exchange of targeted nucleotides in H3.3K4A/K36A mutant cell
lines.
31
Chapter 2.
2.2.4 Knockout of H3.3A
Individual knock-out experiments of one of the two H3.3 encoding genes have shown
that only one copy of H3.3 is absolutely required for viability and reproduction in
mice (Tang et al., 2013, 2015; Jang et al., 2015). Thus, I deleted H3.3A, after having
introduced point-mutations into both alleles of H3.3B. This step was taken because
removal of one gene copy is not expected to compromise differentiation potential and
pluripotency state of ESCs, but will facilitate the generation of mutant cell lines. To
remove H3.3A from ESCs, I used Cas9 and a guide targeting the first coding exon of
the H3f3a gene. RNA-Seq of knock-out clones revealed significantly reduced levels
of the entire H3.3A transcript compared to wild type cells (Fig. 2.6) suggesting that
deletions inside the first coding exon result in non-sense mediated decay of the re-
maining mRNA. The few remaining reads detected for H3.3A are mapping to other
non-targeted exons, which confirms the successful targeting of the first coding exon
by CRISPR-Cas9 and thereby knock-out of H3.3A (Fig. 2.6).
As a next step, I want to confirm that during clonal selection and CRISPR targeting
the integrity of the genome was not affected, e.g. by chromosomal rearrangements.
In agreement with knock-out of one gene copy, I consistently observed reduction of
H3.3 protein levels for control (H3.3A knock-out) and H3.3K4A and H3.3K36A mu-
tants (H3.3A knock-out + H3.3B editing) compared to wild-type cells by approximately
50% as analyzed by immunoblot (Fig. 2.6). This confirmed the successful knock-out
of H3f3a in CRISPR clones on the protein levels, and furthermore indicated that gene
editing of H3f3b did not significantly reduce protein expression of H3.3B in ESCs.
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Figure 2.6: Successful knock-out of H3f3a in CRISPR clones. (a) Normalized mRNA expression of the
H3f3a gene measured by RNA-Sequencing shows strongly reduced gene expression levels and successful
gene knock-out in control, K4A and K36A CRISPR cell lines. Each dot represents one biological replicate.
(b) Immunboblot analysis of H3.3 protein levels in CRISPR cell lines. Control, K4A and K36A mutant
cells have reduced H3.3 protein expression compared to wild type cells (WT) after deletion of H3.3A.
(c) Visualization of RNA-Sequencing reads in the H3f3a gene for CRISPR cell lines and wild type cells.
Black box indicates the first coding exon that was targeted for deletion with CRISPR. Only few reads
are detected for the entire H3f3a gene. Track height is indicated on the left and shows strongly reduced
expression for the CRISPR clones compared to wild type, suggesting non-sense mediated decay of the
mRNA.
2.2.5 CRISPR off-target analysis for large chromosomal deletions
Double-strand cleavage by Cas9 can cause unintended off-target effects that affect
genome integrity. (Lee and Kim, 2018; Zhang et al., 2015). As a part of this study, I
generated RNA-Seq data from the CRISPR-Cas9 targeted cell lines, therefore I wanted
to test if RNA-Seq data can be used to detect whether genomic integrity is affected
in these cells. The advantage would be to exclude clonal cell lines with chromosomal
deletions or duplications, which could otherwise complicate downstream analysis.
Using mRNA-Seq, I determined gene expression changes in CRISPR cell lines rela-
tive to their wild type ESC line of the same genetic background. The gene expression
changes were compared to the genomic coordinates of the respective gene. Systemati-
cally down- or up-regulated genes that are located in proximity to each other indicate
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large-scale chromosomal abnormalities (Fig. 2.7a).
Using this strategy, I found that incomplete repair of a chromosome by NHEJ or HDR
can result in deletions of chromosome pieces, ranging from the CRISPR target site
to the end of a chromosome (Fig. 2.7b,c,d). Such deletions result in one-allelic loss
of hundreds of genes, and I will refer to these unintended on-target effects as chro-
mosome arm-loss. I observed that chromosome arm-losses can occur independent of
the exact CRISPR guide sequence and on different chromosomes, because they were
detected during the targeting of H3f3a on chromosome 1 or H3f3b on chromosome 11
(Fig. 2.7b,c). Since both H3.3-encoding genes are located at the periphery of chro-
mosome 1 and 11, respectively, it is possible that CRISPR-targeting of genes at the
ends of chromosomes are more likely to result in one-allelic chromosome-arm loss. It
should be noted that such deletions are not detectable by traditional Sanger Sequenc-
ing, because only the intact allele is amplified in a PCR reaction. Additionally, I also
observed rearrangements of chromosomes that were not targeted by CRISPR, e.g. of
chromosome 6 (Fig. 2.7d). These rearrangements can potentially be CRISPR off-target
effect, but may also have occurred spontaneously during clonal selection.
To increase the confidence in genome integrity predictions from RNA-Seq data and to
validate the method, I tested whether the predicted chromosomal deletions/duplications
can be confirmed on the genomic level by means of DNA sequencing.
From RNA-Seq data of a chosen cell line, a cluster of cluster of up-regulated genes
and a cluster of down-regulated genes between the CRISPR target site and the chro-
mosome end were detected (Fig. 2.8a). The same chromosomal abnormality was also
detectable using DNA-Seq data (Fig. 2.8b) and this confirmed that the gene expression
changes were the result of a duplication-deletion rearrangement on the genomic level.
Compared to the DNA-Seq analysis, RNA-Seq data yields a lower resolution because
the predictions are dependent on the gene-density per chromosome, which is rather
sparse considering that only 62% of the genome is transcribed, and an even smaller
fraction of this corresponds to coding exons (5.5%) (ENCODE, 2012). Thus, DNA-Seq
data allows a more detailed analysis of chromosomal abnormalities with higher preci-
sion and confidence, but with RNA-Seq data it is possible to make similar predictions
especially in the case of large chromosomal abnormalities.
The occurrence of CRISPR-dependent and -independent effects on genome integrity
suggests that an extensive on- and off-targeted analysis for generated clonal cell lines
is recommended and should be integrated into the standard workflow for validation of
CRISPR cell lines. In addition, these results suggest that for generating knock-out cell
lines, it would be best to choose cell lines that show deletions of different lengths in
the two targeted alleles, which can help in avoiding chromosome-arm loss and ensure
that two intact chromosomes remain. The two alleles need to be amplified and appear
as amplicons of different sizes on an agarose gel after PCR and can be extracted and
sequenced individually. However, large-scale deletions can also occur during gene
editing and it is necessary to test genome integrity either by sequencing or by qPCR
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for systematic down- or up-regulation of proximal genes.
In conclusion, the summarized strategy for gene editing in ESCs is displayed in Fig.
2.9. It was developed for editing of H3.3 encoding genes in mouse ESCs, but should
be applicable to any gene of interest and cell line.
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Figure 2.7: Prediction of chromosomal rearrangements from RNA-Sequencing data. (a) Strategy for
analyzing genome integrity from RNA-Seq data. (b,c,d) CRISPR off-target analysis from differentially
expressed genes. log2(FoldChanges) of gene expression in three different CRISPR clones compared to
unmodified wild type ESCs were determined by DESeq2 and plotted over chromosome position for all
(left) or a specific chromosome (right). Lines indicate CIRSPR cleavage site inside H3f3a gene (yellow) and
H3f3b gene (blue). Loss or duplication of a chromosome part can be detected by coordinated up- or down-
regulation of proximal genes. (b) CRISPR clone showing a cluster of systematically down-regulated genes
on chromosome 1 close to the CRISPR targeting site in H3f3a gene. (c) CRISPR clone showing a cluster of
systematically down-regulated genes on chromosome 11 close to the CRISPR targeting site in H3f3b gene.
(d) CRISPR clone showing a cluster of systematically down-regulated genes on chromosome 1 close to
the CRISPR targeting site in H3f3a gene and a large cluster of up-regulated genes on chromosome 6.
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Figure 2.8: Comparison between RNA-Seq and DNA-Seq data in predicting chromosomal rearrange-
ments.(a) Differential gene expression analysis with regard to the genomic coordinates from RNA-Seq
data. CRISPR clone shows two clusters of systematically up- and down-regulated genes on chromo-
some 1 close to the CRISPR targeting site, suggesting a partial chromosomal duplication and deletion.
(b) Analysis of DNA-Seq reads with respect to genomic coordinates confirms the duplication-deletion
rearrangement at the CRISPR targeting site on chromosome 1 on the genomic level. Analysis of genomic
DNA-Seq data in (b) was performed by Christopher Buccitelli from Jan Korbel’s group.
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Figure 2.9: Overview of CRISPR-editing workflow in mouse ESCs. General scheme used to introduce
point-mutations into H3.3B. Cas-9 plasmid with guide and single-stranded repair templates are delivered
into ESCs by nucleofection. Transduced GFP-positive cells are selected by flow cytometry and single
cells are sorted into 96-well plates. Clonal cell lines are expanded and split into two identical plates for
freezing and screening. For Mismatch-qPCR, cells are lysed directly in a 96-well plate and successful
editing events are detected in a qPCR reaction. Editing events can be confirmed by Sanger sequencing
and optionally by restriction digest. Large-scale on- and off-target analysis is performed in selected clonal
lines from RNA- or DNA-Seq data.
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2.3 Discussion
Genome engineering by CRISPR-Cas9 provides a powerful tool to exchange endoge-
nous histone residues and to probe their function in mammalian development. Tar-
geting of the H3.3 genes (H3f3a and H3f3b) showed that gene editing occured at low
frequencies in mouse ESCs and it required extensive screening of many clonal cell
lines to obtain successfully edited clones. The observed frequencies were not suffi-
ciently high to achieve editing of both H3.3 genes in a single targeting step and two
consecutive rounds of CRISPR targeting would be required to exchange both genes.
However, knock-out studies in mice suggest a partial redundancy of the two H3.3
genes, with only one of them being absolutely required for the completion of an entire
mouse life cycle (Jang et al., 2015; Tang et al., 2015). Therefore, I introduced muta-
tions into one of the two H3.3 encoding genes (H3f3b/H3.3B) in combination with the
knock-out of the second gene (H3f3a/H3.3A), thereby generating clonal cell lines that
have the entire protein pool of H3.3 mutated. Specifically, I introduced homozygous
point-mutations into H3.3B at lysine 4 and 36, respectively. The resulting half-dosage
of H3.3 could potentially become a problem in post-mitotic cells, which dependent on
H3.3 as the predominant H3 variant (Maze et al., 2015). Furthermore, H3.3 has been
shown to be critical to maintain genome integrity and complete loss of H3.3 in mice
results in embryonic lethality due to DNA segregation defects during mitosis (Jang
et al., 2015). Therefore, it is crucial to include H3.3A knock-out cells as controls for
downstream analysis rather than wild type cells that have both H3.3 genes intact. This
will allow to discriminate the effect of the introduced H3.3 mutation from a dosage-
dependent effects of H3.3 itself.
To this end, I generated numerous clonal cell lines to have a complete set of con-
trols and H3.3 mutants for downstream characterization. To simplify this effort and
to screen clonal cell lines with high through-put, I developed a qPCR-based method
(Mismatch qPCR) that could reliably identify CRISPR-edited clones. By direct compar-
ison with the restriction digest method (Ran et al., 2013), Mismatch qPCR proved to be
a faster screening method that did not require the insertion of a restriction site into the
genome. The read-out can be observed during the qPCR reaction without requiring
subsequent analysis steps. Sanger sequencing was required to exclude false positive
clones and to confirm the precise genotype of the clonal cell lines. Nevertheless, se-
quencing of few clones after screening by Mismatch qPCR was more economical than
to sequence all generated clonal cell lines. The limitation of Mismatch qPCR is cer-
tainly the requirement of suitable primer pairs for screening. Dependent on the DNA
sequence and GC-content of the targeted locus, it is not always possible to design
primers that fall into the recommended property range (e.g. melting temperature),
which is predicted to result in less efficient PCR amplification. However, the read-out
of Mismatch qPCR is qualitative and not quantitative and should not be compromised
by less efficient primers.
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Following the generation on CRISPR-edited clones, I wanted to confirm that their
genomic integrity had not been compromised by the targeting. Chromosomal rear-
rangements can occur simply during clonal selection of ESCs, and recently, it has been
reported that large chromosomal deletions and complex genomic rearrangements can
occur at the CRISPR-targeted site in mouse ESCs and other cell types (Kosicki et al.,
2018). These results caution against neglecting the risk of on- and off-target effects
introduced by CRISPR-Cas9. Testing the genomic integrity of generated clonal lines
from commonly available genomic datasets such as RNA-Seq and DNA-Seq data can
help in excluding affected cell lines. Using RNA-Seq data, I frequently observed dele-
tions at the site of CRISPR-targeting, and less commonly rearrangements on other
chromosomes. At the CRISPR-taret site, double-strand DNA cleavage resulted in
the one-allelic loss of a chromosome arm and thus down-regulation of hundreds of
genes. Large-scale deletions and rearrangements severely affected genome integrity,
and suggest that an extensive on- and off-target analysis for generated clonal cell
lines is indeed necessary and should be integrated into the standard workflow for
CRISPR editing. Depending on the availability, both RNA- or DNA-Sequencing data
are suitable for this analysis and these datasets are often publicly available for already
published studies, e.g. input DNA sequencing data from Chromatin Immunoprecip-
itation (ChIP) experiments. A sequencing based approach for identifying off-target
clones will be easily implemented and might be comparable with the traditional kary-
otype analysis.
With the growing list of mutations associated with human diseases, CRISPR-Cas9
mediated editing is becoming increasingly important to study disease mechanisms.
Economical screening methods with high-throughput such as Mismatch qPCR in com-
bination with a large-scale off-target analysis can facilitate the generation of multiple
biological replicates for a mutation, which is essential for data interpretation and re-
producibility. Furthermore, several publications have proposed alternative CRISPR
based platforms for genome editing, such as Cas9 proteins from various bacterial
species or different endonucleases like Cpf1 (Ran et al., 2015; Zetsche et al., 2015). Ex-
panding Mismatch qPCR screening to other CRISPR systems would allow the direct
comparison of their efficiency in a quantitative manner.
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2.4 Materials & Methods
Cell culture
Murine ESCs (129XC57BL/6J) were cultured in ESC media containing Knockout-DMEM
(Thermo Fisher) with 15% EmbryoMax FBS (Millipore) and 20 ng/ml leukemia in-
hibitory factor (LIF, produced by Protein Expression Facility at EMBL Heidelberg), 1%
non-essential amino acids, 1% Glutamax, 1% Pen/Strep, 1% of 55mM beta-Mercaptoethanol
solution. Cells were maintained at 37°C with 5% CO2. ESCs were routinely tested for
mycoplasma.
CRISPR editing
This paragraph summarizes the final CRISPR editing strategy, individual steps are described in
more details underneath this paragraph. Guide sequences were cloned into pSpCas9(BB)-
2A-GFP (PX458, Addgene) according to instructions by Ran et al. (2013). For gene
editing, 2x106 ESCs were transfected with 2 µg Cas9-GFP plasmid and 100 µM ssODN
repair templates (180 bp, IDT ultrameres) using electroporation (Nucleofector, Lonza).
Prior to nucleofection, ESCs were treated with 10 µM Scr7 inhibitor (Xcessbio, M60082-
2s) for 12 hours to promote gene editing (Maruyama et al., 2015). Single-cell sorting
was performed 48 hours post-electroporation for GFP positive cells. Colonies were
expanded for genotyping and freezing. To detect gene editing events, clonal cell lines
were lysed in a 96-well plate and screened for successful mutation. Editing events
were confirmed and checked for homozygosity by Sanger Sequencing.
We used sgRNA guides that recognized the following genomic sequences:
Guide target 5’→ 3’ Sequence
sgRNA_H3f3a_g3 Knock-out H3.3A CCTGGGTGCTTTACCACCGG
sgRNA_H3f3b_g7 Edit H3.3B K36A AAGCGCGCCCTCTACCGGCG
sgRNA_H3f3b_g3 Edit H3.3BK4A TTTGCGGGGGGCTTTCCCAC
Repair template 5’→ 3’ Sequence
ssODN_H3f3b_g3_H3.3K4A GGAGCCCGGTGACCTGGCCTTGAACGTCGCTTGTCTCGCAGG
TGAAAAAAAATGGCCCGAACCGCCCAGACCGCTAGGAAGTCC
ACTGGTGGGAAGGCGCCCCGCAAACAGCTGGCCACCAAGGCG
GCTCGGAAAAGCGCGCCCTCTACCGGCGGGGTGAAGAAGCCT
CACCGCTACAGGT
ssODN_H3f3b_g7_H3.3K36A CCAAGCAGACCGCTAGGAAGTCCACCGGTGGGAAAGCCCCCC
GCAAACAGCTGGCCACCAAGGCGGCTCGGAAAAGCGCGCCCA
GTACTGGCGGGGTGGCCAAGCCTCACCGCTACAGGTAGGCAG
AGGGCTGGGAACAATGACTTGGCCGCCGGCTTGCGGGCGGGC
GCTCTCTCCCTTC
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Guide design and cloning into CRISPR plasmid
Guides were designed with homology to a sequence close to the mutation site of in-
terest using MIT’s Optimized CRISPR design tool. As a general guideline, the guide
binding site should ideally be less than 30 nucleotides away from the mutation site
of interest, and can also overlap the mutation site. If the mutation site is close to an
intron, it is recommendend to use an intronic guide sequence in case additional in-
dels occur at the CRISPR cutting site, but this is optional. Guide sequences with an
aggregate score of greater than 50% were selected and cloned into pSpCas9(BB)-2A-
GFP (PX458, Addgene) or pSpCas9(BB)-2A-RFP (modified from PX458) according to
instructions by Ran et al. (2013). For this purpose, phosphorylated DNA oligos (5’-
Phos) were ordered from Eurofins according to this scheme:
CACC + G + guide sequence forward
AAAC + guide sequence reverse + C
pSpCas9(BB)-2A-GFP was digested with BbsI, followed by dephosphorylation using
Antarctica Phosphatase (NEB) and separated from undigested plasmid by 1% agarose
gel electrophoresis. Digested plasmid was extracted from the gel (Gel extraction Kit,
Qiagen). Complementary guide oligos were annealed and cloned into pSpCas9(BB)-
2A-GFP/RFP plasmid, from here on referred to as Cas9-GFP-guide or Cas9-RFP-guide
plasmid.
Design of repair template
The single-stranded repair template was designed to encompass the DNA 90 bp up-
stream and downstream of the Cas9 cutting site as suggested by Ran et al. (2013). I
used IDT’s DNA ultrameres (up to 200 bp) as DNA template. The repair template
contains the mutation of interest (e.g. a lysine to alanine exchange in H3.3 at lysine
4 or lysine 36) and 3 synonymous mutations inside the guide binding site to prevent
repeated cleavage by Cas9. Editing efficiency can be improved if one of these addi-
tional mutations changes the PAM sequence into a non-PAM sequence. Synonymous
mutations do not change the resulting protein sequence, and should be chosen in a
way that codon usage frequency is considered and codons with very low frequencies
should not be used as they can alter expression levels of the encoded protein. To
generate double-stranded repair templates (dsDNA) the single-stranded repair tem-
plate was amplified in a PCR reaction using one primer annealing to the 5’end of the
template. This results in linear amplification of the complementary strand.
Nucleofection
For gene editing 2x106 ESCs were transfected with 2 µg Cas9-GFP-guide plasmid and
5 µl of 100 µM ssODN repair templates (180 bp, IDT ultrameres) using electroporation
(Nucleofector, Lonza). Cells were resuspended in 100 µl of P3 solution (Lonza) and
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2 µg plasmid DNA and 5 µl donor template were added. Cells were transferred into
a cuvette and electroporated with pulse code CG 104 for mouse ESCs (“ES, mouse”).
After electroporation cells were plated into a T-25s flask with pre-plated MEFs contain-
ing ESC media. For drug treatment, ESCs were treated with 5 µM L755,505 (Xcessbio,
M60237-2s) or 10 µM Scr7 inhibitor (Xcessbio, M60082-2s) for 12 hours prior to nu-
cleofection and for additional 24 hours after nucleofection to promote gene editing
(Maruyama et al., 2015; Chu et al., 2015; Yu et al., 2015).
Single-cell sorting by flow cytometry
Single-cell sorting by flow cytometry was performed 48 hours post-electroporation for
GFP positive cells. Single ESCs were sorted into the wells of a 96-well plate containing
pre-plated MEFs and 150 µl of ESC media. Cells were sorted on an FacsAria Fusion
sorter (BD Biosciences). Gating was performed with BD’s FACSDiva 8.0.1 software
and single cells were chosen for analysis after doublet discrimination by detection of
disproportions between cell size (FSC-A) vs. cell signal (FSC-H). Correlation of FSC A
vs. H, the same cell will have the same (or very similar) values in both axis. Therefore,
all singlet events will fall more on a diagonal than doublets. The gating strategy for
GFP-positive transfected cells is depicted in Supp. Fig. S1.
Cell expansion and lysis
Growing cell colonies were dispersed 6 days after sorting and 9 days after sorting split
into 2 identical 96-well plates. One plate was used for freezing in DMSO-containing
medium and the second was used for screening of clones. To detect gene editing
events, clonal cell lines were lysed directly in a 96-well plate. For cell lysis medium
was removed from wells and 70 µl of direct-lysis solution (301-C, Viagen Biotech) sup-
plemented with 0.5 mg/ml proteinase K (Roche 03115887001) were added to each well.
Cells were lysed at 55°C for 2 hours, shaking at 350 rpm and afterwards proteinase K
was heat deactivated for 45 min at 85°C. Cell lysates can be stored at 4°C for up to one
week, for long-time storage (1-2 months) lysates were frozen at -20°C.
Mismatch qPCR
Screening primers to detect genome editing events by qPCR should be suitable for
standard qPCR reaction and the total amplicon size should be under 150 bp to guaran-
tee successful amplification during elongation step. One of the primers encompasses
the editing site, ideally directly ending with a point mutation on the 3’ end. Thus,
amplification with this primer should not work on the wild type sequence. Instead,
the wild-type primer is designed to recognize the unmodified genomic sequence. Re-
verse primer recognizes the wild-type sequence away from the CRISPR editing site.
For editing screen, 0.5 µl of the crude lysate are sufficient for a 20 µl qPCR reaction
(96-well plate) or 0.25 µl for a 10 µl qPCR reaction (384-well plate), higher amounts
of crude lysate can interfere with PCR reaction. DNA from a bulk sorting should be
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included as a positive control and wild type DNA from unmodified cells as a negative
control. qPCR is run with a standard cycling program to detect cycle threshold (Ct)
values. All clones with significantly lower Ct numbers than the negative control (wild
type), and similar or lower Ct values than the positive control were used for down-
stream validation. For sanger sequencing, a region of 1-1.5 kb around the mutation
site was amplified by PCR and sequenced from both ends to confirm editing. The
crude lysates can also be used for genotyping, but may result in low-quality Sanger
sequencing. In this case it is recommended to thaw all positive clones, expand them
and extract genomic DNA (Puregene Core Kit B, Qiagen) to improve the quality of the
sequencing reaction. Editing events were confirmed and checked for homozygosity by
analyzing the chromatogram (SnapGene Viewer) of the Sanger Sequencing reaction.
Restriction Digest
A DNA fragment of 1kb around the CRISPR cutting site was amplified using PCR.
PCR product was digested with a suitable restriction enzyme (for which restriction
site was inserted into the genome) for 30 minutes at 37°C. Digestion products were
analyzed by agarose gel electrophoresis.
Knock-out of H3.3A
For knockout of H3.3A, ESCs were nucleofected with 2 µg Cas9-GFP plasmid as de-
scribed above for gene editing, but without Scr7 treatment or a repair template. For
screening of knock-out, RNA was extracted from cells and 1 ug of total RNA was
reverse transcribed using random primers (High Capacity Reverse Transcriptase, Ap-
plied Biosystems). Resulting cDNA was used as template for PCR reaction. Primers
were complementary for the H3.3A coding sequence. Length of the amplicon was
visualized by agarose gel electrophoresis and shorter amplicons were indicative for
successful removal of the first exon and therefore knock-out of H3.3A. Alternatively,
deletions were detected by by PCR on genomic DNA of clonal cell lines followed by
agarose gel electrophoresis. Deletions were visible by shifts to lower amplicon sizes.
Finally, deletions were confirmed by Sanger sequencing and RNA-Seq analysis.
CRISPR off-target analysis by RNA-Seq analysis
CRISPR off-target effects in the form of chromosomal duplications/deletions were
ruled out by RNA-sequencing. RNA-Seq analysis. RNAs were extracted from approx.
1x106 cells using RNeasy Kit (Qiagen), followed by DNase digestion using TURBO
DNase (Thermo Fisher). mRNAs were isolated from 1 µg of total RNA using a PolyA
selection kit (NEB) and sequencing libraries were prepared following instructions
from NEBs Ultra Library Preparation Kit for Illumina. All samples were barcoded,
pooled and sequenced on a HiSeq2000 Sequencer (Illumina) using a 50 bp single-end
run. Sequencing reads were mapped to mouse reference genome (mm10 assembly)
using Tophat2 aligner with default settings for single-end reads. Reads per gene
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were counted using HTSeqCount union or intersection_nonempty mode. We used
Ensembl gene annotation Mus_musculus.GRCm38.83. Differential RNA-Seq analysis
between clone and wild type cells was performed and log2(FoldChanges) were plot-
ted over chromosome position to obtain distribution profiles of overall gene expression
changes. Cell lines that displayed deletions or duplications of chromosome regions,
as seen by concomitant up- or down-regulation of close-by genes, were discarded and
not used for analysis.
Protein extraction & Immunoblotting
For crude nuclear extraction, cells were resuspended in PBS+0.05% Triton-X and ro-
tated for 30 min at 4°C to lyse cells. Nuclei were pelleted by centrifugation at 1000xg
for 5 min at 4°C, resuspended in SDS loading dye and sonicated with EpiShear Son-
icator (Active Motif). Prepared lysates were separated in MES buffer on precast
4–12% Bis-Tris SDS-PAGE gels (Thermo) and transferred onto nitrocellulose mem-
branes. Blots were incubated overnight with primary antibodies, for 1 hour with
HRP-conjugated secondary antibody and developed using enhanced chemilumines-
cent substrate (Thermo Fisher). I we used the following antibodies: H3.3 (09-838,
Millipore), H3 (ab18521, abcam), H4 (ab10158, abcam), and secondary antibodies goat
anti-mouse IgG-HRP (1721011, BioRad), goat anti-rabbit IgG-HRP (1706515, BioRad).
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histone H3.3 mutants
3.1 Background
Histone H3 plays a central role in the chromatin-based epigenetic regulation of gene
expression. The dependence on histone H3 tail residues can vary greatly between
different organisms, and single mutations that are viable in yeast can have severe phe-
notypic outcomes in animals. In yeast, remarkably few residues within the N-terminal
tail are essential for viability, and even long deletions of the N-terminal region of H3
are tolerable to a great extent (Dai et al., 2008; Nakanishi et al., 2008). In animals,
mutations of H3 tail residues can induce morphological defects (Pengelly et al., 2013;
Herz et al., 2014), result in lethality (McKay et al., 2015) or can contribute to the devel-
opment of cancer (Schwartzentruber et al., 2012; Wu et al., 2012; Lu et al., 2016). Thus,
histone tail residues appear to be increasingly important in organisms that exhibit
diverse regulation of genome activity across different cell types and developmental
stages. The expansion of histone mutation studies to mammalian development will
greatly increase our understanding of the functional role of the H3K4 and H3K36, and
other histone residues. In the following, I will summarize the roles that have been
attributed to the methylation of H3K4 and H3K36, respectively.
H3K4 methylation
H3K4 methylation is an evolutionarily conserved histone modification that marks
transcription start sites (TSS) and promoters (Hyun et al., 2017; Shilatifard, 2012). In
yeast, the only H3K4 Histone methyltransferase (HMTase) is Set1, which acts as part
of the multi-subunit COMPASS complex (Briggs et al., 2001; Miller et al., 2001; Roguev
et al., 2001). Set1 and its H3K4 methyltransferase activity are conserved from yeast to
humans, but animals carry multiple homologs of this protein. D. melanogaster has three
Set1 homologs (Set1, Trx and Trr), and mammals harbor six homologs (Set1a, Set1b,
Mll1, Mll2, Mll3, and Mll4), which form different complexes with non-redundant func-
tions (Hyun et al., 2017; Shilatifard, 2012). Among these, mammalian Set1a and Set1b
are the orthologs of yeast Set1 and can produce all three H3K4 methylation states,
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Mll1/2 can catalyze H3K4 mono- and di-methylation, whereas the activity of Mll3/4
is restricted to H3K4 mono-methylation (Shinsky et al., 2015). Mutations in H3K4
HMTases are highly associated with the development of cancer (Rao and Dou, 2015)
and various translocations of the Mll gene underlie a variety of lymphoid tumors, as
well different types of leukemia in children and adults (Shilatifard, 2012; Tenney and
Shilatifard, 2005).
H3K4 methylation is associated with regulatory regions of the genome and the degree
of methylation differs depending on the genomic site. H3K4me1 is highly enriched
at enhancers, H3K4me2 is highest toward the 5’end of transcribed genes (Kim and
Buratowski, 2009), and H3K4me3 is a hallmark of promoter (Heintzman et al., 2007).
In yeast, H3K4 methylation is deposited downstream of transcription and is medi-
ated by the recruitment of the HMTase Set1 to the 5’end of the coding region by the
transcribing Pol II (Ng et al., 2003; Haberle and Stark, 2018). Thus, H3K4me3 only
marks promoters of actively expressed genes in yeast (Santos-Rosa et al., 2002), and it
has been suggested to provide a memory mark of recent transcriptional activity, and
to facilitate new rounds of transcription (Ng et al., 2003). Instead, the mammalian
Set1 complex is targeted to many promoters by binding to unmethylated CpG islands
through its Cfp1 subunit (Clouaire et al., 2014, 2012; Brown et al., 2017). In animals,
H3K4me3 marks both inactive and active promoters (Barski et al., 2007; Guenther
et al., 2007; Mikkelsen et al., 2007), suggesting that H3K4 methylation alone is not suf-
ficient to activate transcription. The co-occurence of H3K4 methylation with H3K27
acetylation distinguishes active promoters (Wang et al., 2008) and enhancers (Rada-
Iglesias et al., 2011; Bonn et al., 2012; Creyghton et al., 2010) from their disengaged
state in mammals and Drosophila. Conversely, at poised promoters H3K4me3 is found
together with PRC2-mediated H3K27me3, which keeps developmental genes in a re-
pressed state primed for fast activation during development (Mikkelsen et al., 2007).
Although H3K4me3 and H3K27ac correlate with transcriptional activity (Wang et al.,
2013; Barski et al., 2007; Guenther et al., 2007; Heintzman et al., 2007), whether they
are causally involved in mammalian transcription is not clear.
H3K36
Similar to H3K4, methylation of H3K36 is highly conserved from yeast to humans
(Wagner and Carpenter, 2012). Set2 is the sole H3K36 methyltransferase in yeast,
which catalyzes all three methylation states (Kizer et al., 2005). Mammalian cells
contain at least eight different H3K36 HMTases and among these Setd2, Nsd1, Nsd2
and Nsd3 are considered to catalyze the majority of H3K36 methylation (Hyun et al.,
2017). Only Setd2 can produce H3K36 tri-methylation, whereas the other enzymes
including Nsd1/2/3 are restricted to mono- and/or di-methylation (Edmunds et al.,
2008). Mutations of H3K36 HMTases have been reported in numerous human diseases,
such as Sotos syndrome (Kurotaki et al., 2002; Douglas et al., 2003), Wolf–Hirschhorn
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syndrome (Stec et al., 1998; Nimura et al., 2009) and blood cancer (acute myeloid
leukaemia) (Jaju et al., 2001).
Genes display a progressive shift from di- to tri-methylation of H3K36 between their
promoters and 3’end (Wagner and Carpenter, 2012; Bannister et al., 2005) and vari-
ous functions have been attributed to H3K36 methylation. In yeast, Set2 is recruited
co-transcriptionally by Pol II (Li et al., 2003; Krogan et al., 2003) and deposits H3K36
methylation during transcriptional elongation, resulting in high levels of H3K36me3
in gene bodies of actively transcribed genes (Kizer et al., 2005; Li et al., 2003, 2002).
Because of its association with active transcription, H3K36me3 is generally viewed as
an activating mark. However, in other cases it has been reported to recruit repressors
of transcriptional elongation to specific target genes (Wen et al., 2014).
Another reported function of H3K36 methylation is the suppression of cryptic tran-
scription initiation. In yeast, H3K36 methylation (H3K36me1/me2) by Set2 recruits
histone deacetylases to coding regions to suppress transcription initiation inside genes
(Carrozza et al., 2005). Similarly, associations of mammalian Set2 homologs with elon-
gating Pol II have also been observed (Yuan et al., 2009; Sun et al., 2005). In mammalian
cells, H3K36 methylation has been reported to prevent cryptic transcription initiation
either by promoting the demethylation of H3K4 (Fang et al., 2010) or by recruiting
DNA methyltransferase Dnmt3a to gene bodies (Dhayalan et al., 2010).
Furthermore, low rates of histone exchange have been observed inside coding regions
(Dion et al., 2007; Kraushaar et al., 2013; Rufiange et al., 2007; Deal et al., 2010) and
methylation of H3K36 in newly deposited histones has been reported to suppress hi-
stone exchange inside genes of the yeast genome (Smolle et al., 2012). This suggests
that H3K36 modifications could be important for recycling of old histones during tran-
scriptional elongation.
Furthermore, H3K36 methylation has an antagonistic relationship with H3K27 methy-
lation (Young et al., 2011), and methylation of H3K36 in a nucleosome usually pre-
cludes deposition of H3K27 methylation (Yuan et al., 2011). This inhibition of PRC2
by H3K36me2/me3 is conserved in mammals and flies, and could restrict the expan-
sion of PRC2-mediated repressive H3K27me3 to transcriptionally active chromatin and
other regions (Schmitges et al., 2011).
In animals, exons are generally marked by higher H3K36me3 levels than introns
(Kolasinska-Zwierz et al., 2009; Wilhelm et al., 2011) and it has been repeatedly sug-
gested that H3K36 methylation by Setd2 regulates alternative splicing (Luco et al.,
2010; Kim et al., 2011). Evidence for this comes from observations that Setd2 depletion
causes deregulation of exon exclusion (Luco et al., 2010). Furthermore, splicing events
result in enhanced recruitment of Setd2 to genes, which is in line with observations
that intron-less genes have generally lower H3K36me3 levels than intron-containing
genes (de Almeida et al., 2011).
Together, this demonstrates the need of directly testing the function attributed to hi-
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stone residues, rather than relying purely on correlation or indirect interference from
phenotypes of mutant enzymes that catalyze modifications. In this chapter, I will
describe the characterization of mouse ESCs that carry homozygous point mutations
in histone H3.3 at lysine 4 and 36 (H3.3K4A/K36A). I aim to test the impact of the
mutation on transcriptional regulation and splicing in pluripotent ESCs and neuronal
development by RNA-Seq. Second, I profile how lysine residues in H3.3 contribute to
H3.3 deposition and histone turnover at distinct chromatin types, such as active genes
and regulatory regions. Last, I address how the epigenetic landscape of mouse ESCs
is perturbed by H3.3 mutations using antibody-based approaches such as immunoblot
and ChIP-Seq and antibody-independent approaches such as mass spectrometry.
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3.2 Results
I conducted the experiments and analyzed the data described in this chapter, unless indicated
otherwise. Nichole Diaz repeatedly assisted me with cell culture work and she performed the
growth assay of mutant and wild type ESCs in Fig. 3.3a. Marlena Lübke, a master student,
who conducted her master thesis under the supervision of Kyung-Min Noh and myself, per-
formed immunofluorescence in differentiated neuron cultures and the images are depicted in
Fig. 3.5b. She also collected the data for the cell cycle analysis in Fig. 3.4. Simone Sidoli per-
formed mass spectrometry measurements of histone modifications and analyzed the data in Fig.
3.18. Daria Bunina performed the clustering analysis of combined ChIP-Seq and RNA-Seq
data and generated the heatmap displayed in Fig. 3.21a).
3.2.1 Characterization of H3.3K4A and H3.3K36A mutant ESCs and their
developmental potential
In ESCs, H3.3 provides approximately 25% of the entire H3 pool, but it accumulates in
cells of the brain throughout development and into adulthood, replacing canonical H3
in neuronal nucleosomes (Pina and Suau, 1987; Maze et al., 2015). Thus, I expected that
H3.3 mutations would have a severe impact in post-mitotic neurons but not in rapidly-
dividing, pluripotent ESCs. I characterized the control and K4A/K36A mutants at the
ESC stage and I differentiated them into neural precursor cells (NPCs) and post-mitotic
glutamatergic neurons to investigate whether H3.3 mutants can give rise to specialized
cell types (Fig. 3.1, overview of differentiation protocol in Fig. S2).
Neuronal Differentiation
ctrl
(n = 2)
K4A
(n = 3) 
K36A
(n = 3)
- LIF
+ Retinoic acid
stem cells
ESC - Day 0
neural precursors
NPC - Day 8
mature glutamatergic 
neurons - Day 12
H3.3A:  KO
H3.3B:  WT
H3.3A:  KO
H3.3B:  Lys4 to Ala
H3.3A:  KO
H3.3B:  Lys36 to Ala
Gene editing with CRISPR
Figure 3.1: Experimental design to study the role of histone H3.3K4 and H3.3K36 residues. Three
independent clonal lines with a homozygous H3f3a gene knock-out and homozygous H3f3b mutations of
lysine 4 or 36 to alanine, along with two independent clonal lines with a homozygous H3f3a knock-out
as controls are established using CRISPR-Cas9. Control and mutant ESCs are differentiated by formation
of embryoid bodies (EBs) into neural precursors (Day 8), then further into glutamatergic neurons (Day
12) according to a modified protocol by Bibel et al. (2007).
At the ESC stage, K4A and K36A mutants grown on feeder layer of mouse embryonic
fibroblasts (MEFs) displayed normal morphology and grew in round, dense colonies
comparable to controls (Fig. 3.2). When ESCs were removed from the feeder layer,
K4A mutants displayed a minor morphology change and cells were slightly flatter
and larger than those of controls and K36A cells, which grew more densely packed.
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Figure 3.2: Morphology of control and K4A/K36A mutant ESCs. ESCs of control and K4A/K36A
mutants were grown either on feeder layer of MEFs (+ MEFs) or as feeder-free culture on gelatine (-
MEFs).
K4A and K36A clones showed comparable growth rates with wild type and control
clones at the ESC stage (Fig. 3.3a). Cell cycle analysis revealed that ESCs are highly
proliferative with approximately 70% of all cells residing in S-Phase (Fig. 3.3b). K4A
and K36A mutants had comparable, but slightly elevated proliferation rates compared
to controls. This suggests that mutants displayed no cell cycle arrest and that self-
renewal of ESCs was maintained.
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Figure 3.3: Self-renewal of K4A/K36A mutant ESCs is maintained but K4A results in slower cell
growth during neuro-differentiation. (a) Cell growth assay of wild type, control and mutant ESCs.
Error bars indicate standard deviation of biological replicates; n=3. Wild type are ESCs without CRISPR
targeting. (b) Cell proliferation analysis of control and mutant ESCs. The percentage of proliferating
cells residing in S-Phase were measured in ESCs by detecting the incorporation of labeled nucleotides
(EdU) during DNA synthesis followed by flow cytometry analysis. Displayed are the percentages of cells
detected in S-Phase (EdU+). Flow cytometry analysis was performed according to gating strategy in
Fig. S3. Biological replicates were n=2, except for wild type (n=1). Unpaired t-test was used to calculate
significance. (c) Quantification of cell numbers obtained from EBs on differentiation day 4 and 8 of
wild type, control, K36A and K4A cells. Error bars indicate standard deviation of biological replicates.
Unpaired t-test was used to calculate significance. Biological replicates were n=2 (control), n=3 (K4A or
K36A).
Once neuronal differentiation into NPCs was induced, K4A mutants displayed sig-
nificantly reduced cell numbers by 25% on day 4 and by 50% on day 8 compared to
controls and K36A mutants (Fig. 3.3c). Cell cycle analysis revealed that NPCs are less
proliferative than ESCs and only 20% of cells reside in S-phase (Fig. 3.4). Whereas
51
Chapter 3.
K36A mutant NPCs displayed comparable proliferation rates to controls, the K4A mu-
tant NPCs had a higher frequency of proliferating cells in the population, which could
indicate that K4A mutants were slower at exiting the cell cycle during neuronal dif-
ferentiation compared to controls. Alternatively, this data can also suggest that K4A
mutants have a prolonged S-phase and require longer time to replicate their DNA. It
will require further investigation to test if a prolonged S-phase caused the strongly
reduced cell numbers of the K4A mutants at the NPC stage, or whether other factors,
such as increased apoptosis, contributed to this.
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Figure 3.4: Cell cycle analysis of H3.3K4A/K36A mutants in neuronal development. The percentage
of proliferating cells residing in S-Phase were measured in ESCs and during neuronal differentiation
by detecting the incorporation of labeled nucleotides (EdU) during DNA synthesis followed by flow
cytometry analysis. Analyzed time points include pluripotent ESCs, NPCs (D8), immature neurons (D9)
and mature glutamatergic neurons (D12) and displayed are the percentages of cells detected either in
S-Phase (EdU+), G0/G1/G2/M Phase (EdU-). Flow cytometry analysis was done according to gating
strategy in Fig. S3. Biological replicates were n=2, except for wild type (WT) cells and for K4A cells on
day 9 (n=1, indicated by "S" in plot).
Upon further neuro-differentiation into glutamatergic neurons, K4A cells formed a
heterogeneous population consisting of non-neural cells and neuron-like cells that dif-
fer from control neurons both in their reduced interconnectivity, and viability (Fig.
3.5a). K4A neurons showed less expression of mature neuronal marker (Map2) at den-
dritic and axonal structures, and lacked structural polarity (Fig. 3.5b). We also noted
densely packed areas of the cells expressing neuronal stem cell marker (Sox2), but not
Map2, suggesting that these cells were immature progenitor cells (Fig. 3.5b). In con-
trast, K36A cells differentiated into neurons with normal morphology, forming Map2
positive axonal networks, but at a higher cell density than controls (Fig. 3.5a,b). Cell
cycle analysis revealed that the fraction of proliferating cells has further decreased to
10% in immature neurons (D9) and to less than 5% in mature glutamatergic neurons
(D12), supporting that 12 days of neuronal differentiation were sufficient to obtain
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post-mitotic neurons that exit the cell cycle and enter quiescent G0 phase (Fig. 3.4).
In immature neurons (D9), K36A mutants displayed slightly elevated levels of pro-
liferating cells, which could contribute to the observed higher cell density density of
the neuron culture. At the final neuron stage of differentiation (D12), the majority of
K4A and K36A mutants have exited the cell cycle comparable to controls and reside
in quiescent G0 phase (Fig. 3.4). Overall, morphological differences of derived neu-
rons and reduced cell numbers suggest that neuro-development of K4A mutants is
impaired, and that defects already occurred before commitment to the neuronal lin-
eage. Thus, the majority of H3.3K4A cells, but not K36A cells, failed to undergo cell
lineage specification required for the formation of glutamatergic neurons.
Figure 3.5: H3.3K4A, but not K36A, results in erratic morphology during neuro-differentiation from
ESCs. (a) Representative bright field images of neuron populations on day 12 of differentiation. (b)
Merged immunofluorescence images of neuron populations on day 12 stained with antibodies against
Map2 or Sox2 and DAPI to detect nuclei. Map2 stains axonal and dendritic structures of mature neurons
and Sox2 stains neural stem cells
3.2.2 Impact of H3.3K4A and H3.3K36A mutations on gene expression in
ESCs and neurons
To investigate the effects of the H3.3 mutants on transcription during differentiation,
I used mRNA-sequencing at the ESC and neuron stage. Hierarchical clustering re-
vealed altered gene expression profiles for H3.3K36A mutants only after differentia-
tion into neurons, but for H3.3K4A mutants already in ESCs (Fig. 3.6a). The H3.3K36A
mutation caused relatively small gene expression changes in ESCs (409 differentially
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expressed geness (DEGs) in ESCs, FDR < 0.05, Fig. 3.6b), which indicates that the
H3.3K36A has only a minor impact in ESCs. Notably, H3.3K4A mutants exhibit
widespread gene expression changes in both ESCs and neurons (2766 DEG in ESCs,
4969 DEG in neurons, FDR < 0.05, Fig. 3.6b).
Figure 3.6: H3.3K4A and K36A induce distinct changes in transcription in ESCs and neurons. (a)
Heat map representation of sample relationships of rlog-transformed gene counts obtained from RNA-
Seq data obtained from ESCs (top) and differentiated neurons (bottom). Dendrograms are derived from
unsupervised hierarchical clustering and are indicative of the similarities between samples. (b) Volcano
plot of differentially expressed genes (DEG) for H3.3K4A and H3.3K36A mutants compared to controls
at the ESCs (top) and neuron stage (bottom). Significant DEG with FDR < 0.05 are marked by color and
the total number of significant up- and down-regulated genes are displayed for each condition. Biological
replicates were n=2 (controls) or n=3 (K4A and K36A).
Gene ontology (GO) analysis of DEGs in ESCs showed that down-regulated genes
in K4A mutants were enriched for genes associated with several developmental path-
ways, including brain development, angiogenesis and heart morphogenesis (Fig. 3.7a).
Up-regulated genes were associated with stem cell maintenance and response to leukemia
inhibitory factor LIF, but also with meiosis-related functions (spermatogenesis, ooge-
nesis) and developmental processes. Furthermore, analysis of the expression levels
of pluripotent factors revealed that many pluripotency factors including Klf4, Esrrb,
Oct4 and Sox2, but not Nanog, were significantly higher expressed in K4A mutants,
but their expression was unaffected in K36A mutants (Fig. 3.7b). RNA-Seq analy-
sis suggests that the developmental potential of K4A ESCs is affected, possibly due
to elevated expression levels of pluripotency factors and widespread gene expression
changes, including the misregulation of genes linked to neuronal development.
In agreement with the expectations of an increasing importance of H3.3 in neurons,
the H3.3K36A mutation caused greater gene expression changes in neurons than in
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Figure 3.7: Gene expression analysis of H3.3K4/K36A mutant ESCs. (a) Some of the top most en-
riched GO terms within biological process categories for down-regulated genes (left) or up-regulated
genes (right) in H3.3K4A ESCs (log2Fold change <-0.58, FDR < 0.05). Analysis was performed using the
topGO package (Bioconductor). Significant GO terms were selected using Fisher classic and Fisher elim
algorithm and depicted FDR values are derived from Fisher elim test. (b) Normalized RNA-Seq counts
representing gene expression for pluripotency stem cell markers (Klf4, Esrrb, Nanog, Oct4 and Sox2) in
controls, H3.3K36A, H3.3K4A and wild type (WT) ESCs. Depicted p values for differentially expressed
genes were calculated with DESeq2 and adjusted using the Benjamini Hochberg’s method (padj).
ESCs (409 DEGs in ESCs, 2174 DEG in neurons, FDR < 0.05, Fig. 3.6b). In neurons,
up-regulated genes were enriched with GO terms related to neuron maturation such as
axonogenesis, whereas down-regulated genes were related to proliferation, cell death,
and mature neuronal signaling pathways (Fig. 3.8b). This indicates that K36A mutant
form more immature neurons than control cells, resulting in higher cell density and
significantly lower expression of mature glutamatergic markers (Fig. 3.8c). These
results also indicate that the H3.3K36A mutation induces aberrant expression of genes
that are necessary for development into post-mitotic glutamatergic neurons, but has
only a minor impact in ESCs.
H3.3K4A cells displayed gene expression changes superficially similar to controls
during development, overall expressing neurodevelopmental genes and repressing
pluripotency genes, but with detailed transcriptional regulation clearly perturbed.
Specifically, H3.3K4A neurons showed higher expression levels of genes that should
have been repressed during differentiation relative to controls (e.g., genes linked with
endoderm/mesoderm development and mitosis/meiosis, Fig. 3.8a and Fig. 3.9a,c),
and higher levels of neural stem cell markers comparable to those seen in the neural
precursor state of wild type cells (Fig. 3.8c). In addition, we observed atypically low
expression of genes involved in cell signaling and ectoderm development (neuronal
lineage) (Fig. 3.8 and Fig. 3.9a,c) and mature glutamatergic markers (Fig. 3.8c). Thus,
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Figure 3.8: Gene expression analysis of H3.3K4/K36A mutant neurons. (a) Some of the top most
enriched GO terms within biological process categories for down-regulated (left) or up-regulated genes
(right) in H3.3K4A neurons on day 12 (log2Fold change <-0.58, FDR < 0.05). Analysis using the topGO
package (Bioconductor). Significant GO terms were selected using Fisher classic and Fisher elim algo-
rithm and depicted FDR values are derived from Fisher elim test. (b) GO term analysis as in (a) but
for H3.3K36A mutant neurons. (c) Normalized RNA-Seq counts representing gene expression for imma-
ture neural stem cell markers (Nestin, Notch1, Sox2) and mature glutamatergic neuron markers (Grin2b,
Slc17a6, Grin1) of controls, H3.3K36A, H3.3K4A and wild type (WT) neurons in comparison to WT neu-
ral precursors derived on day 8. Depicted p values for differentially expressed genes were calculated
with DESeq2 and adjusted using Benjamini Hochberg’s method (padj).
H3.3K4A mutants seem to suffer a developmental arrest, suggesting that the H3.3K4
residue is required to maintain gene expression levels in stem cells that in turn co-
ordinate appropriate lineage specifications, such as development into glutamatergic
neurons. A study using H3.3 knockdown (Banaszynski et al., 2013) reported less pro-
nounced transcriptome changes in ESCs than observed in K4A cells, implying that a
H3.3K4A mutation may induce more extensive changes in the chromatin environment
than expected for a loss-of-function mutation.
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Figure 3.9: H3.3K4A affects the activation of developmental genes and repression of pluripotency
genes. (a) Heatmap of RNA-Seq data displaying gene expression changes during neuronal development
of wild type ESCs into glutamatergic neurons. All genes were sorted into five clusters (k-means cluster-
ing) according to their expression during neurodevelopment (D0, D4, D8, D12). Most enriched biological
GO terms for each cluster are indicated and were identified using DAVID database. (b,c) Gene expression
changes of H3.3K4A/K36A ESCs (b) and neurons (c) compared to controls were plotted per gene cluster
defined in (a). Positive values represent overall higher expression of genes inside the cluster compared to
control cells, negative values represent lower expression of genes inside the cluster compared to control
cells.
3.2.2.1 Genomic enrichment of wild type and mutant H3.3 determined by H3.3-
ChIP-Seq
H3.3 enrichment
H3.3 is expressed and assembled into nucleosomes throughout the cell cycle and re-
places replication-dependent canonical H3 in nucleosomes at regions with high hi-
stone exchange, such as regulatory regions of the genome and actively transcribed
genes. As a consequence, H3.3 becomes relatively enriched at these regions compared
to intergenic sites in ESCs (Goldberg et al., 2010). I mapped H3.3 enriched loci in the
ESC genome using chromatin immunoprecipitation coupled with DNA sequencing
(ChIP-Seq) to address if histone mutation influence the localization of H3.3 at distinct
genomic regions. Interestingly, average ChIP-Seq profiles for control and mutant H3.3
at annotated genes revealed a significant depletion of the H3.3K4A protein from the
TSS, but not from gene bodies and transcriptional end sites (TES) (Fig. 3.10a,c). The
most pronounced depletion of H3.3K4A was observed at active TSS (Pol II occupied),
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Figure 3.10: H3.3K4A, but not K36A, is depleted at TSS and enhancers in ESCs. (a) Density profile
of H3.3-ChIP-Seq reads over annotated genes in H3.3 control and K4A/K36A ESCs. Reads per million
mapped reads were plotted over TSS, scaled gene bodies and TES using NGSplot (Shen et al., 2014).
n=2 biological replicates. (b) Analysis of H3.3 enrichment in control, H3.3K4A and H3.3K36A ESCs at
indicated genomic regions. H3.3-ChIP-Seq reads per kilobase per million mapped reads (RPKM) were
calculated for the following features: inactive TSS (±1.5kb), active TSS (±1.5kb); gene body and TES
(±1.5kb) of active genes; ESC-specific enhancers and enhancers of other tissue-types. Enhancers and
activity status of TSS based on Pol II occupancy were predicted by Shen et al. (2012) Number of analyzed
genomic features (n) are depicted underneath boxplot. RPKM levels higher than those of input indicate
enrichment of H3.3. ChIP n=2, Input n=3 biological replicates. (c) ChIP-Seq tracks of representative genes
that display depletion of H3.3K4A mutant around the TSS, marked by H3K4me3. Black boxes indicate
the depleted region. (d) Nucleosome positioning profile around the TSS in H3.3 control and H3.3K4A
ESCs. MNase-digested DNA was prepared for MNase-Seq and reads per million mapped reads were
plotted over TSS of all mm10 genes using NGSplot (Shen et al., 2014). Typical nucleosome pattern (150
bp) is visible.
inactive TSS (Pol II unoccupied) and predicted ESC-specific enhancers (Shen et al.,
2012), compared to wild type H3.3 (Fig. 3.10b). Inside gene bodies and around TES of
active genes, H3.3 was enriched independent of the mutation (Fig. 3.10b). Mapping
the positioning of nucleosomes using MNase-seq showed only a slight reduction in to-
tal nucleosome density around TSS in K4A cells (Fig. 3.10d), suggesting that H3.3K4A
depletion was mostly compensated by nucleosomes containing canonical H3.1/H3.2.
To confirm the TSS-specific depletion of H3.3K4A observed by ChIP-Seq, enrichment
of wild type and mutant H3.3 was measured at the TSS and TES in ESC lines ex-
pressing a SNAP-tagged version of H3.3 (Deaton et al., 2016). For this, H3.3-SNAP
expression was induced with doxycycline from an inducible promoter followed by
pulse-labeling of the available protein with SNAP-biotin (Fig. 3.11a). ChIP-qPCR
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for labeled H3.3 showed again that H3.3K4A was depleted from TSS, but not TES,
compared to wild type and H3.3K36A (Fig. 3.11b). A lysine-to-arginine mutation
(H3.3K4R) that preserves the positive charge on the mutated residue also showed hi-
stone depletion at TSS (Fig. 3.11b), suggesting that the H3.3K4 residue itself, and not
its positive charge, is essential to maintain histones at the TSS.
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Figure 3.11: H3.3K4A is depleted at TSS, but not TES. (a) Experimental overview for a pulse labeling
experiment of H3.3 protein. ESC lines were generated by stably integrating wild type or mutant H3.3
with a C-terminal SNAP-tag into the Hprt locus (Deaton et al., 2016; Iacovino et al., 2011). Expression of
H3.3-SNAP was induced with Doxycycline (Dox) for 48 hours. Cells were incubated with biotin-SNAP
for 30 min to label all available H3.3-SNAP. Cells were washed for 1 hour to remove free biotin. Labeled
H3.3 was precipitated with Streptavidin beads. (b) ChIP-qPCR results for H3.3-SNAP Biotin labeling
experiment. Relative enrichment over input of H3.3 wild type, K4A, K36A and K4R (lysine to arginine)
mutants was measured at TSS and TES of indicated genes, or a gene-free region on chromosome 6 (neg.
ctrl). n=2 biological replicates measured in 2 technical replicates. P-values were measured by Student’s
t-test.
Co-transcriptional H3.3 exchange at coding regions
Histone exchange of H3.3 occurs at both the promoter and the coding regions, but the
turnover rates can vary and coding regions undergo less H3.3 exchange than the pro-
moters (Venkatesh and Workman, 2015; Deaton et al., 2016; Kraushaar et al., 2013). The
exchange in coding regions of genes occurs in a co-transcriptional manner (Venkatesh
and Workman, 2015), and transcriptional elongation by Pol II recruits Set2 and results
in higher H3K36me3 levels at these sites (Kizer et al., 2005). Thus, it has been specu-
lated that H3K36me3 in coding regions prevents histone exchange behind transcribing
Pol II (e.g. recycling through reassembly or preventing disassembly) to facilitate tran-
scriptional elongation, thereby resulting in lower turnover rates. This prediction was
unfulfilled in mutant cells as the H3.3K4A and H3.3K36A mutations did not impact
enrichment of H3.3 inside coding regions or at TES as measured by ChIP-Seq and
ChIP-qPCR (Fig. 3.10b and Fig. 3.11b). Additionally, I tested whether mutant H3.3
shows more rapid exchange at TES than wild type H3.3 using the previously described
SNAP-system (Fig. 3.11a). Wild type and mutant H3.3-SNAP were pulse-labeled in
ESCs and enrichment of labeled protein at the TES was quantified after 3 and 6 hours.
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Exchange with newly synthesized, unlabelled protein is expected to result in lower
H3.3 enrichment as measured by ChIP-qPCR. After 3 hours, H3.3 was still readily de-
tectable at the TES of all tested genes independent of the mutation (Fig. 3.12). After 6
hours, H3.3 was lost from the TES of highly expressed genes Rps19, Slc2a3 and Nanog,
whereas TES of developmental genes Rara and Phc1 still maintained enrichment of la-
beled H3.3. However, I did not observe a significant difference between wild type and
mutant H3.3 at both time points. Thus, histone exchange of H3.3 at coding regions
can vary from gene to gene, but remains unaffected by a K4A or K36A mutation.
neg. control0
0
10
20
30
40
0
10
20
30
40
0
20
40
60
0
20
40
60
0
2
4
6
**
0
10
20
30
40
R
el
at
iv
e 
H
3.
3-
C
hI
P 
en
ric
hm
en
t 
0 hours 3 hours 6 hours
control
N
anog
R
ara
R
ps19
S
lc2a3
P
hc1
n.s.
n.s.
n.s.
n.s.
n.s.
K36A
K4A
K4R
WT
TES
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
Figure 3.12: H3.3K36 and H3.3K4A are not required for histone turnover at TES. ChIP-qPCR results
for H3.3-SNAP Biotin labeling experiment in cells harvested 0, 3, and 6 hours after H3.3 labeling. Relative
enrichment over input of H3.3 wild type, K4A, K36A and K4R (lysine to arginine) mutants was measured
at TES of indicated genes, or a gene-free region on chromosome 6 (control). Decrease in H3.3 enrichment
over time indicates exchange for newly synthesized (unlabeled) histones. Two biological replicates were
measured in 2 technical replicates (n=4), except for wild type H3.3 at timepoint 3 hours (n=2). P-values
were measured by Student’s t-test.
Pre-transcriptional H3.3 exchange at regulatory regions
The results from H3.3-ChIP-Seq analysis suggested that the depletion of H3.3K4A oc-
curs at regulatory regions, where histone exchange occurs pre-transcriptionally, but
not inside coding regions. Furthermore, the depletion occured at both active and
inactive promoters and therefore independent of Pol II transcription or occupancy.
Factors that contribute to the depletion should therefore be present at regulatory re-
gions, but not gene bodies. Possible explanations for the depletion could be: 1) The
H3.3K4A mutation interferes with initial chromatin deposition at regulatory regions
by H3.3-specific chaperones, or 2) the H3.3K4A mutation interferes with chromatin re-
modeling and pre-transcriptional histone exchange at regulatory regions, but not with
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co-transcriptional histone exchange inside coding regions. To address the first hypoth-
esis, I looked at the chaperone complexes which are responsible for H3.3 chromatin
assembly. The histone chaperone complex Hira is specific for assembly of newly syn-
thesized H3.3 into nucleosomes at both gene bodies and regulatory elements (Gold-
berg et al., 2010). Structural and biochemical data suggests that a H3.3K4A mutation is
unlikely to interfere with Hira function, because it recognizes the four variant amino
acids within the H3.3 core (Ahmad and Henikoff, 2002; Ricketts et al., 2015). Further-
more, the enrichment of H3.3K4A at gene bodies and TES remained unaffected (Fig.
3.10b), as opposed to H3.3 depletion at entire genic regions in Hira knockout cells
(Goldberg et al., 2010) (Fig. 3.13a).
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Figure 3.13: H3.3K4A mutation does not affect deposition by chaperones. (a) Analysis of H3.3 en-
richment at genic regions and enhancers in control and HIRA knockout (HIRAnull) ESCs. ChIPSeq data
was obtained from Goldberg et al. (2010) and sequencing reads per kilobase per million mapped reads
(RPKM) were calculated for active TSS (±1.5kb); gene bodies and TES (±1.5kb) of active genes; and ESC-
specific enhancers (Shen et al., 2012). RPKM levels higher than those of input indicate enrichment of
H3.3. (b) Interaction analysis between wild type and mutant H3.3 with histone chaperones Daxx and
Atrx. ESC lines were generated by stably integrating wild type or mutant H3.3 (K4A/K36A) with a
C-terminal HA-FLAG-tag into the Rosa26 locus (Perez-Pinera et al., 2012; Chu et al., 2016). MNase-
digested mono-nucleosomes were immunoprecipitated using anti-FLAG-beads for cell lines expressing
FLAG-tagged H3.3WT, H3.3K4A, H3.3K36 or in unmodified wild type cells (negative control) and mea-
sured by mass spectrometry analysis. Histone chaperones Daxx and Atrx were identified to bind mutant
and wildtype nucleosomes and log2(signal intensities) are displayed. n=2 biological replicates.
The other known chaperone of H3.3 is Daxx, which acts together in a complex with
the SWI/SNF-like chromatin remodeling protein ATRX (Drane et al., 2010; Lewis et al.,
2010; Xue et al., 2003). The Daxx/ATRX complex mediates H3.3 deposition into repet-
itive genomic regions such as pericentric DNA and telomeres (Drane et al., 2010;
Wong et al., 2010; Lewis et al., 2010), but not regulatory elements or genes (Goldberg
et al., 2010), suggesting that Daxx/ATRX complex is not responsible for the observed
H3.3K4A depletion. Furthermore, immunoprecipitation coupled with mass spectrom-
etry (IP-MS) analysis showed that both H3.3 wild type and H3.3K4A/K36A mutant
nucleosomes were still bound by both Daxx and ATRX (Fig. 3.13b). The chaperone
Hira was not detected in this experiment, likely because it binds free histone H3.3
rather than already assembled nucleosomes, which were mostly immunoprecipitated
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in this analysis. Together, these results and evidence from previous studies indicates
that the H3.3K4A mutation does not impair binding to known chaperons, nor initial
chromatin assembly in general.
Addressing the second hypothesis is more difficult, because chromatin remodeling
and histone exchange are mediated by many different remodeling complexes. To this
end, I identified remodelers that mediate chromatin remodeling pre-transcriptionally
(promoters/enhancers), but not co-transcriptionally (gene bodies) in mouse ESCs.
Analysis of publicly available ChIP-Seq data for chromatin remodelers in ESCs (de Dieuleveult
et al., 2016) showed that specific remodelers are enriched mostly inside coding regions
(Chd2, Chd6 and Chd9), whereas others are specifically enriched at promoters and
enhancers (Chd1, Chd4, Chd8, Brg1 and Ep400) (Fig. 3.14a). Of the latter category,
Ep400, Brg1 and Chd4 displayed a relatively narrow peak at the TSS and -/+1 nucle-
osome (de Dieuleveult et al., 2016), and only the remodeler Chd1 showed a broader
enrichment and occupied multiple nucleosomes around the TSS. This enrichment pat-
tern strongly resembled H3.3 WT enrichment around promoters of control cells (Fg.
3.14b). Comparison with the region of the H3.3K4A depletion showed that Chd1 was
strongly enriched throughout the entire region of the depletion, but not inside gene
bodies that display maintained occupancy by H3.3K4A (Fig. 3.14b). Interestingly,
Chd1 has been previously reported as a potential H3.3 chaperone in Drosophila (Konev
et al., 2007), but no evidence for a similar role in mammals has been reported at this
point. Human Chd1 has also been reported to be recruited by binding to methylated
H3K4 (Sims et al., 2005). In summary, Ep400, Brg1, Chd4, Chd8 and especially Chd1
are potential candidates that might be responsible for the depletion of H3.3K4A from
regulatory regions. Further experiments will be required to address if the mode of
action for these remodeling complexes depends on the lysine 4 residue of histone H3
for nucleosome binding.
62
3.2. Results
1
2
3
4
TSS 
(inactive)
TSS
(active)
gene
body
ESC
enhancer
C
hI
P
−S
eq
 re
ad
 d
en
si
ty
 (R
P
K
M
)
Input
Chd1
Chd2
Chd4
Chd8
Chd9
Ep400
Smarca4
0.
06
0.
08
0.
10
0.
12
0.
14
0.
16
R
ea
d 
co
un
t P
er
 M
ill
io
n 
m
ap
pe
d 
re
ad
s
−2000 TSS 33% 66% TES 2000
Chd1_rep1
Chd1_rep2
H3.3 WT
H3.3 K4A
Chromatin
remodeler
Figure 3.14: Remodelers Chd1, Chd4, Ep400, Smarca4 are enriched at regulatory regions and Chd1
displays a similar enrichment profile to H3.3 at promoters in ESCs. (a) Analysis of chromatin remodeler
enrichment in wild type ESCs at indicated genomic regions for Chd1, Chd2, Chd4, Chd8, Chd9, Ep400
and Smarca4. ChIP-Seq data was obtained from de Dieuleveult et al. (2016) and reads per kilobase per
million mapped reads (RPKM) were calculated for the following features: inactive TSS (±1.5kb), active
TSS (±1.5kb); gene body of active genes; ESC-specific enhancers. ESC-specific enhancers and activity
status of TSS based on Pol II occupancy were predicted by Shen et al. (2012). RPKM levels higher
than those of input indicate enrichment of the remodeling complex. Chd1, Chd4, Chd8, Ep400 and
Smarca4 are enriched at regulatory regions compared to gene bodies. ChIP n=1-2, Input n=1 biological
replicates. (b) Density profile of Chd1 and H3.3-ChIP-Seq reads over annotated genes. Chd1 ChIP-Seq
was performed in wild type ESCs and data was obtained from de Dieuleveult et al. (2016) (n=2). H3.3
ChIP-Seq was performed in H3.3 control and K4A ESCs as indicated. Reads per million mapped reads
were plotted over TSS, scaled gene bodies and TES using NGSplot (Shen et al., 2014).
Protein stability
The depletion of H3.3 at regulatory regions could suggest that K4A mutant histone is
less stable, therefore I investigated whether the H3K4 residue is required for histone
stability. Using specific antibodies recognizing either the variant H3.3 (wild type and
mutant) or canonical H3.1/H3.2, I tested the abundance of H3 histones during neu-
ronal differentiation (Fig. 3.15). In ESCs, protein levels of H3.3K4A were comparable
to the controls implying that the observed depletion at active regulatory regions was
not coupled with changes in total protein abundance. Surprisingly, H3.3K4A was less
abundant in NPCs and strongly reduced in neurons. Protein abundance of canon-
ical H3.1/H3.2 was not affected by this depletion and levels remained unchanged.
H3.3K36A mutant histone was stably expressed throughout differentiation compara-
ble to levels of wild type H3.3 in control cells.
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Figure 3.15: Lysine 4 residue is required for histone H3 protein stability in differentiated neurons.
Immunoblot of nuclear fraction of wild type, control and H3.3K4A/K36A mutants in ESCs and during
neuronal differentiation to detect levels of endogenous H3.3 protein. Embryoid bodies were obtained
on day 4, neural precursors on day 8 and neurons on day 12 of differentiation. Antibody is recognizing
endogenous H3.3 variant or canonical H3.1/H3.2. WT refers to unmodified ESCs with two H3.3 genes
intact; and control, K4A, K36A cells have H3.3A gene removed.
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Reduced protein abundance of H3.3K4A in neurons was not due to changes in the
RNA expression levels of this gene, as shown from RNA-Seq analysis (Fig. 3.16a).
In ESCs, RNA expression of H3.3K4A was significantly up-regulated, suggesting that
lower stability of the protein was compensated by higher gene expression and is there-
fore less obvious as measued by immunoblot (Fig. 3.15). Furthermore, gene expression
of the chaperone complexes was maintained in H3.3K4A neurons, suggesting that hi-
stone instability was not due to misregulation of chaperone expression (Fig. 3.15b).
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Figure 3.16: H3.3K4A instability is noe due to lower expression of H3.3-specific chaperones. (a)
Normalized RNA-Seq counts representing gene expression for H3.3B of controls, H3.3K36A, H3.3K4A
and wild type (WT) ESCs (left) and neurons (right). Depicted p values for differentially expressed genes
were calculated with DESeq2 and adjusted using Benjamini Hochberg’s method (padj). Significantly
lower gene expression of H3.3 in K36A ESCs and neurons is due to difficulties in mapping reads inside
the mutated exon to the wild type reference genome (5 nucleotide changes introduced). (b) Normal-
ized RNA-Seq counts representing gene expression for components of the histone chaperone complexes
Atrx/Daxx or Hira (Ubinuclein-1, Hira, Cabin-1) of controls, H3.3K36A, H3.3K4A and wild type (WT)
neurons. p values for differentially expressed genes were calculated with DESeq2 and adjusted using
Benjamini Hochberg’s method (padj) and padj values > 0.05 were consideres not significant (n.s.).
Ectopic expression of wild type and mutant H3.3 in human embryonic kidney cells
(HEK) 293T cells confirmed lower abundance of H3.3K4A protein, supporting that
lower expression was not due to differentiation defects or a developmental delay (Fig.
3.17). Furthermore, cellular fractionation followed by immunoblotting revealed that
H3.3K4A, but not H3.3K36A, was degraded selectively in the nuclear chromatin frac-
tion, but did not affect protein stability in the cytoplasm (Fig. 3.17b). Mutants mim-
icking acetylated lysine (H3.3K4Q) and non-acetylated lysine (H3.3K4R) were also de-
pleted in nuclear but not cytosolic fractions (Fig. 3.17c). Moreover, K4A substitution in
the canonical H3 protein (H3.1) also shows degradation comparable to H3.3K4A (Fig.
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3.17d). Inhibition of the proteasome by MG-132 treatment rescues protein levels of
H3.3K4A to those of wild type H3.3 in whole cell lysates (Fig. 3.17e). However, inhibi-
tion of the proteasome in ESCs could not rescue the observed site-specific depletion of
H3.3K4A from promoters, as measured by ChIP-qPCR (Supplementary Fig. S4), sug-
gesting that degradation occurs downstream of chromatin eviction. Taken together,
these results are consistent with the model that the H3K4 residue itself, and not its
charge state, maintains histone H3 protein stability of all H3 variants on chromatin.
Figure 3.17: Lysine 4 residue is required for histone H3 protein stability in HEK293T cells. (a) Scheme
for stability analysis of H3.3 mutants in HEK293T cells. Cells were transfected with H3.3 or H3.1 encod-
ing constructs. H3.3/H3.1 was fused to HA and FLAG-tag for antibody detection and is transcribed
together with P2A-GFP. Construct expresses two proteins, mostly nuclear H3.3-HA-FLAG and mostly
cytosolic P2A-GFP (expression control). (b) Immunoblots after cellular fractionation of HEK293T cells.
HEK293T cells were transfected with either wild type or K4A/K36A mutant H3.3. FLAG antibody was
used to detect H3.3 and GFP antibody is used as transfection control. (c) Immunoblots of cytosolic and
nuclear fractions of HEK293T cells. HEK293T cells were transfected with either wild type or K4A/R/Q
or K36A/R/Q mutant H3.3 (Q for mutation to glutamine and R for mutation to arginine). HA antibody
was used to detect H3.3 and GFP antibody is used as expression control. (d) Immunoblots of whole cell
lysates of HEK293T cells to measure expression of wild type compared to K4A mutant H3.1/H3.3. (e)
Immunoblots of whole cell lysates of HEK293T cells that were either untreated or treated with the pro-
teasome inhibitor MG-132 (5 µM for 5 hours) prior to harvesting. The expression of wild type compared
to K4A mutant H3.3-FLAG was detected with FLAG antibody and antibody against GFP was used as
expression control.
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3.2.3 The epigenetic landscape of H3.3K4A and H3.3K36A mutants
3.2.3.1 Assessment of global differences in histone modifications by immunoblot
and mass spectrometry
Presence of mutant histone H3.3 can alter global levels of histone methylation lev-
els. Especially lysine-to-methionine mutations in a fraction of H3 can act in a domi-
nant manner to deplete global methylation levels on the remaining wild type histones
(Herz et al., 2014). Immunoblotting of H3.3K36A mutant ESCs revealed a marked
reduction of H3K36me2 (10-fold), a moderate reduction of H3K36me3 (1.7-fold), a
moderate reduction of H3K27ac (2.6-fold), and an increase of H3K27me3 (4-fold) (Fig.
3.18a,b). In parallel, we used mass spectrometry to identify changes in the global
abundance of other H3 modifications (H3.1/H3.2) and confirmed the concomitant
change of H3K36me2, H3K36me3 and H3K27me3 (Fig. 3.18c). This crosstalk between
H3K27me3 and H3K36me2 is consistent with observed results in mesenchymal tumor
cells carrying a H3.3K36M mutation (Lu et al., 2016), which has been shown to result
in loss of H3K36 methylation and spread of repressive H3K27me3 to intergenic re-
gions (Streubel et al., 2018).
In H3.3K4A mutant ESCs, we only detected globally reduced levels of H3K4me3 (5-
fold) by immunoblotting, whereas other tested modifications remain unchanged (Fig.
3.18a,b). Also mass spectrometry analysis detected no significant effect of the H3.3K4A
mutation on other histone modifications present on wildtype H3.1/H3.2 (Fig. 3.18c).
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Figure 3.18: H3.3K36A mutation reduces global levels of H3K36me2/me3 and H3K27ac, and inversely
increases H3K27me3 levels, whereas H3.3K4A mutation reduces H3K4me3 levels. (a) Immunoblot
analysis of H3.3 control and K4A/K36A mutants using antibodies recognizing different modification
states of the N-terminal H3 tail (me - methylation, ac - acetylation). Antibodies are not specific for canon-
ical H3.1/2 or H3.3 variant, but recognize entirety of H3 histone. Protein samples were loaded 3x in
increasing amounts. H4 serves as loading control and one representative immunoblot is depicted. (b)
Western blot quantification of H3 modifications relative to H4. Log2(FoldChanges) of histone modifica-
tion were calculated normalized to H4 loading controls. (c) Volcano plot displaying global changes in
histone modifications in H3.3K36A (left) or H3.3K4A (right) mutants compared to controls. The abun-
dance of histone modifications was measured by middle-down mass spectrometry analysis of N-terminal
histone tails (Sidoli et al., 2014). Log2FoldChanges were calculated for canonical H3.1/H3.2 in mutant
ESC compared to control ESCs and plotted against -log2(p-values) derived from Student’s t-test. The 10
(K36A) or 7 (K4A) most significant modifications are depicted in black. H3K4me3 was not detected in
this analysis. n=3 biological replicates. Mass spectrometry analysis was done by Simone Sidoli.
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Turnover of histone modifications
In collaboration with Simone Sidoli in the laboratory of Benjamin A. Garcia, I tested if
the H3.3K36A mutation impacts the turnover of histone modifications. The turnover
is representative of how compacted the genomic regions are that are marked by a
specific histone modification. For this, we grew cells in heavy SILAC medium for
24 hours and measured the ratios of histone modifications on old (light) and newly
synthesized (heavy) histones. Surprisingly, we did not detect changes in turnover of
H3K27me3 or H3K36me2 (Fig. 3.19), despite the observed global changes in abun-
dance observed previously, and the predicted redistribution of H3K27me3 to inter-
genic regions. However, we observed significantly higher turnover rates of H3K27
acetylation (on canonical H3.1/H3.2) in H3.3K36A mutants (4-Fold change), which
was also globally reduced as measured by immunoblot (Fig. 3.18a,b) and mass spec-
trometry analysis (Fig. 3.19). The higher turnover rate suggests that chromatin regions
marked by H3K27ac are more open, resulting in the more rapid deposition of H3K27ac
onto newly synthesized histones. Possibly, the turnover of H3K27ac could be directly
or indirectly affected by the global decrease in H3K36me2 and spread of H3K27me3 in
H3.3K36A mutants. These results are preliminary and further experiments will be re-
quired to define this interactions. To this end, I propose to perform ATAC-Sequencing,
a technique that measures the accessibility of chromatin. In this way, I would test if
regions marked by H3K27ac are actually more open (higher turnover) in H3.3K36A
mutants.
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Figure 3.19: Analysis of turnover of histone modifications in H3.3K36A mutants by Mass Spec-
trometry. Scatter plot displaying changes in the abundance (x-axis) and the turnover (y-axis) of histone
modifications in H3.3K36A mutants compared to controls. The turnover is a measure for the chromatin
compaction state of genomic regions marked by a modification. ESCs were grown for 24 hours in heavy
SILAC medium and the abundance of histone modifications was measured by bottom-up mass spectrom-
etry analysis (Sidoli et al., 2014). The turnover was calculated from the ratio of heavy to light peptides
detected for each modification. FoldChanges were calculated in H3.3K36A mutant ESCs compared to
control ESCs. Some of the most significant modifications are depicted in black. n=3 biological replicates.
Mass spectrometry analysis was done by Simone Sidoli.
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3.2.3.2 ChIP-Seq analysis of region-specific histone modifications
H3.3K36A
H3K36me3 is enriched inside coding regions and has been proposed to regulate tran-
scriptional outcome and alternative splicing of the underlying gene (Wagner and Car-
penter, 2012). This association is based on observations that the H3K36 HMTase Set2
is recruited co-transcriptionally by Pol II (Li et al., 2003; Krogan et al., 2003) and de-
posit H3K36 methylation during transcriptional elongation, resulting in high levels of
H3K36me3 in gene bodies of actively transcribed genes (Kizer et al., 2005; Li et al.,
2003, 2002). However, it remains unclear whether the deposition of H3K36me3 in cod-
ing regions facilitates transcription and splicing, or whether it is just a by-product of
active transcription. To address these questions, I used ChIP-Seq and RNA-Seq in
wild type and H3.3K36A mutants and correlated changes of H3K36me3 inside genes
with gene expression in ESCs, during neuronal development (NPCs) and in terminally
differentiated neurons. I observed a positive correlation in ESCs (Pearson=0.3), neural
precursor cells (Pearson=0.6) and neurons (Pearson=0.4), but H3K36me3 levels do not
necessarily alter gene expression of the majority of genes (Fig. 3.20a). These results
suggest that H3K36me3 is deposited dependent on transcription, but that a reduction
in H3K36me3 levels, as induced by a H3.3K36A mutation, has a minor impact on gene
expression especially in undifferentiated ESCs. The increasing correlation in develop-
ing NPCs could indicate that Setd2 is recruited to developmental genes to mediate its
function there.
To test whether splicing is affected, I used DEX-Seq to identify differentially spliced
exons in K36A mutants compared to controls. In ESCs, I observed small numbers of
alternative splicing events (Fig. 3.20b), and the inclusion or exclusion of an exon did
not correlate with H3K36me3 levels inside the affected exon (Fig. 3.20c). K36A neu-
rons displayed more alternative splicing events than observed in ESCs (Fig. 3.20b), but
these events again did not correlate with H3K36me3 levels inside the exon (Fig. 3.20c).
This suggests that in our system, alternative splicing of an exon is not the consequence
of reduced or increased H3K36me3 levels.
69
Chapter 3.
Figure 3.20: H3K36me3 levels do not directly regulate gene expression or differential splicing. (a)
Scatter plot correlating genic H3K36me3 levels (ChIP-Seq) with gene expression changes (RNA-Seq) in
ESCs (D0), NPCs (D8) and neurons (D12). Significant Fold-changes (FDR < 0.05) of genic H3K36me3
levels (x-axis) are plotted against log2(FoldChanges) in gene expression (y-axis) measured in H3.3K36A
mutant cells compared to wild type cells. The colour of dots indicates whether gene expression changes
are significant (FDR < 0.05, absolute log2(FoldChange)>0.58) and numbers of significant changes are
indicated per quadrant. Pearson correlation coefficients (r) are depicted in plots. (b) Venn Diagram de-
picting total numbers of significant alternative splicing events in H3.3K36A ESCs and neurons compared
to controls. Analysis was done using DEX-Seq (Anders et al., 2012) with a significance threshold of
FDR<0.1. Biological replicates were n=2. (c) Boxplot depicting H3K36me3 levels in alternatively spliced
exons in H3.3K36A and control ESCs (left) and neurons (right). H3K36me3-ChIP-Seq reads per kilobase
per million mapped reads (RPKM) were calculated for exons that were significantly more included or
excluded from the mRNA, or for randomly selected exons that were not differentially spliced. Number
of analyzed genomic features (n) are depicted underneath boxplot. Significance was calculated using an
unpaired Wilcoxon test. All comparisons were not significant (n.s.).
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H3.3K4A
In mammalian cells, H3K4me1 is found at enhancer regions and H3K4me3 is a hall-
mark of promoters (Barski et al., 2007; Guenther et al., 2007; Mikkelsen et al., 2007).
Additionally, regulatory elements can be marked by H3K27ac, which is predictive of
their activity state (Rada-Iglesias et al., 2011; Bonn et al., 2012; Creyghton et al., 2010;
Wang et al., 2008).
H3.3K4A ESCs displayed widespread gene expression changes, and I investigated
whether changes in H3K4 methylation or H3K27 acetylation were causally involved
in these changes. I used ChIP-Seq to examine the genomic distributions of H3K27ac,
H3K4me1, H3K4me3, and H3.3 in control and H3.3K4A ESCs (Supplementary Fig.
S5), and correlated them with transcriptional changes of genes (Fig. 3.21). Cluster-
ing analysis of all datasets revealed that distinct biological GO term categories were
associated with groups of up- and down-regulated genes and histone modification
profiles (Fig. 3.21a and Supplementary Fig. S6a). Notably, H3.3K4A ESCs showed a
substantial decrease in H3K27ac that was highly correlated with H3.3 depletion at TSS
and promoter-proximal active enhancers (Fig. 3.21a). Moreover, the H3.3 depletion at
TSS and enhancers occurred regardless of differential gene expression changes (Fig.
3.21b), but the extent of the H3K27ac reduction correlated with gene expression, and
down-regulated genes displayed no or very low H3K27ac levels at their TSS compared
to other genes (Fig. 3.21b). The same trend was observed for promoter-proximal en-
hancers of up- and down-regulated genes, which both showed reduced H3K27ac, but
the extent of the reduction correlated with the expression of the proximal gene (Sup-
plementary Fig. S6b).
In contrast, H3.3K4A ESCs showed a significant increase of H3K4me1 signal at H3.3
depletion sites around TSS independent of gene expression changed (Fig. 3.21a). ESC-
specific enhancers displayed overall reduced levels of H3K4me1 (Fig. 3.21b), and at
promoter-proximal enhancers H3K4me1 levels correlated with gene expression of the
nearby gene (Fig. S6b). I found that H3K4me3 was mildly increased directly at the TSS
(Fig. 3.21a,b). Instead, H3K4me3 peaks that reside within or upstream/downstream
of genes, including enhancers, were significantly reduced (Supplementary Fig. S6b,c),
consistent with the observed global decrease of this mark detected by immunoblot
(Fig. 3.18a).
Collectively, the depletion of H3.3K4A occurred at all genes independent of transcrip-
tional alterations, and induced correlated changes in H3K27ac and anti-correlated
changes in H3K4me1 at TSS. The extent of H3K27ac reduction at promoters and en-
hancers was predictive of the differential gene expression status. The reduction in
H3K27ac levels could be the result of a destabilization of HATs, such as p300, by the
H3.3K4A mutation. The severity of this destabilization at genes might in turn be asso-
ciated with the transcriptional outcome in the K4A mutant. Alternatively, if H3.3K4A
is the target of acetylation, the removal of mutant H3.3 at depletion sites could also be
responsible for reduced H3K27ac levels. The increase in H3K4me1 could be the result
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of the replacement of H3.3 with canonical H3.1/H3.2, which might be the preferred
target for HMTases that catalyze H3K4me1.
My study revealed that a H3.3 lysine 36 mutation affected differentiation and tran-
scription at later stages of neurodevelopment, whereas H3.3 lysine 4 mutation lead
to widespread changes in both the histone modification landscape and transcription
program in ESCs, which resulted in impaired neuronal differentiation. In particular,
the H3.3K4A mutation caused a significant decrease in H3K27ac at active regulatory
elements, which is not observed in H3.3 knockdown cells (Banaszynski et al., 2013),
and clearly differentiates the effect of the mutation from a loss-of-function phenotype.
Despite the overall decrease of H3K27ac enrichment at active regulatory regions, the
extent of H3K27ac reduction at promoters correlated with changes in gene expres-
sion, suggesting that subsets of genes were more affected by the H3.3K4A mutation.
Furthermore, I showed that lysine 4 itself is crucial for enrichment of H3.3-containing
nucleosomes at TSS and active enhancers in ESCs. This result suggests that the cel-
lular machinery mediating nucleosome exchange/remodeling at regulatory elements
depends on H3 lysine 4 itself. I also found that in differentiated cells, the depletion of
H3.3K4A was not restricted to regulatory regions, but resulted in widespread protea-
somal degradation of the mutant histone from the chromatin fraction, strongly arguing
that lysine 4 is required for stability.
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Figure 3.21: H3.3K4A mutation induces histone modification changes at regulatory elements. (a)
Heatmap clustering of differentially expressed genes in H3.3K4A mutants (FDR<0.05). Genes were
grouped by RNA expression changes and signal intensity changes of H3.3, H3K27ac, H3K4me1,
H3K4me3 ChIPSeq data using k-means clustering. Clusters 1-5 contain up-regulated genes (n=2859)
and 6-10 downregulated genes (n=3196). Representative GO-terms are indicated per cluster (full list in
Supplementary Fig. 1.2). Gene length is indicated by colour (left). RNA-expression values are z-scored
across samples and based on normalized read counts per gene. Biological replicates for RNA-Seq n=3
(ctrl), n=4 (K4A). For ChIP-Seq, changes in signal intensity (K4A vs ctrl) were plotted from 5 kb up-
stream of the TSS (500bp per window) and for scaled gene bodies (10% of gene per window). Biological
replicates for ChIPSeq n=2 (ctrl), n=3 (K4A). (b) Analysis of H3K4me1, H3K4me3, H3K27ac and H3.3
enrichment in control and H3.3K4A ESCs at TSS and enhancers. ChIP-Seq reads per kilobase per million
mapped reads (RPKM) were calculated for TSS (±1.5kb) of differentially expressed genes and unchanged
genes, and for all ESC-specific enhancers (Shen et al., 2012). Differential gene expression status for up-
and down-regulated genes was determined by RNA-Seq analysis in H3.3K4A ESCs compared to control.
Number of analyzed genomic features (n) are depicted underneath boxplot. RPKM levels higher than
those of input indicate enrichment of the histone modification. ChIP n=3, Input n=2 biological replicates.
Boxes display median RPKM values, third and first quartile, whiskers show 1.5 × the interquartile range
above and below the box. Daria Bunina performed clustering analysis of combined RNA-Seq and ChIP-Seq data
and generated heatmap displayed in (a).
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3.3 Discussion & Outlook
In yeast and Drosophila, systematic mutation of histone H3 has proven to be an invalu-
able tool to discern the functional role of a histone residue. In humans, the study of
oncogenic histone mutations has recently emerged and helped in understanding the
function of histone residues in healthy and diseased cells (Lu et al., 2016; Fang et al.,
2016; Chan et al., 2013; Lewis et al., 2013). These oncogenic mutations often occur in
only one allele of the histone variant H3.3, but nevertheless can have severe conse-
quences on the epigenetic landscape of cells and can contribute to the development of
cancer (Schwartzentruber et al., 2012; Wu et al., 2012; Behjati et al., 2013). Thus, muta-
tions of the histone variant H3.3 could provide a suitable system to test the functional
role of histone residues in mammalian development, without the need to exchange
the canonical H3 genes. Using this system, we aimed to test whether histone mod-
ifications, such as H3K36me3, H3K4me3, H3K27me3 and H3K27ac, which strongly
correlate with transcriptional activity (Barski et al., 2007; Guenther et al., 2007; Heintz-
man et al., 2007), are causally involved in mammalian transcription and to identify
uncharacterized functions of histone residues.
In this study, I used the mutation of histone residues K4 and K36 to complement the
studies that have perturbed the respective histone modifying enzymes, thereby assess-
ing their contributions to chromatin regulation. This strategy has been successful in
the past to unravel the functions of a HMTase from that of the deposited histone mod-
ification, as seen for pioneering histone mutation studies in Drosophila melanogaster,
which have delivered evidence for the role of H3K27me3 and H3K27ac for transcrip-
tional regulation. Mutations of H3K27 to arginine (H3K27R) in wing imaginal disc
cells of Drosophila melanogaster fail to repress transcription of PRC2-target genes and
these flies display morphological differences similar to PRC2 mutants (Pengelly et al.,
2013). At the same time, H3K27R mutant cells do not show widespread transcriptional
changes of other genes or impaired transcriptional activation (Pengelly et al., 2013;
McKay et al., 2015). While these results emphasize the importance of H3K27me3 for
transcriptional repression by PRC2 (Young et al., 2011), it also suggests that transcrip-
tional activation might not require H3K27 acetylation on canonical H3 (Pengelly et al.,
2013; McKay et al., 2015). It is a compelling idea that H3K27ac is only a byproduct
of histone acetyl-transferase p300, whose relevant targets include transcription factors
and the Pol II complex itself (Imhof et al., 1997; Weinert et al., 2018; Schroder et al.,
2013; Haberle and Stark, 2018).
Alternatively, it would be possible that acetylation of histone variant H3.3, which re-
mained intact in this Drosophila study, might be sufficient to promote transcriptional
activation. Nonetheless, a H3.3 knockdown study in mouse ESCs did not result in
reduced H3K27ac enrichment at promoters (Banaszynski et al., 2013), arguing that
H3K27ac can be sufficiently maintained by canonical H3 in ESCs and that H3.3 deple-
tion itself does not result in a decrease of H3K27ac.
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In H3.3K4A mutant ESCs, I observed a reduction of H3K27ac enrichment, which was
highly correlated with depletion of mutant H3.3 from regulatory regions. This poses
the question how a H3.3K4A mutation can have such a severe impact on H3K27ac at
active promoters and enhancers. H3K4 methylation is highly correlated with H3K27ac
at active regulatory regions, suggesting that H3K4 HMTases and HATs function in
proximity to each other. Thus, the H3.3K4A mutation could directly or indirectly
destabilize the binding of HATS, such as p300, to regulatory regions, thereby per-
turbing gene expression and resulting in the reduction of H3K27ac levels at sites of
H3.3K4A depletion.
Transcriptional regulation by H3K4 methylation
H3K4 methylation is associated with regulatory regions of the genome and the degree
of methylation differs depending on the genomic site. H3K4me1 is highly enriched
at enhancers and H3K4me3 is a hallmark of promoters (Heintzman et al., 2007). In
yeast, H3K4me3 only marks promoters of actively expressed genes (Santos-Rosa et al.,
2002; Ng et al., 2003), whereas in mammalian cells H3K4me3 marks both inactive and
active promoters (Barski et al., 2007; Guenther et al., 2007; Mikkelsen et al., 2007), and
its implication in transcription is less clear. Recently, the pervasive enhancer mark
H3K4me1 has been shown to be dispensable for enhancer activity and gene regula-
tion by HMTases in pluripotent cells and Drosophila development (Dorighi et al., 2017;
Rickels et al., 2017). In these two studies, the authors used catalytically dead enzymes
to analyze if the H3K4 HMTases Mll 3 and 4 can mediate their regulatory function at
enhancers independent of their HMTase activity. Indeed, they found that enhancer ac-
tivity, as measured by enhancer RNA synthesis by Pol II, and regulation of associated
genes can occur in the absence of H3K4me1 deposition. Similarly, H3K4me3 at pro-
moters of constitutively active genes was shown to be dispensable for gene transcrip-
tion in mouse ESCs (Clouaire et al., 2012, 2014). Such data demonstrate the need of
directly testing the function attributed to histone residues, rather than relying purely
on correlation or indirect inference from phenotypes of mutant enzymes that catalyze
modifications (Pollex and Furlong, 2017).
Efforts to understand the role of H3K4 methylation for transcription have been made
in Drosophila by Hödl et al. The authors have replaced H3K4 with alanine in canonical
and variant H3 of D. melanogaster and the results suggest that gene regulation and tran-
scription can occur in the absence of H3K4 methylation (Hodl and Basler, 2009, 2012).
H3K4A wing imaginal disc cells can respond to developmental cues by activating key
transcription factors, but the mutant cell patches remain small and display a strongly
diminished proliferative capacity. Similarly, mutations of H3K4 to alanine or arginine
in Saccharomyces cerevisiae result in slow-growth defects, which are also observed for
deletions of the sole H3K4 HMTase, Set1 (Briggs et al., 2001). This data suggests that
H3K4 HMTases regulate transcription often independent of histone methylation, but
H3K4 might have other uncharacterized functions that are relevant for normal cell sur-
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vival and growth. In agreement with this, H3.3K4A ESCs in this study maintained the
ability to activate developmental genes and repress pluripotency genes during neu-
ronal differentiation, but displayed reduced fitness and a developmental delay. As a
result, H3.3K4A mutants yielded lower cell numbers in differentiation and were not
able to give rise to a homogenous population of glutamatergic neurons. Furthermore,
the transcriptional program of H3.3K4A ESCs and neurons was severely perturbed,
and this was not due to diminished H3K4me3 or H3K4me1 levels at promoters and en-
hancers. Instead, the H3.3K4A mutation resulted in depletion of H3.3 from regulatory
regions, which may explain the minor impact of the mutation on H3K4 methylation
levels.
Histone exchange
The reasons for the depletion of H3.3K4A from regulatory regions is less obvious. The
mutation is unlikely to affect initial chromatin assembly of newly synthesized H3.3 by
its chaperone Hira, which does not bind the histone tail, but instead recognizes four
variant amino acids in the folded histone core (Ahmad and Henikoff, 2002; Ricketts
et al., 2015). Several chromatin remodeling complexes have already been identified to
also act as histone chaperones that can assemble H3 into nucleosomes (Konev et al.,
2007; Pradhan et al., 2016; Lewis et al., 2010). In proliferating cells, H3.3 is enriched
at genomic sites with active histone exchange (Kraushaar et al., 2013; Deaton et al.,
2016) and H3.3K4A mutant protein might interfere with the action of some chromatin
remodeling complexes.
Co-transcriptional histone exchange inside coding regions occurs more slowly and
is mediated by different proteins, which catalyze restructuring of the nucleosome
before and behind transcribing Pol II. Histone modifications in newly deposited hi-
stones, such as methylation of H3K36, have been reported to suppress histone ex-
change in coding regions of the yeast genome (Smolle et al., 2012; Venkatesh and
Workman, 2015), suggesting that H3K36 methylation could be important for recycling
of old histones during transcriptional elongation. Unlike the yeast study, I did not
observe that the deposition, or the enrichment of H3.3K36A or H3.3K4A inside cod-
ing regions of ESCs was impaired compared to wild type H3.3. Furthermore, mutant
H3.3K4A/K36A was not exchanged more rapidly at TES than wild type H3.3. To-
gether, these results indicate that H3K4 and H3K36 methylation of histone H3.3 is not
required for histone recycling behind transcribing Pol II in mammals.
Compared to coding regions, histone exchange at regulatory regions occurs in the
absence of transcription (Venkatesh and Workman, 2015) and higher turnover rates fa-
cilitate transcription factor binding and assembly of the transcriptional machinery on
DNA (Henikoff, 2008). In ESCs, specific chromatin remodeling complexes have been
shown to preferentially bind at regulatory regions (de Dieuleveult et al., 2016) and it
is possible that one or multiple of these remodelers depend on the H3K4 residue for
histone exchange and nucleosome re-assembly at regulatory regions. Comparison of
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the enrichment profiles of these remodelers revealed that Chd1 occupies similar nucle-
osomes as H3.3 at promoters. Chd1 is evolutionary conserved from yeast to humans,
and human Chd1 has developed the ability to distinguish and bind different H3K4
methylation states (Sims et al., 2005) compared to its yeast counterpart. The H3K4
residue might be required for viability in animals, because it is recognized by one or
multiple chromatin remodelers that mediate histone exchange processes at regulatory
regions of higher organisms, e.g. Chd1.
Interestingly, in differentiated cells depletion of H3.3K4A was not restricted to regu-
latory elements and I observed widespread degradation of H3.3K4A in the chromatin
fraction. Chromatin of differentiated cells is more compacted than ESCs and the ac-
tion of chromatin remodeling complexes might be increasingly important in differ-
entiation at all chromatin types to enable cellular plasticity and access to the DNA
template. Furthermore, differentiating cells are proliferating more slowly than ESCs
and increasingly depend on the H3.3 variant for replication-independent nucleosome
assembly (Maze et al., 2015). Functional analysis of the association of chromatin re-
modelers and mutant H3.3K4A will be required to address the question how and if
histone exchange is involved in the observed depletion of H3.3K4A.
Transcriptional regulation by H3K36 methylation
The co-transcriptional recruitment of H3K36 HMTases during transcriptional elon-
gation results in high levels of H3K36 methylation at gene bodies. Because of the
association with active transcription, H3K36me3 is generally viewed as an activating
modification that facilitates alternative splicing and transcriptional elongation, e.g. by
preventing cryptic transcription initiation from inside coding regions (Carrozza et al.,
2005; Fang et al., 2010; Dhayalan et al., 2010). In H3.3K36A mutant ESCs, transcrip-
tion remained largely unaffected and resulted in only few differentially expressed
genes and alternative splicing events, despite a significant reduction in H3K36me3
levels. While I observed increasing numbers of differentially expressed genes and al-
ternative splicing events in H3.3K36A neurons compared to ESCs, these events were
not directly regulated by H3K36me3 levels. These results suggest that transcriptional
elongation and alternative splicing are not directly affected by changes in H3K36me3
levels inside coding regions. However, changes in H3K36me3 levels moderately cor-
relate with changes in transcription (H3.3K36A mutant vs. control), supporting the
co-transcriptional deposition of H3K36me3 by HMTases. Furthermore, I observed the
highest correlation between changes in H3K36me3 levels and changes in transcription
in neural precursor cells, suggesting that Setd2, which is the only HMTase depositing
H3K36me3 (Yuan et al., 2009; Edmunds et al., 2008), might be recruited during the
activation of developmental genes to mediate its function.
Our findings are in agreement with histone mutation studies in Drosophila, in which
H3K36R mutant embryos did not show perturbed transcriptional elongation by cryp-
tic transcription initiation or alternative splicing (McKay et al., 2015). Thus, the role of
77
Chapter 3.
H3K36 methylation in transcriptional elongation might not be conserved from yeast
to flies and mammals, or the HMTases might have evolved to mediate these function
independent of H3K36 methylation. However, H3K36R mutant larvae die before the
completion of development (Meers et al., 2017), which is also observed for the deple-
tion of dSet2, the sole H3K36 HMTase in Drosophila (Stabell et al., 2007). Similary, the
loss of Setd2 in mice results in early embryonic lethality by severe vascular defects
(Hu et al., 2010). This suggests that H3K36 HMTases have a developmentally essential
function that directly depends on H3K36 methylation.
PRC2 activity
Furthermore, H3K36 methylation has been suggested to restrict the activity of PRC2
and prevent expansion of repressive H3K27me3 to active chromatin, because H3K36
and H3K27 methylation are mutually exclusive for the same nucleosome (Young et al.,
2011; Schmitges et al., 2011; Yuan et al., 2011). H3K36 mutations have been shown
to inhibit the activity of H3K36 HMTases in vitro (Lu et al., 2016). Specifically, the
oncogenic H3.3K36M (lysine-to-methionine) mutation dominantly inhibited the major
H3K36 HMTases Setd2 and Nsd1/2, and thereby reduced all three methylation states
of H3K36, which resulted in spread of repressive H3K27me3 to intergenic regions (Lu
et al., 2016). The H3.3K36A (alanine) mutation showed a more pronounced inhibitory
effect on Nsd1/Nsd2 in vitro, which deposit only H3K36me1/me2 (Yuan et al., 2009;
Edmunds et al., 2008). In agreement with this, we observed that H3K36me2 on total
H3 is the most reduced histone mark in H3.3K36A ESCs, suggesting that H3.3K36A
does indeed have a dominant inhibitory effect on Nsd1 and/or Nsd2 in vivo.
Additionally, H3.3K36A mutant ESCs displayed a global gain of H3K27me3, which
supports the role of H3K36 methylation to restrict PRC2 activity. In agreement with
this, inhibition of the H3K36 HMTase Nsd2 has been shown to cause a switch in
H3K36me2-occupied chromatin domains to H3K27me3-occupied domains, strongly
arguing that H3K36me2 specifically restricts H3K27me3 (Streubel et al., 2018). This
role of H3K36me2 in restricting PRC2 might be limited to mammals, because a H3K36
to arginine (H3K36R) mutation in Drosophila does not result in a global increase of
PRC2-mediated H3K27me3 (McKay et al., 2015; Meers et al., 2017), or the H3K36R mu-
tation might sufficiently mimic methylated H3K36. Surprisingly, these severe changes
in the epigenetic landscape had no major impact on the transcriptional program of
ESCs, whereas gene expression was perturbed only at later stages of neuronal devel-
opment. The restriction of PRC2-mediated H3K27me3 might not be as important in
pluripotent ESCs, which have been shown to have a more open and permissive chro-
matin state compared to differentiated cell types (Bhattacharya et al., 2009; Bickmore
and Zaret, 2010; Mattout and Meshorer, 2010; Meshorer and Misteli, 2006). During
differentiation, chromatin gets more compacted, and the distribution of H3K36 and
H3K27 methylation might contribute in setting a balance of active and repressed chro-
matin states.
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Cell proliferation and growth
The oncogenic histone mutation H3.3K36M is detected in over 95% of chondroblas-
tomas (Behjati et al., 2013), which are characterized by the accumulation of immature
chondroblasts and the growth of this cancer has been suggested to arise from uncon-
trolled proliferation and incomplete differentiation of mesenchymal progenitor cells
(Lu et al., 2016). Similarly, I observed that H3.3K36A neurons in this study were less
committed to the glutamatergic lineage and grew to a much higher density compared
to wild type neurons. Interestingly, similar tissue overgrowth phenotypes have also
been observed in human diseases with underlying mutations in a H3K36 HMTase
(Kurotaki et al., 2002). Specifically, loss-of-function mutations of Nsd1 are the ma-
jor cause of Sotos syndrome (Tatton-Brown et al., 2005; Douglas et al., 2003; Cecconi
et al., 2005), which is characterized by pre-natal and post-natal overgrowth, distinc-
tive facial appearance, advanced bone age and developmental delay of mental and
movement abilities. Strikingly, the affected children tend to grow quickly and have
unusually large heads, which could indicate neuron over-growth (Tatton-Brown et al.,
2005; Cecconi et al., 2005). It would be interesting to test if deletions of Nsd1 result
in an increased density of the neuron population as observed for the H3.3K36A muta-
tion, which would suggest that the H3K36 HMTase activity of Nsd1 and thus H3K36
methylation is required to restrict organism growth and uncontrolled cell prolifera-
tion. Together, this suggests that the H3K36 residue is important to restrict cell growth
by facilitating lineage commitment of cells into the terminally differentiated cell type.
While the exact mechanism of H3.3 turnover has yet to be elucidated, this study iden-
tifies a direct link between a specific histone residue (H3K4) and histone enrichment
at promoters and enhancers. In the light of the growing list of H3 mutations asso-
ciated with human diseases, this study shows that endogenous H3.3 mutations can
serve as an experimental platform to study the functional role of histone residues in
mammalian development.
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3.4 Materials & Methods
Cell culture. HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Thermo Fisher) containing 10% fetal bovine serum. Murine ESCs (129XC57BL/6J)
were cultured in ESC media containing Knockout-DMEM (Thermo Fisher) with 15%
EmbryoMax FBS (Millipore) and 20 ng/ml leukemia inhibitory factor (LIF, produced
by Protein Expression Facility at EMBL Heidelberg), 1% non-essential amino acids,
1% Glutamax, 1% Pen/Strep, 1% of 55 mM beta-Mercaptoethanol solution. Cells were
maintained at 37°C with 5% CO2. ESCs were routinely tested for mycoplasma. For
ESC growth assay, cells were seeded at a density of 104 cells per well. Per cell line
12 wells were seeded on day 0. Two wells per cell line were trypsinized and counted
daily for a total of 6 days, while the remaining wells received fresh media. Growth
curves were generated using the averaged duplicate cell counts.
Neuronal differentiation. ESCs were differentiated into glutamatergic neurons ac-
cording to Bibel:2007 with small modifications. 4x106 ESCs were resuspended in 15
ml differentiation media without LIF (regular DMEM supplemented with 10% FBS
(Gibco), 1% non-essential amino acids, 1% Glutamax, 1% Pen/Strep, 1% Sodium
Pyruvate) and grown in suspension using non-adherent bacteriological petri dishes
(Greiner, 633102, 10 cm with vents) to promote the formation of embryoid bodies.
Differentiation media was changed every two days. For this embryoid bodies were
transferred to 50 ml Falcon tubes, collected at the bottom of the tube by allowing them
to settle within 5 minutes. Supernatant medium was removed and EBs were resus-
pended in 15 ml fresh differentiation media and transferred to a new bacteriological
petri dish. On day 4, 5 µM retinoic acid was added to the media. Embryoid bodies
were cultured for 4 additional days in the presence of retinoic acid to obtain neural pre-
cursor cells on differentiation day 8. Embryoid bodies were dissociated with trypsin
and cells were plated in N2 media composed of regular DMEM supplemented with
1xN2 and 1xB27-VitaminA (Thermo Fisher) at a density of 2x105 cells/cm2. For neural
culture, plates were pre-coated with Poly-D-Lysine (Sigma) and Laminin (Roche). N2
media was changed every two days without exposing neuron culture to air. Four days
after plating, neurons were harvested after a total of 12 differentiation days.
RNA-Seq analysis. RNAs were extracted from approx. 1x106 cells using RNeasy
Kit (Qiagen), followed by DNase digestion using TURBO DNase (Thermo Fisher).
mRNAs were isolated from 1 µg of total RNA using a PolyA selection kit (NEB) and
sequencing libraries were prepared following instructions from NEBs Ultra Library
Preparation Kit for Illumina. All samples were barcoded, pooled and sequenced on
a HiSeq2000 Sequencer (Illumina) using a 50 bp single-end run. Sequencing reads
were mapped to mouse reference genome (mm10 assembly) using Tophat2 aligner
with default settings for single-end reads. Reads per gene were counted using HT-
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SeqCount union or intersection_nonempty mode. We used Ensembl gene annotation
Mus_musculus.GRCm38.83. Differential gene expression analysis was carried out us-
ing DESeq2 (Love et al., 2014). Genes with a FDR of FDR<0.05 were considered dif-
ferentially expressed. For visualization of gene expression changes, gene counts were
normalized using DESeq2 and plotted per gene. Enrichment analysis for GO terms
associated with biological processes was performed using topGO package using dif-
ferentially expressed genes with FDR<0.05 and absolute log2(FoldChange)>0.58. Sig-
nificantly enriched GO terms were identified using Fisher classic and Fisher elim al-
gorithm. Numbers of biological replicates used are indicated underneath each figure.
For Fig. 3.6 two biological replicates were used to detect differentially expressed genes
to compare between timepoints and conditions. For heatmap in Fig. 3.21, three bio-
logical replicates for control and 4 biological replicates for K4A mutants were used to
calculate differentially expressed genes.
SNAP experiment. ESC lines stably expression H3.3-SNAP were generated using a
p2lox plasmid containing cDNA of H3.3 (wildtype or mutant) with a C-terminal HA-
and SNAP-tag. H3.3-HA-SNAP was integrated into the hprt locus of A2lox.Cre ESCs
(Iacovino et al., 2011) according to instructions in Deaton et al. (2016). A2lox.Cre ESCs
were treated with 500 ng/ml doxycycline for 24 hours, nucleofected (Lonza) using 2
µg of p2lox-H3.3-HA-SNAP plasmid and plated on drug-resistant MEFs. 24 hours af-
ter nucleofection, cells were treated with 300 µg/ml G418 for 7 days. Visible colonies
were picked and screened for integration of H3.3-HA-SNAP using immunoblotting.
For biotin pulse-labelling experiment, cells were expanded and H3.3-SNAP expression
was induced by the addition of doxycycline for 48 hours. ESC were harvested and 30
x106 cells were incubated in 150 µl of media supplemented with 10 µM SNAP-Biotin
(NEB) for 30 min at 37°C. Cells were washed twice by resuspension in 10 ml of fresh
media followed by centrifugation at 1100 rpm, 4 min. Cells were resuspended in 10
ml media and incubated for 30 min at 37°C to allow unbound biotin to soak out.
Cells were washed one last time. For time point 0 hrs, 30x106 cells were harvested,
for later time points 30x106 cells were re-plated in a 15 cm plate and harvested after
3 or 6 hours, respectively. Cell lysates were prepared from 30 x106 cells for native ChIP.
Native ChIP. DNA for native ChIP was digested by MNase treatment to obtain mainly
mononucleosomes and a fraction of dinucleosomes using a modified protocol from
Barski et al. (2007). In each sample, 107 cells were resuspended in digestion buffer,
treated with 100 U MNase (Worthington) and incubated at 37°C for 5 minutes while
shaking at 500 rpm. Samples were immediately moved to ice and MNase was quenched
by addition of EDTA. Lysates were sonicated using Bioruptor Pico (Diagenode) and
dialyzed against RIPA buffer for 3 hours at 4°C. Insoluble materials was pelleted at
10,000rpm for 10 min, 4°C and supernatant was used as input for ChIP. To check
that mostly mono-nucleosomes and di-nucleosomes were obtained, DNA fragment
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sizes of inputs were analyzed by agarose gel electrophoresis. 5% of inputs were set
aside for sequencing. For native ChIP of histone modifications, Protein-G-Dynabeads
(Invitrogen) were pre-coated with antibodies for 4 hours at 4°C. For ChIP we used
the following antibodies: H3K4me1 (39297, active motif), H3K4me3 (39915, Active
Motif), H3K27ac (39685, Active Motif). For SNAP-Biotin ChIP we used MyOne-
StreptavidinT1-Dynabeads (Thermo Fisher). Beads were added to lysates and ro-
tated over night at 4°C. On the next day, beads were washed and finally rinsed with
TE+50mM NaCl Buffer. Samples were eluted from ProteinG Dynabeads using SDS-
elution buffer (50 mM Tris-HCl ph8.0, 10 mM EDTA, 1% SDS) at 65°C for 30 minutes,
shaking at 1500 rpm. For streptavidin dynabeads, samples were eluted at 65°C for 10
min followed by incubation 85°C for 10 min while shaking at 1500rpm. Proteinase K
was added (0.2 mg/ml final) to eluted samples and digestion was carried out for 2
hours at 55°C followed by PCR purification (Qiagen).
Crosslink-ChIP. For H3.3-ChIP, 106 cells were harvested and resuspended in 20 ml
of 1% fresh paraformaldeyde (PFA) diluted in PBS and rotated for 10 min at room
temperature. Unreacted PFA was quenched with glycine. Cells were washed twice
to remove PFA. Lysates were prepared by resuspending crosslinked cells in hypotonic
buffer (15 mM HEPES pH8, 5 mM MgCl2, 10 mM KCl, 0.5mM EDTA, 2x Protease
Inhibitors) followed by douncing to release intact nuclei. Nuclei were pelleted and
resuspended in digeston buffer (15 mM HEPES pH8, 5 mM MgCl2, 30 mM KCl, 3mM
CaCl2, 2x Protease Inhibitors) by douncing. In-nuclei MNase digestion was started
by addition of 150U MNase (Worthington). Samples were then quickly vortexed and
incubated at 37°C for 5 min while shaking at 500 rpm. Reaction was quenched by
addition of 10x Quenching buffer (150mM HEPES pH8, 1500mM NaCl, 50 mM EDTA,
30 mM EGTA, 0.2% TritonX-100) and by placing samples on ice. 0.1% sodium de-
oxycholate, 0.5% sarcosine and 1% Triton-X were added to lysates and samples were
sonicated in Bioruptor Pico (Diagenode) to further promote DNA fragmentation. In-
soluble material was removed by centrifugation at 20.000rpm for 10 min, 4°C and the
soluble supernatant was used as ChIP Input. DNA fragment sizes of lysates were
checked by agarose gel electrophoresis. Mainly mono-, di-, tri-nucleosomes were ob-
tained. Protein-G Dynabeads were precoated with H3.3 antibody (Millipore) for 4
hours at 4°C. Beads were washed, added to lysates and incubated over night at 4°C
while rotating. On the next day, beads were washed 8x with RIPA buffer (50 mM
HEPES pH7.6, 100 mM LiCl, 1 mM EDTA, 1% NP-40, 0.7% Sodium deoxycholate) and
gently rinsed once with TE buffer+50 mM NaCl. Elution was carried out using SDS
elution buffer (50 mM Tris-HCl pH8.0, 10 mM EDTA, 1% SDS) at 65°C for 30 minutes
while shaking samples at 1500rpm. Samples were Proteinase K digested (0.2 mg/ml
final) for 2 hours at 55°C and crosslink was reversed over night at 65°C. Samples were
purified using Qiagen’s PCR purification kit and used for ChIP-library preparation.
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ChIP-Seq Data Analysis. Sequencing libraries were prepared using DNA Ultra II
library preparation kit (NEB) according to the manufacturer’s instructions and se-
quenced either on Illumina’s HiSeq2000 Sequencer (50 bp single-end mode) or NextSeq
500 Sequencer (75 bp single-end mode). Sequencing reads were aligned to mouse ref-
erence genome (mm10 assembly) using Bowite2 (Langmead and Salzberg, 2012). Only
non-duplicated, uniquely mapped reads were retained for further analysis. ChIP-Seq
peak calling was done using MACS2 (Zhang et al., 2008) (for H3K4me1, H3K4me3,
K3K27ac) or SICER (Xu et al., 2014) (for H3.3). Differential peak calling of ChIP-
datasets for H3.3K4A mutants and controls was done using R and DiffBind package
(Bioconductor). Reproducibility between ChIP-Seq replicates was assessed by PCA
analysis on binned and library size normalized bigwig files using deeptools (Ramirez
et al., 2016). PCA plots and Differential Peak analysis for ChIP-Seq experiments are
found in Supplementary Fig. S5. Metagene plot to visualize distribution of ChIP-Seq
density over scaled gene bodies was generated using NGSplot (Shen et al., 2014). For
Boxplot in Fig. 3.10, genomic coordinates of predicted ESC-specific enhancers and en-
hancers of other tissue-types were obtained from Shen et al. (2012). To obtain genomic
windows, enhancer coordinates were extended by ±1kb. Active TSS were defined
as annotated RefSeq TSS±1.5kb that display Pol II occupancy in ESCs and inactive
TSS±1.5kb as those without Pol II occupancy in ESCs (Shen et al., 2012). Genome
coordinates were lifted to mm10 using UCSC’s LiftOver Tool. TES of active genes (at
least one active TSS) were defined as ±1.5kb around gene end coordinates obtained
from Ensembl biomart (version: “Ensembl Genes 91”). Gene bodies were defined
from gene start coordinates+1.5kb until gene end coordinates-1.5kb as obtained from
Ensembl biomart. ChIP-Seq reads or Input-reads in defined regions were counted
using multiBamSummary (deepTools) and normalized to sequencing depth and gene
length to obtain RPKM values in R.
For ChIP-Seq heatmaps in Fig. 3.21, read coverage for each sample was normalized
by the total number of reads, then average coverage for each feature was calculated
for all mutant (or control) samples and subtracted from each other to get the final
score. The locations of TSS and TES of differentially expressed genes were taken from
Ensembl biomart. The heatmap was produced in R using a pheatmap package. For
the boxplots in the Supplementary Fig. S6 we calculated the fold change of similarly
obtained average coverage scores for mutant vs. control samples within each region of
interest. TSS regions were defined as ±1.5kb from the gene start position, TES regions
- as ±1.5kb from the gene end position. Gene bodies were defined from TSS+1.5kb
until TES-1.5kb (for genes shorter than 3 kb the entire TSS to TES region was taken).
Enhancers were selected from the list of predicted ESCs-specific enhancers14 overlap-
ping the region 0-50kb upstream of the gene’s TSS.
ChIP-qPCR. Prepared libraries from ChIP experiment were diluted 1:20 and used
as input for qPCR reaction with SYBR Green PCR Master Mix (Applied Biosystems).
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qPCR was performed on a StepOnePlus Real-Time PCR machine. For each condi-
tion we used two biological replicates (ChIP material from two different Knock-in Cell
lines) which were measured in technical duplicates. The following qPCR primers were
used:
Nanog_TSS: F 5-CATGAGTGTGGGTCTTCCTG, R 5-CAGAATTCGATGCTTCCTCA;
Nanog_TES: F 5-AGTTGGAATGGCCTGGTAAC, R 5-TCCAGTTCTTGACTGGATGC;
Rara_TSS: F 5-GGAATCTAAGCCACGGAGAA, R 5-GTCACCGAGCACTTCCTTTT;
Rara_TES: F 5-ATTCTGGGAAAGGAGAGCTG, R 5-CAAGGACTGGCTTCCTCTCT;
Rps19_TSS: F 5- GCATGGGTTTGGATTTATGG, R 5-AGGCCTCAGTTCCAACAAAC;
Rps19_TES: F 5-GCTGCCAACAAGAAGCATTA, R 5-ACCAAAACCAGATCCAGACC;
Rpl6_TSS: F 5-TAACCAGCAGGAGTTCGTCA, R 5-TGCTCTAGCACGGGACACTA;
Rpl6_TES: F 5-GGCTTTGGATTAGAGGCACA, R 5-GCAAAACCACAGCCACAGTA;
Phc1_TSS: F 5-GCAAAAGATGTGGGGAGAAA, R 5-ACTCTGGGACCGAACAAATG;
Phc1_TES: F 5-AGGGTCACCAGCCATCATAG, R 5-TGCAGAAAGAATGGCAACAG;
Slc2a3_TSS: F 5-TGCTCCGGTTTCTCCTAAGT, R 5-TATCGAATTGCTTGCTGGAG;
Slc2a3_TES: F 5-TCAGACCCTTTAGGCAAACC, R 5-CACAGGGAGTGGAGAGTTGA;
GD_Chr6: F 5-ACGCCATATACAGCAAACCA, R 5-GCCTTGACTTGTCCCTGATT
Immunofluorescent staining. Immunofluorescence staining was performed by Marlena
Lübke. A modified protocol from Hycult biotech (Version: 04-2010) was used for
IF staining. Neurons were grown on coverslips and on neuronal differentiation day
12, the cells were fixed in PBS with 2% paraformaldehyde (Electron Microscopy Sci-
ences) for 20 min at RT, rinsed three times with PBS, and permeabilized with ice-cold
methanol for 10 min at -20 °C. Cells were incubated with primary antibody in PBS+2%
BSA for 60 min and then incubated with 1:200 diluted Alexa Fluor 594-conjugated sec-
ondary antibody for 30 min at room temperature. Cells were then counterstained with
100 ng/ml DAPI for 5 min and coverslips were mounted on slides with Prolong Gold
antifade reagent (Life Technologies). Primary Antibodies in this study include MAP2
(M9942, Sigma), Sox2 (AB5603, UBI) and secondary antibodies Alexa Fluor 594 goat
α-rabbit or α-mouse (A11012 and A11005, Life Technologies). Images were taken with
an Olympus ScanR (IX81, cube4, 10x UplanSApo NA 0.4 Air, Dapi: Ex: 347/50 EM:
460/50 (AHF F31-000 Set Dapi), Cy3: Ex: 545/30 EM: 610/72 (AHF F46-04 Cy3 ET
Set)). Image analysis was done in Fiji. For the depicted images the contrast was en-
hanced as follows: MAP2 (0.7%)/DAPI (2.5%), Sox2 (1%)/DAPI (3 %).
Cell cycle analysis. Cell cycle analysis was performed by Marlena Lübke. The percent-
age of proliferating cells in S-Phase was measured using the The Click-iT Plus EdU
Alexa Fluor 488 Flow Cytometry Assay Kit (Invitrogen, C10632) in ESCs (D0), NPCs
(D8), immature neurons (D9) and mature neurons (D12). Cells in 6-well plate were
incubated in media supplemented with 10 µM EdU for 1 hour at 37°C. As a negative
staining control, DMSO was used instead of EdU. ESCs were harvested by trypsiniza-
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tion. Neurons were harvested by removing half the media, adding cOmplete protease
inhibitor (P.I., Roche, 11873580001) to a final concentration of 1x, and using a cell lifter
to detach the neurons. The cells were washed once with PBS/1% (w/v) BSA. For
fixation, 100 µl Click-iT fixative was added to the cell pellets for 15 min at room tem-
perature in the dark. Cells were stored temporarily in PBS/1% (v/v) formaldehyde
(Merck, 1.04003.1000) at 4°C until analysis. For permeabilization cell pellets were re-
suspended in 1 x Click-iT saponin-based permeabilization and wash reagent for up to
15 min. The Click-iT Plus reaction cocktail (PBS, copper protectant, fluorescent dye
picolyl azide, reaction buffer additive) was added for 30 min at room temperature in
the dark, followed by a wash with 1 x Click-iT saponin-based permeabilization and
wash reagent. Cells were then stained for DNA content by adding a final concentra-
tion of 1 µg/µl DAPI in 500 µl 1 x Click-iT saponin-based permeabilization and wash
buffer. On D0 and D12 the cells were incubated at 4 °C for 2 h before FACS analysis
and an additional measurement was performed after 3 days. On D8 and D9, the DAPI
staining was done solely overnight. A BD LSRFortessa was used for FACS and FlowJo
for subsequent data analysis.
Histone extraction and mass spectrometry analysis of histone modifications. I col-
lected and purifief histone samples and mass spectrometry data collection and analysis was
performed by Simone Sidoli. Histones were purified from 107 ESCs by acidic extraction
as described by Sidoli and Garcia (2017); Sidoli et al. (2014). Briefly, cell nuclei were iso-
lated by using a nuclear isolation buffer enriched with protease/deacetylase/phosphatase
inhibitors and 0.2% NP-40. Histones were extracted using 0.2M H2SO4, and they were
precipitated with 33% trichloroacetic acid. Histones were digested with the protease
GluC at an enzyme:sample ratio of 1:20 at room temperature overnight in 5 mM am-
monium acetate (pH:4.0). Samples were loaded onto a 150x0.075 mm nanocolumn
in-house packed using Hypercarb™ Porous Graphitic Carbon (Thermo Scientific) us-
ing an EasyLC-1000 nanoHPLC (Thermo Scientific, San Jose, CA, USA) coupled online
with an Orbitrap Fusion mass spectrometer (Thermo). Histone tails were separated us-
ing a 90 min gradient from 10% to 15% buffer B (buffer A: 0.1% formic acid, buffer
B: 80% acetonitrile, 0.1% formic acid). The flowrate for the analysis was set to 300
nL/min. Data acquisition was performed in the Orbitrap for both precursor and prod-
uct ions, with a mass resolution of 60,000 for MS and 30,000 for MS/MS. MS acquisi-
tion window was set at 665-705 m/z. Only charge state 8+ was accepted for MS/MS
fragmentation. The isolation width was set at 2 m/z. The most intense ions with
MS signal higher than 5,000 counts were isolated for fragmentation using ETD with
an activation time of 20 msec. Data processing was performed as described in Sidoli
et al. (2014). Briefly, spectra were deconvoluted with Xtract (Thermo) and searched
with Mascot (v2.5, Matrix Science, London, UK), including mono- and dimethylation
(KR), trimethylation (K) and acetylation (K) as dynamic modifications. The histone se-
quence database was customized to include mutated forms. Mass tolerance was set to
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2.1 Da for precursor mass and 0.01 Da for product mass. Mascot results were filtered
for unambiguous identifications and peptides were quantified using the latest version
of isoScale (Sidoli et al., 2017). For turnover experiment in Fig. 3.19, ESCs were grown
for 24 hours in ESC medium supplemented with heavy L-Arginine-HCl (13C- and
15N-labeled amino acid, Thermo Fisher 89989) prior to harvest. Histones were cleaved
by tryptic digestion and analyzed by mass spectrometry as described previously. The
ratio of heavy (newly synthesized histones) and light (old histones) was calculated to
determine turnover.
H3.3-FLAG-Immunoprecipitation. ESC lines stably expression tagged H3.3 were gen-
erated using CRISPR-mediated integration into the Rosa26 gene locus (Perez-Pinera
et al., 2012; Chu et al., 2016). We generated a MCS-Rosa26 plasmid (37200, Addgene)
containing cDNA of H3.3 (wildtype or mutant) with a C-terminal HA-FLAG-tag and
a self-cleaved P2A-GFP. A Guide sequence targeting Rosa26 locus19 was cloned into
pSpCas9(BB)-2A-GFP (PX458, Addgene). For integration 2x106 ESCs were transfected
with 2 µg Cas9-GFP plasmid and 2 µg MCS-Rosa26 plasmid using electroporation
(Nucleofector, Lonza). Bulk cell sorting was performed 48 hours and 4 days post-
electroporation for GFP positive cells. Single-cell sorting was performed after 8 days
post-electroporation. Clonal cell lines were screened for integration of H3.3-HA-FLAG
using immunoblotting. ESC were harvested and 108 cells were lysed using hypotonic
lysis buffer and douncing to release nuclei. DNA was fragmented using MNase di-
gestion in nuclei to obtain mostly mononucleosomes. Soluble fraction was used as
input for immunoprecipitation. Magnetic M2 Flag-beads (Thermo Fisher) were added
to lysates and incubated over night while rotating. On the next day, Flag-beads were
washed and samples were eluted for 30 min at 4°C using Flag-peptide. Eluates were
processed for mass spectrometry analysis by the proteomics facility of EMBL Heidelberg. Specif-
ically, Frank Stein performed the data analysis. In brief, for quantitative comparison be-
tween wildtype and mutant H3.3, samples were labeled using TMT and labelled pep-
tides were measured. Measured peptides were mapped and quantified by MaxQuant
software (Tyanova et al., 2016). Data was normalized by applying a variance stabiliza-
tion normalization method with the R package vsn (v 3.44) and analyzed using R. As
negative control, unmodified wild type cells without tagged H3.3 were used (back-
ground for knock-in cell lines).
Plasmid construction and HEK293T cell ectopic expression. Wildtype H3.3 or H3.1
cDNA sequences were cloned into pBluescript(+) to introduce point-mutations at
H3K4 and H3K36 using standard site-directed mutagenesis techniques. For expression
in HEK293T cells, cDNA sequences were subcloned into pcDNA3.1-CMV or Rosa26-
EF1α-MCS. HEK293T cells were transfected with H3.1/H3.3-encoding plasmids using
Fugene (Promega) or Lipofectamine3000 (Thermo Fisher) reagent. Cells were har-
vested after 48 hr post-transfection for protein expression analysis.
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Protein extraction. Whole cell lysates were prepared by resuspending cell pellets
in SDS loading dye and DNA was fragmented by sonication with EpiShear Sonicator
(Active Motif). For subcellular fractionation into cytoplasma, nucleoplasm and chro-
matin, one 10 cm plate of HEK293T cells or 10x106 ESCs were fractionated according
to Conrad et al. (2014) with small adjustments. To pellet nuclei or chromatin, cen-
trifugation speed was reduced to 1000xg. Chromatin pellet was resuspended directly
in SDS loading dye to extract proteins and samples were sonicated until viscosity
was reduced. Nucleoplasm and cytoplasm fraction were diluted in SDS-loading dye
and sonicated if required. For crude nuclear extraction, cells were resuspended in
PBS+0.05% Triton-X and rotated for 30 min at 4°C to lyse cells. Nuclei were pelleted
by centrifugation at 1000xg for 5 min at 4°C, resuspended in SDS loading dye and
sonicated. For inhibition of the proteasome, HEK293T cells or mESCs were treated at
a final concentration of 5 µM MG-132 for 4 hours prior to harvesting.
Immunoblotting. Prepared lysates were separated in MES buffer on precast 4–12%
Bis-Tris SDS-PAGE gels (Thermo) and transferred onto nitrocellulose membranes. Blots
were incubated overnight with primary antibodies, for 1 hour with HRP-conjugated
secondary antibody and developed using enhanced chemiluminescent substrate (Thermo
Fisher). In this study we used the following antibodies: H3K4me1 (39297, active mo-
tif), H3K4me3 (39915, active motif), H3K27ac (39685, Active Motif), H3K27me3 (9733,
Cell Signaling), H3K36me3 (ab9050, abcam), H3K36me2 (07-369, Millipore), H3.3 (09-
838, Millipore), H3 (ab18521, abcam), H4 (ab10158, abcam), FLAG-M2 (F3165, Sigma),
HA (ab9110, abcam) and secondary antibodies goat anti-mouse IgG-HRP (1721011,
BioRad), goat anti-rabbit IgG-HRP (1706515, BioRad).
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Figure S1: Gating strategy for Cas9-GFP-positive cells flow cytometry analysis. Representative gating
strategy for an untransfected wild type cells is displayed. Single cells were chosen for analysis after
doublet discrimination by detection of disproportions between cell size (FSC-A) vs. cell signal (FSC-H).
The same cell displays higher correlation on the two axis (FSC-A/SSC-A and FSC-H/SSC-H) and all
singlet events will fall more on a diagonal than doublets. Transduced GFP-positive cells can be detected
outside of the negative population of cells measured with a 488-530 nm laser.
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Figure S2: In vitro differentiation of ESCs into mature glutamatergic neurons. Bright field images
cells during neuronal differentiation into mature glutamatergic neurons according to a modified protocol
developed by (Bibel et al., 2007). Cells are grown in suspension for 4 days without LIF, resulting in cell
accumulation into embryoid bodies, which grow larger in size over a course of 8 days. The addition of
retinoic acid to the medium directs the cells towards the neuronal lineage, yielding neuronal precursor
cells on day 8. Neural precursors are dissociated and plated to give rise to terminally differentiated
glutamatergic neurons after 12 days of total differentiation.
FSC-A
SS
C-
A
DAPI - Height
355 - 450 nm
D
A
PI
 - 
A
re
a
35
5 
- 4
50
 n
m
 
DAPI - Area
355 - 450 nm
Ed
U
 - 
FI
TC
48
8 
- 5
30
 n
m
S-Phase
67.2%
G2/M-Phase
9.03%G1/G0-Phase
19.3%
Single Cell Intact Cell EdU and DAPI  (+/-) cells
Figure S3: Gating strategy for cell cycle analysis by flow cytometry. Wild type ESCs were labeled with
EdU to detect proliferating cells and with DAPI to measure DNA content. Single cells were detected by
analysing the DAPI cell area versus the DAPI height, singlets fall on the diagonal between the two axis.
Intact cells were selected by comparison of cell size (FSC-A) and cell granularity (SSC-A). For detection
of cell cycle phase, EdU signal (incorporation of EdU into DNA during S-Phase) was compared to DAPI
(DNA content). Experiment was performed by Marlena Lübke.
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Figure S4: Proteasomal degradation is not responsible for H3.3K4A depletion at TSS. H3.3-ChIP-
qPCR results control and K4A mutant ESCs that were either untreated or treated with the proteasome
inhibitor MG-132. Relative enrichment of H3.3 was measured at the promoter (TSS) of the highly ex-
pressed genes Nanog and Rps19. H3.3K4A is depleted compared to control and depletion is not rescued
by MG-132 treatment. Enrichment of H3.3 is depicted relative to the untreated control. Ct values were
normalized to a intergenic region.Experiment was performed by Marlena Lübke.
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Figure S5: Quality control of ChIP-Seq data. (a) PCA analysis plots displaying differences/similarities
between samples for H3.3-, H3K27ac-, H3K4me1- and H3K4me3-ChIP-Seq experiments. PCA analysis
was done on binned and library size normalized bigWig files. (b) MA-plot displaying logFoldChanges
in signal intensities in ChIP-Seq data of H3.3K4A mutants compared to controls. Sites that are identified
to be significantly differentially (FDR < 0.05) bound are shown in red and were identified using DiffBind
package. Total number of significant changes (more or less bound than control) are depicted each plot.
Plots in this figure were generated by Daria Bunina.
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Figure S6: Promoters and enhancers of differentially expressed and unchanged genes are similarly
affected by H3.3 depletion, but H3K27ac reduction correlates with gene expression in H3.3K4A mu-
tants. (a) Gene ontology terms (biological processes) significantly enriched in each of the indicated
clusters of differentially expressed genes from the heatmap in Fig. 3.21. (b) Distribution of histone
marks at enhancers and TSS in the vicinity of either differentially expressed genes in K4A mutants (up-
or down-regulated) or unchanged genes (random). TSS represent ±1.5kb around gene start site and
promoter-proximal enhancers are ESC-specific enhancers overlapping region 0 to 50kb upstream of the
gene start site. Boxplots show the distribution of the log2 fold change of the average ChIP-Seq signal be-
tween K4A mutant and control cell lines. Boxes display median log2 fold change, third and first quartile,
whiskers show 1.5 × the interquartile range above and below the box. (c) Boxplot displaying signifi-
cant FoldChanges of H3K4me3 signal in H3.3K4A mutant relative to controls. Significant differentially
methylated regions of H3K4me3 were detected using the DiffBind package (FDR < 0.05) and grouped
based on their location relative to the nearest gene. Numbers of significant differential peaks are depicted
each box. Boxes display median fold change, third and first quartile, whiskers show 1.5 × the interquar-
tile range above and below the box, dots represent outliers. Daria Bunina performed clustering analysis of
combined RNA-Seq and ChIP-Seq data and generated plots seen in (a) and (b).
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